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Type 1 diabetes (T1D) is an autoimmune disease affecting millions of people 
worldwide, wherein the insulin producing pancreatic islets are destroyed. Shortage of donor 
cells, combined with immune rejection, limits transplantation as a viable therapy. However, 
human pluripotent stem cells (hPSCs) have the capacity to become any cell type, and the 
potential to provide an unlimited supply of hPSC-derived insulin producing cells. Additionally, 
immune rejection is still a hurdle which must be overcome before hESC-based therapy for T1D 
can be brought to fruition. It is therefore necessary to develop suitable culture and 
differentiation strategies which employ cell encapsulation with an appropriate material which 
can protect the new insulin producing cells from the body’s immune system and is supportive of 
hPSC biomanufacturing.  
Alginate encapsulation has been previously used for providing the needed immune 
protection of donor insulin-producing cells for transplantation. Therefore, in this work we first 
showed that alginate encapsulation supports efficient differentiation of hPSCs to insulin 
producing cells, and also significantly enhanced maturation of hPSCs compared to 2D 
controls. Previous studies for islet encapsulation have also shown that alginate hydrogel 
composition significantly affects the capacity for immune isolation. However, such capsule 
compositions could modify the differentiation of the encapsulated cells. Thus, we next
University of Pittsburgh, 2017
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evaluated the effect of capsule composition on material properties and thus on pancreatic 
differentiation of encapsulated hESCs. Our results clearly showed that even in the presence of 
chemical differentiation factors, substrate stiffness greatly affects the efficiency of pancreatic 
differentiation. Taking this a step further, we developed a high throughput 3D alginate array 
platform that allowed for multivariate perturbations of insoluble differentiation cues, namely 
alginate stiffness and cell-cell contact, during pancreatic differentiation. Our results 
accordingly indicated that while stiffness did influence proliferation and pancreatic 
differentiation, the effect of cell-cell contact was more significant.  
Finally, we developed an e-cadherin mimicking peptide-conjugated alginate substrate 
which mimics cell-cell contact, to meet the biomanufacturing needs of hPSCs. The designed 
biomimetic substrate supported single cell survival and propagation, as well as maintained hPSC 
pluripotency and differentiation potency. Overall, the findings from this dissertation represent 
a significant advancement in strategies supporting the propagation and pancreatic 
differentiation for biomanufacturing of hPSCs as an effective cell therapy treatment for T1D. 
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1.0  INTRODUCTION 
1.1 TYPE 1 DIABETES 
Type 1 diabetes (T1D) is an autoimmune disease which constitutes approximately 5-10% of all 
diabetes cases, wherein the immune system destroys the insulin producing β-cells in the islets of 
Langerhans in the pancreas [1]. This leaves the individual dependent on a regular insulin supply, 
and blood glucose levels can no longer be properly controlled without exogenous intervention. 
Decreased, or complete loss of insulin production, results in high blood glucose levels.  This can 
lead to nerve, kidney, eye, or even foot damage. Current treatment options include exogenous 
insulin injection, whole organ pancreas transplantation, or pancreatic islet transplantation. 
Exogenous insulin injections require regular patient compliance and are inconvenient.  An 
alternate option is transplantation of donor pancreata, which offers a more permanent solution. 
However, this requires a complicated surgical procedure often performed in conjunction with 
kidney transplantation. Encouragingly, in 2000, Shapiro et al. showed that T1D patients could be 
returned to normoglycemia after islet transplantation while on regular immunosuppression, 
known as the Edmonton Protocol,  establishing islet transplantation as a promising diabetes 
therapy [2].  
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Pancreatic islets of Langerhans consist of 3D cluster of five different endocrine hormone 
producing cell types (Figure 1.1). The insulin producing beta cells are most predominant, 
followed by glucagon producing alpha cells. .  
 
Figure 1.1 Schematic of Islet of Langerhans anatomy [3]. 
In addition islets consist of a small population of somatostatin producing delta cells, and 
pancreatic polypeptide producing cells. Each of these endocrine cells work in concert to regulate 
blood glucose levels through hormone production and regulation. 
However, as with any other organ transplantation, patients with islet transplantations 
were still required to be on regular immunosuppression treatments. Additionally, 
immunosuppression is also required to combat the abnormal patient autoimmune response to the 
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new insulin producing cells. This leaves the patient immune deficient and thus, at a high risk for 
infection. While the Edmonton protocol has shown success in restoring normoglycemia, regular 
immunosuppression leaves the patient unable to fight infection. As an alternative strategy, 
isolation of islets from the patient’s immune system has been proposed to overcome the need for 
the use of immunosuppressants. A well-studied approach to immunoisolate implanted primary 
islets for T1D treatment is to encapsulate the donor islets within a material which acts as a 
semipermeable membrane. This allows for the diffusion of nutrients and waste, but isolates and 
protects the cells from the larger immune cells [4-7].   
1.2 ALGINATE ENCAPSULATION 
Many materials have the capacity to form a semi-permeable hydrogel for encapsulation and 
immunoisolation of islets, including alginate, polysulphone, poly(ethylene glycol), 
dimethylaminoethyl methacrylate-methyl methacrylate copolymer, and poly(vinyl alcohol) [8]. 
However, alginate has been the most widely used naturally derived material as it is non-toxic, 
chemically inert, non-degradable, easily forms a hydrogel under mild conditions, and cells can be 
encapsulated with high viability, while still having excellent biocompatibility. Alginate is a 
naturally derived copolymer composed of guluronic (G) and mannuronic (M) acid, which forms 
a 3D network when divalent cations bind with the G residues of two adjacent polymer chains 




Figure 1.2. Schematic of alginate structure and immunoisolation.  
(A) Alginate chemical structure and schematic representation of hydrogel formation when exposed to a 
cation such as calcium [10]. (B) Schematic of islet immunoisolation using the semi-permeable alginate 
hydrogel [11]. 
This material is a chemically inert non-degradable polymer, but most importantly, it has the 
capability to immunoisolate encapsulated cells (Figure 1.2B) [9]. These characteristics make it 
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an ideal encapsulation system for islet transplantation, and thus, it has been utilized extensively 
for this purpose [5, 12-23]. The seminal study by Lim and Sun in 1980 was the first to utilize 
alginate encapsulation of islets, for the treatment of streptozotocin-induced diabetes in rats [6]. 
Since then, alginate has been used for cell encapsulation extensively, as well as for drug/protein 
delivery [24-27], and wound dressing [28, 29]. The physical properties of alginate capsules can 
be modulated by changing the synthesis parameters during capsule formation [30]. This is done 
primarily by altering the alginate and cation cross linker types and the ensuing concentration of 
each. Alginates are available in varying ratios of G/M content, as well as molecular weights.  
The G/M ratios can vary widely, but is typically classified as either low G (~25-35%) or high G 
(~65-75%) content [9]. For cell encapsulation, alginate concentrations used are typically between 
1-3% [31-35]. Alginate type and concentration can affect capsule properties and thus can 
influence cellular response.  Additionally, cross linker type and concentration can also be used to 
further modulate the physical properties of the alginate capsules [36]. The most common cation 
cross linker is calcium, but larger divalent cations such as barium and strontium are also used. 
Increasing the cation concentration will increase the stiffness of the resulting capsule because the 
G residues are more highly cross linked, and this is further enhanced by cations such as barium 
which have higher binding affinity [36, 37].  
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1.3 HUMAN PLURIPOTENT STEM CELLS  
1.3.1 General Background and pancreatic differentiation 
Although islet encapsulation can protect the cells from the host immune response, this treatment 
option is limited in its wide spread applicability due to the shortage of donor organs. In addition 
to the shortage of donor organs, due to the loss of islet viability after harvesting and 
transplantation, it takes approximately 2-3 pancreata worth of islets to return a diabetic patient to 
normoglycemia [38]. However, human pluripotent stem cells (hPSCs), either human embryonic 
stem cells (hESCs) or induced pluripotent stem cells (iPSCs), have the potential to alleviate this 
problem. hPSCs have two unique characteristics which make them highly valuable for tissue 
engineering and cell therapy applications: (1) they can self-renew indefinitely and (2) have the 
ability to differentiate into any cell type in the body, known as pluripotency. hPSC differentiation 
is achieved by mimicking the stages of in vivo development in the laboratory setting. Cells are 
first committed to one of the three germs layers, definitive endoderm (DE), mesoderm, or 
ectoderm, by modulation of key cell signaling pathways (Figure 1.3).  
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Figure 1.3. Schematic of hESC differentiation [39]. 
Generation of the desired functional cell type is then accomplished by subsequent stage wise 
differentiation through necessary progenitor stages. Current strategies have revealed the 
feasibility of deriving functional islet-like cells from hPSCs, thereby enabling the feasibility of 
replacing donor islets by hPSC-derived islets for the treatment of T1D. 
Our laboratory, as well as others, have developed stage-wise pancreatic differentiation 
protocols which mimic major stages of pancreatic development. Undifferentiated hESC are first 
differentiated to the definitive endoderm (DE) germ layer, followed by further induction to a 
pancreatic progenitor (PP) stage, and finally to mature insulin producing cells (MAT).  Previous 
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studies have focused on the induction of islet-like cells from hESCs primarily on tissue culture 
plastic (TCP), a two-dimensional monolayer (2D) platform, by the stage-wise addition of soluble 
chemical factors in the culture medium [40-45]. However, more recently the benefits of 3D 
culture configurations are gaining appreciation in tissue engineering in general and stem cell 
differentiation in particular. Specifically for pancreatic differentiation, the Melton group and the 
Kieffer group have reported significant breakthroughs in generating glucose responsive insulin 
producing β-cells from hPSCs in vitro, using 3D cell aggregate configurations [46, 47]. While 
this will overcome the cell source restriction, the next step towards successful clinical translation 
of hPSC-derived β cells for T1D therapy will require protection of the cells from the host 
immune system [48]. Additionally, while these studies have been successful in deriving insulin 
producing cells from hPSCs, they are not directly translatable for type 1 diabetes treatment. 
1.3.2 Alginate Encapsulation for the culture and differentiation of hPSCs 
Encapsulation of ESCs has been an active area of research over the last decade. We hypothesize 
that the implementation of this culture strategy is supportive of scalable culture, as well as fulfills 
the requirement of immunoisolation, necessary for type 1 diabetes therapy. The majority of the 
efforts, however, have been restricted to mouse embryonic stem cells (mESCs) and its 
differentiation to various cell types [49-51]. Since platforms established for mESCs cannot be 
directly translated to hPSCs; targeted platforms need to be developed to handle issues associated 
with hPSC encapsulation. Alginate encapsulation has previously been shown to support long 
term hESC propagation [52], as well as prevent teratoma formation in mice [53]. Additionally, 
alginate encapsulation has also been shown to support differentiation to the endoderm germ layer 
[54], midbrain neurons [55], and retinal cells [56]. These studies clearly establish the potential 
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benefits in encapsulating hESCs and demonstrate the feasibility of inducing early differentiation 
in these encapsulated hESCs.  
Alginate encapsulation provides an environment during differentiation which is 
drastically different from conventional adherent culture on TCP. Cells cultured on TCP 
experience a stiff and noncompliant environment, while cells encapsulated in alginate experience 
a more compliant environment. The cellular response is further influenced by the alginate 
capsule physical properties. The seminal 2006 study by Engler et al. showed that mesenchymal 
stem cell (MSC) lineage specificity could be controlled by substrate stiffness [57]. Cells cultured 
on soft substrates mimicking the brain committed to neurogenic phenotype, while cells cultured 
on stiffer substrates mimicking muscle or bone, committed to myogenic and osteogenic 
phenotypes, respectively. It has become clearly evident that hPSC differentiation is controlled by 
both soluble factors, as well as insoluble factors, such as substrates stiffness, interactions with 
extracellular matrix proteins, and cell-cell interactions (Figure 1.4) [58, 59].    
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Figure 1.4. Schematic of culture stimuli which can influence hPSC fate [60]. 
As mentioned previously, the properties of alginate capsules can be easily modulated by alginate 
and cation type and concentration, and thus can be utilized to influence cell response. Wilson et 
al. showed that encapsulation of preformed mESC aggregates in either high G or high M content 
alginate resulted in delayed differentiation of cells encapsulated with high G content alginate 
[31]. Lee et al. have shown that encapsulation of preosteoblast cells differentiated more 
efficiently when alginate concentration increased from 1% to 2%, but cell proliferation decreased 
[61]. Banerjee et al. have shown that decreasing calcium concentration while maintaining 
constant alginate concentration resulted in a decrease in elastic moduli and an increase in 
proliferation and differentiation of encapsulated neural stem cells [62]. Previous studies for islet 
encapsulation have shown that alginate capsule composition has a significant effect on the 
materials capacity to immunoisolate [63]. On the other hand, as discussed above, such capsule 
composition can modify the differentiation of the encapsulated cells. 
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1.4 HUMAN PLURIPOTENT STEM CELL BIOMANUCFACTURING AND LARGE 
SCALE CULTURE 
hPSCs have the capacity to differentiate into all mature cell types, making them attractive 
candidates for cell therapy based regenerative medicine [64]. Current success in deriving various 
functional cell types from hPSCs, including beta cells [46, 47], neurons [65], cardiac cells [66], 
and retinal epithelial cells [67], have moved the field closer to realizing its clinical potential. To 
date, 11 clinical trials involving hPSC-based therapies have been registered with the NIH, 
including trials for treatment of diabetes, Parkinson’s disease, heart failure, and macular 
degeneration, among other therapeutic targets.  While current clinical trials are primarily using 
laboratory scale culture and propagation methods of hPSCs, such methods will be restrictive for 
large scale clinical translation of hPSCs. Hence, the first step towards biomanufacturing of 
therapeutic hPSCs will be to ensure controlled, scalable propagation of hPSCs with reduced 
variability and retained pluripotency.  
Laboratory scale productions of hPSCs utilizes adherent culture, and has been 
traditionally conducted on TCP coated with Matrigel, an ECM extract from mouse sarcoma cells. 
Since Matrigel is a poorly defined animal product, there has been extensive recent effort to 
replace it with xeno-free, chemically defined  recombinant protein based substrates, which are 
compatible with downstream cell-therapy applications [68, 69]. However, recombinant proteins 




1.4.1 Current approaches for large scale hPSC biomanufacturing 
Current approaches towards scalable culture of hPSCs include planar culture on adherent 
surfaces and suspension cultures [70]. Planar cultures offer precise control of the cell 
microenvironment but are limited in their throughput, and require enormous surface area to 
produce clinically relevant cell numbers [71, 72]. On the other hand, suspension 3D culture 
systems have the potential for large scale non-linear hPSC expansion. Current suspension 
cultures use either microcarriers for adherent cells or culture hPSC aggregates in suspension [73, 
74]. Microcarrier culture consists primarily of hPSCs attached to protein coated polymer spheres; 
however, controlling microcarrier agglomeration and harvesting of cells from the carrier is a 
limitation of this technology. Suspension cultures are highly scalable; but controlling aggregate 
size and preventing multi-aggregate coalescence is difficult. Further, in both of these platforms, 
cells are exposed to hydrodynamic shear stress when cultured in a bioreactor, which can result in 
uncontrolled spontaneous differentiation, increased variability and also enhanced cell death [75-
77]. Hence, in current 3D culture methods it is difficult to ensure controlled hPSC propagation 
with reduced variability. 
Finally, use of single cell hPSCs, to date, results in high cell death, thereby compromising 
its potential for clonal expansion.  Single cell hPSCs trigger the apoptotic pathway upon losing 
cell-cell contact. A critical requirement for hPSC survival and proliferation is the tight cell-cell 
contact, the absence of which results in ROCK pathway activation, actomyosin hyperactivation, 
and ultimately dissociation induced apoptosis. This effect can be somewhat overcome through 
chemical inhibition of the ROCK pathway, which still results in over 50% cell death upon 
dissociation [78]. The Rho/ROCK signaling cascade is initiated by dissociation of the 
transmembrane glycoprotein E-cadherin, a primary homophilic adhesion molecule responsible 
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for hPSC survival [79]. Thus current culture strategies often require hPSC colonies as the 
starting population to retain high viability, while compromising its scalability.  
1.5 SPECIFIC AIMS 
The use of hPSCs has the potential to provide an unlimited supply of any cell type in the body, 
and thus, can be used to alleviate donor organ shortages. hPSCs can be differentiated to any cell 
type in response to chemical stimuli, physical stimuli, or a combination of both. The overall goal 
of this work is to understand how encapsulation affects the growth and pancreatic differentiation 
of hPSCs, as encapsulation is a requirement for transplantation-based T1D therapy. Over the last 
decade there has been significant progress in deriving functional cells from hPSCs. The next 
stage of clinical translation will require overcoming the challenge of immune rejection and 
scalable culture. We hypothesize that encapsulation will allow us to meet both challenges using 
the same platform. Encapsulation will allow 3D culture of cells in aggregates, which is 
increasingly being seen as preferable to 2D adherent culture. However, interaction of the cells 
with the substrate will also make the cell fate susceptible to substrate properties.   Hence, in the 
first two aims of this dissertation we will test the feasibility of achieving pancreatic 
differentiation under encapsulation, and subsequently, investigate how substrate properties affect 
cell fate. Then in the 3
rd
 aim, we will develop a biomimetic hydrogel which can support single 
cell hPSC growth and propagation for large scale hPSC culture. Accordingly, three specific aims 
have been formulated as detailed below. 
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1.5.1 Specific Aim 1: To evaluate the feasibility of obtaining hPSC derived pancreatic cell 
types under encapsulation. 
The objective of this aim is to use alginate encapsulation as a platform for islet-like 
differentiation of hPSCs to offer a potentially directly transplantable treatment option for T1D.  
In Chapter 2, we have investigated the specific stage of pancreatic differentiation most amenable 
to encapsulation and differentiation. hPSCs were encapsulated at various stages of the directed 
differentiation protocol, and analyzed for cell phenotype and viability upon encapsulation. These 
results demonstrated that hESCs can be efficiently differentiated to the pancreatic lineage under 
alginate encapsulation, which could be used as a directly translatable treatment option for T1D.   
1.5.2 Specific Aim 2: To determine the effect of cell physical microenvironment on the 
pancreatic differentiation of hPSCs.   
The objective of this aim is to investigate the effect of physical stimuli on the pancreatic 
differentiation of hPSCs. This aim is spread across 2 chapters: Chapter 3 and Chapter 4. In 
Chapter 3, we determined the effect of varying alginate capsule composition by varying cation 
concentration on the pancreatic differentiation of hESCs. The results of this chapter elucidate the 
role that capsule stiffness plays on pancreatic differentiation of hESCs.  In the second part of this 
aim, in Chapter 4, we developed a high throughput 3D alginate array platform to expose the cells 
to multivariate perturbations. Analysis of cell response with a statistical model helped to identify 
the sensitivity of cell fate to individual perturbations. Using this approach, we dissected the role 
of capsule substrate properties and culture configuration on pancreatic islet cell fate of hPSCs.  
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1.5.3 Specific Aim 3: To develop a synthetic biomimetic substrate for supporting single 
cell viability and biomanufacturing of hPSCs. 
The objective of this aim is to develop an alginate based substrate that can support single hPSC 
viability for the improved expansion potential of hPSCs for large scale culture applications. The 
dissociation of hPSCs into single cells results in the loss of cell-cell contact through the 
transmembrane protein, E-cadherin, and results in dissociation induced apoptosis.  Considering 
this limitation of hPSC culture, in Chapter 5, we incorporated peptides into the alginate substrate 
which mimic the bioactive domains of E-cadherin. E-cadherin mimicking peptides were 
conjugated onto alginate, and subsequent hPSC attachment, viability, pluripotency, and the 
differentiation potential were evaluated to determine peptide efficacy. This aim was thus 
intended to transition the alginate differentiation platforms developed in Aims 1 and 2, into one 




2.0  ALGINATE ENCAPSULATION OF HUMAN EMBRYONIC STEM CELLS TO 
ENHANCE DIRECTED DIFFERENTIATION TO PANCREATIC ISLET-LIKE CELLS 
The content of this chapter is taken from Richardson Thomas, Kumta Prashant N., and Banerjee 
Ipsita. Alginate Encapsulation of Human Embryonic Stem Cells to Enhance Directed 
Differentiation to Pancreatic Islet-Like Cells. Tissue Engineering Part A July 2014, 20 (23-24) 
2.1 INTRODUCTION 
It is well known that type 1 diabetes constitutes approximately 5-10% of all diabetes cases, 
wherein the immune system destroys the insulin producing β-cells of the pancreas [1]. Success of 
the Edmonton protocol has established islet transplantation as a promising diabetes therapy [2]. 
However, as with any other organ transplantation, with islet transplantations, patients were still 
required to be on regular immunosuppression treatments. As an alternative strategy, 
encapsulation of islets has been proposed to overcome the need for immunosuppressants. The 
encapsulation systems utilize materials that are permeable enough to allow the diffusion of 
glucose and other nutrients to the islets, and the diffusion of waste and insulin away from the 
islets; while masking the islets from the host immune response [80-83]. Alginate is a chemically 
inert non-degradable polymer, and most importantly it has the capability to immunoisolate 
encapsulated cells [9]. A simple and commonly used method to ensure alginate encapsulation 
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provides sufficient immunoisolation for many cells types is the application of a polycationic 
coating, followed by an alginate coating [84-86]. These characteristics make it an ideal 
encapsulation system for islet transplantation, and thus it has been utilized for this purpose for 
decades [5, 12-19]. Although these methods of transplantation isolate the islets from the host 
immune response, this treatment option is plagued by shortage of donor islets. Specifically, 
approximately 2-3 pancreata worth of islets are necessary to return a diabetic patient to 
normoglycemia [38].   
A promising alternative to the whole organ or islet transplantation is the use of human 
embryonic stem cells (hESCs). Pluripotent stem cells have the potential to differentiate to any 
cell type in the body and are also in virtually unlimited supply, rendering hESC-derived islet-like 
cells a promising alternative to islets. The focus of our study, thus, is to establish the feasibility 
of obtaining encapsulated hESC derived islet like cells, which can be directly transplanted for 
diabetes therapy. While immunoisolation is the primary advantage of islet encapsulation, it offers 
the additional advantage of scalability for hESC derived islets. The high throughput of 
encapsulation systems will allow the capability of producing the enormous number of pseudo-
islets needed for tissue engineering applications.  
Encapsulation of embryonic stem cells has been an active area of research over the last 
decade. The majority of the efforts, however, had been restricted to mouse embryonic stem cells 
(mESCs) and its differentiation to various cell types [49-51]. Since platforms established for 
mESCs cannot be directly translated to hESCs; targeted platforms need to be developed to 
handle issues associated with hESC encapsulation. Siti-Ismail et al. [52] have recently shown the 
feasibility of propagating hESCs encapsulated in calcium alginate for up to a period of 260 days. 
The encapsulated hESCs were reported to retain their characteristic pluripotency, and could be 
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further induced to each specific germ layer. In another report, Chayosumrit et al. [54] have 
shown the feasibility of inducing definitive endoderm in encapsulated hESCs. Dean et al. [53] 
have shown that encapsulation of hESCs could prevent teratoma formation for up to four weeks 
after implantation into mice. Finally, Kim et al. [55] have used alginate encapsulation for 
differentiation of hESC to midbrain dopamine producing neurons. Finally, most recently Hunt et 
al. have shown that  hESC-derived embryoid bodies (EBs) maintained in RGD-modified alginate 
showed an increased percentage of EBs with pigmented retinal pigmented epithelium (RPE) foci, 
optic vessels, and pigmented RPE [56]. These initial studies cleary establish the potential 
benefits in encapsulating hESCs and demonstrate the feasibility of inducing early differentiation 
in these encapsulated hESCs. There have been no reports to date however, to the best of our 
knowledge on exploiting encapsulation strategies for achieving late stage differentiation of 
hESCs to the pancreatic lineage. The objective of this chapter is thus to demonstrate for the first 
time the feasibility of generating hESC derived islet-like cells under alginate encapsulation, 
which can be readily transplanted for diabetes therapy.  
In our previous studies we have reported directed differentiation of hESCs to pancreatic 
islet cell types in adherent 2D culture consisting of the following stages: definitive endoderm 
(DE), pancreatic progenitor (PP), and maturation (MAT) [87]. Translation of this protocol into a 
3D encapsulation configuration first requires determination of the specific stage of 
differentiation when the hESCs can be encapsulated. First we evaluated the possibility of 
encapsulating fully or partially differentiated hESCs. Encapsulation of hESC-derived mature 
cells resulted in both low viability and reduction of the maturation markers upon culture. 
Encapsulation of hESC-derived DE cells resulted in high maturation upon further differentiation; 
however the viability of the cells was low. Finally, we showed that encapsulation of 
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undifferentiated hESCs followed by the stage-wise differentiation, successfully results in islet 
specific maturation and high viability. Furthermore, the maturation obtained under encapsulation 
was significantly stronger than parallel differentiation conducted in the conventional adherent 2D 
configuration. Hence these results show that the stage of encapsulation greatly affects the 
translation of this protocol. We have further investigated the mechanisms mediating this 
enhanced maturation under encapsulation and determined that extracellular matrix molecules or 
adhesive molecules may not be mediating the process. On the other hand, investigation of the 
involved signaling pathways revealed that while the magnitude of key protein expression was 
low under encapsulation, the ratio of pSMAD/pAKT was significantly higher than the 
corresponding 2D cultures, indicating the encapsulation strategy as being an efficient approach 
enhancing differentiation. 
2.2 MATERIALS AND METHODS 
2.2.1 Cell Culture 
Undifferentiated H1 hESCs were maintained on hESC-qualified Matrigel (BD Biosciences) 
coated tissue culture plate for 5-7 days in mTeSR1 (StemCell Technologies) at 37°C and 5% 
CO2 before passaging. Experiments were performed with p55-p70 hESCs. 
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2.2.2 hESC Encapsulation 
Single cell suspension of undifferentiated or predifferentiated hESCs was encapsulated according 
to previous studies [54, 88]. hESCs were incubated with 10µM Y-27632 (Millipore) for two 
hours prior to passaging. Cells were incubated with Accutase (Life Technologies) for 5-7 min at 
37°C to detach cells, and pipetted to obtain single cell. Cells (1x10
6 
cells/ml) were suspended in 
filtered 1.1% (w/v) low viscosity alginate (Sigma-Aldrich) with 0.2% (v/v) gelatin (Sigma-
Aldrich) and added drop wise to a solution of 100 mM CaCl2 (Sigma-Aldrich) with 10 mM 
HEPES (Sigma-Aldrich) using a 22 gauge needle. The resulting capsules were 1.98 ± 0.14 mm 
in diameter. The alginate used for encapsulation consisted of 39:61 guluronic to manuronic acid 
residues and an endotoxin content of approximately 88 EU/g [89]. Alginate capsules were 
incubated for 6-8 min in the CaCl2 solution. Capsules were washed three times with PBS and 
suspended in appropriate medium with 10 µM Y-27632 for 4 day prior to differentiation.   
2.2.3 Differentiation of Encapsulated hESCs 
The stage-wise induction protocol for mature islet-like differentiation of hESCs was adopted 
from our previous study [87]. First, definitive endoderm was induced using 100 ng/ml ActivinA 
(R&D Systems, Minneapolis, MIN) with 25 ng/ml Wnt3A (R&D Systems) for 4 days. 
Afterwards, pancreatic progenitor was induced with 0.2 µM KAAD-cyclopamine (Millipore) for 
2 days and 0.2 µM KAAD-cyclopamine with 2 µM retinoic acid (Sigma-Aldrich) for 2 days. 
Finally, maturation was induced by 10 µM nicotinamide (Sigma-Aldrich) for 2 days and 10 µM 
nicotinamide with 30 µM DAPT (Santa Cruz, CA, USA) for 7 days.  All differentiation media 
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was made using DMEM/F12 (Life Technologies), supplemented with 0.2% BSA (Sigma-
Aldrich) and 1xB27® (Life Technologies). 
2.2.4 Viability  
LIVE/DEAD (Life Technologies) viability assay was performed according to manufacturer’s 
instructions. Briefly, encapsulated cells were incubated with 2 µM ethidium homodimer-1 and 1 
µM calcein-AM in DMEM/F12 for 25 min at room temperature. Capsules were washed three 
times with DMEM/F12 before fluorescent imaging.  
2.2.5 Proliferation 
Cell proliferation was measured using AlamarBlue (Life Technologies) assay according to 
manufacturer’s instructions. Briefly, encapsulated cells were incubated with medium containing 
10% (v/v) AlamarBlue for 4 hours. Fluorescence intensity of the supernatant was measured using 
a Synergy 2 multi-mode Microplate Reader (BioTek, Winooski, VT, USA). 
2.2.6 Quantitative reverse transcription polymerase chain reaction 
Cells were decapsulated with 100 mM EDTA (Sigma) and washed twice with PBS before lysis. 
mRNA was isolated using the NucleoSpin RNA II kit (Macherey-Nagel, Bethlehem, PA). cDNA 
was obtained using the ImpromII Reverse Transcription System (Promega, Madison, WI). Each 
PCR reaction contained 5 µl SYBR Green Master Mix (Agilent, Santa Clara, CA), 2 µl nuclease 
free H2O, 2 µl primer, and 1 µl cDNA. Samples were normalized to the house keeping gene 
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 PCR array analysis, cDNA was obtained using the RT
2
 First Strand kit according 
to manufactures instruction (SA Biosciences, Valencia, CA). Each qRT-PCR reaction for the 
Extracellular matrix and Adhesion molecule array (human) contained 12.5 µl RT
2 
qRT-PCR 
Master Mix, 0.94 µl cDNA, and 11.56 µl RNase-free water and was distributed (25 µl) into each 
well of the PCR 96-well array. Encapsulated samples were normalized to the house keeping gene 
GAPDH and analyzed relative to hESC differentiated on TCP using the ΔΔCt method. Gene 
expression was measured with quantitative polymerase chain reaction (qRT-PCR) using an 
MX3005P system (Agilent). 
2.2.7 MagPix 
Intracellular expression of the proteins c-peptide and glucagon was measured by MagPix 
analysis using the BioPlex Pro Human Diabetes kit (Bio-Rad) according to the manufacturer’s 
instructions. Briefly, samples and standards were incubated with 1x c-peptide and glucagon 
labeled magnetic beads at room temperature for 1 hour.  All incubation steps were done on at 
plate shaker for at 300 RPM. After incubation, the beads were washed and incubated with a 1x 
biotinylated detection antibody solution at room temperature for 30 minutes. Next, the beads 
were washed and incubated with 1x steptavidinePE for 15 minutes at room temperature. The 
TGFβ pathway was analyzed using the MILLIPLEX MAP TGFβ Signaling Pathway Magnetic 
Bead 6-Plex (Millipore) for pSMAD2, pSMAD3, pERK1/2, and pAKT as well as total TGFβII 
and SMAD4 according to manufactures instruction. Briefly, 25 µl of each control and sample 
was incubated with 25 µl of a 1x beads solution over night at 4°C. After incubation, the beads 
were washed twice and incubated with 1x detection antibody for 1 hour in the dark, followed by 
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1x streptavidin-PE for 15 min. Fluorescence intensity was measured using the xMAP (Luminex, 
Austin, TX) machine. The total protein was measured using a BCA total protein kit (Thermo 
Scientific), according to manufactures instruction.  
2.2.8 Glucose Stimulated Hormone Release 
After mature differentiation of UD encapsulated hESC, cells were incubated overnight in low 
glucose (2.8 mM) differentiation media containing 10 µM nicotinamide.  Next the cells were 
included for 1 hour in Krebs-Ringer buffer at 37°C followed by a 1hour or 3 hour stimulation 
with high glucose (16.7 mM) differentiation media containing 100 µM tolbutamide and 30 µM 
KCl. Levels of secreted glucagon and c-peptide in the supernatant were measured at basal 
conditions (low glucose) and after stimulation using MagPix analysis as previously described. 
Secreted hormones were normalized to the total protein of the stimulated cells. 
2.2.9 Western Blot 
Cell lysis was carried out in Cell Extraction Buffer (Invitrogen) by incubation with cells on ice 
for 30 minutes, followed by centrifugation for 30 minutes at 3220xg at 4°C. Proteins (30 µg per 
sample) were separated using 4-20% SDS-PAGE at 100 V, and were transferred to nitrocellulose 
membrane at 4°C overnight. The membrane was blocked with Odyssey blocking buffer (LI-COR 
Biosciences, Lincoln, NB) for 2 hours at room temperature. Primary antibodies against β-Catenin 
(Cell Signaling, 1:1000), and GAPDH (Cell Signaling, 1:5000) were diluted in Odyssey blocking 
buffer with 0.1% tween (Sigma-Aldrich) and were added to the membrane and incubated 
overnight at 4°C. The membrane was washed three times for 5 minutes each and incubated with 
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IR conjugated anti-rabbit secondary antibody (LI-COR, 1:20,000) for 1 hour at room 
temperature. The membrane was washed three times for 5 minutes each before analysis using the 
Odyssey CLx (LI-COR) machine. Samples were normalized with GAPDH values. 
2.2.10 Flow Cytometry 
Cells were harvested after Accutase treatment to obtain a single cell suspension, and were fixed 
with 4% formaldehyde (Thermo Scientific) in PBS for 30 minutes.  Cells were permeabilized 
with 0.1% Saponin (Sigma-Aldrich) with 0.5% BSA in PBS for 30 minutes.  Blocking for non-
specific binding was done by incubating cells with 3% BSA with 0.25% dimethyl sulfoxide 
(DMSO) and 0.1% Saponin in PBS for 30 minutes.  Samples were incubated in blocking buffer 
with rabbit anti-c-peptide (1:500, Abcam, Cambridge, MA) primary antibody for 30 min at room 
temperature.  Next, cells were incubated with donkey anti-rabbit Alexafluor 555 (Life 
Technologies) for 30 min at room temperature.  Secondary antibody only without primary 
antibody was used as the negative control.  Samples were washed and suspended in PBS before 
transferring to flow cytometry tubes. Accuri C6 © Flow Cytometer was used to quantify the 
protein expression.  The gate was set beyond cells positive for secondary antibody only to 
eliminate false positives.   
2.2.11 Immunostaining  
Encapsulated cells were fixed with 4% formaldehyde for 30 min. Cells were dehydrated with 
increasing concentrations of ethanol and paraffin embedded for sectioning. Antigen retrieval was 
done using citrate buffer. Slides were permeabilized with 0.1% Triton-X (Sigma) in PBS for 5 
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min.  A blocking step with 10% donkey serum in PBS was done for 1 hour. For primary 
antibodies, we used goat anti-SOX17 (1:200 dilution, Santa Cruz Biotechnology, Santa Cruz, 
CA), rabbit anti-FOXA2 (1:200 dilution, Santa Cruz), goat anit-PDX1 (1:50 dilution, R&D 
Systems), rabbit anti-c-peptide (1:500 dilution), goat anti-glucagon (1:200 dilution, Santa Cruz), 
rabbit anti-MAFA (1:500 dilution, Bethyl Laboratories, Montgomery, TX), and mouse anti-
somatostatin (1:200, Beta Cell Biology Consortium, Nashville, TN). The incubation time for 
primary antibodies were overnight at 4°C. The slides were incubated with the secondary 
antibody for 45 min at room temperature. Secondary antibodies used were: donkey anti-rabbit 
Alexafluor 555 (1:500 dilution), anti-goat Alexafluor 555 (1:500 dilution), and anti-mouse 
Alexafluor 488 (1:500 dilution). The slides were washed three times with PBS (5-10 min) before 
covering with hardening mounting medium containing DAPI (Vectashield, Vector laboratory). 
2.2.12 Statistical Analysis 
Data were presented as mean ± SD. Statistical significance between groups was determined 
using the two tailed Student T-test for two group comparisons. Probability values at P < 0.05 (*) 
and P < 0.01 (**) indicated statistical significance. 
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2.3 RESULTS 
2.3.1 Pancreatic differentiation and characterization of hESCs 
We have previously reported a stage-wise directed differentiation protocol for induction of 
human embryonic stem cells (hESC) to mature islet-like cell types [87] on conventional 2D 
monolayer (2D) tissue culture plastic. Figure 2.1 shows our protocol for islet-like differentiation 
of hESCs, which consists of the following stages: definitive endoderm (DE), pancreatic 
progenitor (PP), and maturation (MAT).  
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Figure 2.1. Stage-wise differentiation protocol for deriving mature islet-like cell types from hESCs.  
Our first objective was to investigate the possibility of calcium alginate encapsulation of 
predifferentiated hESCs either after full maturation or upon DE induction, and test the viability 
and functionality upon encapsulation. UD hESCs were first induced to mature or DE cells on 
Matrigel-coated tissue culture plastic using the previously described differentiation protocol, and 
encapsulated in alginate. The mature stage was characterized by upregulation of insulin 
(~9.5x10
5
, Figure 2.2A) by qRT-PCR, as well as flow cytometry and immunostaining for c-
peptide (Figure 2.2B, C). Our differentiation protocol yielded approximately 24% of the 
population positive for c-peptide by flow cytometry.  
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Figure 2.2. Characterization of mature islet-like cells before encapsulation.  
A) Gene expression by qRT-PCR at the mature stage on tissue culture plastic (TCP) for glucagon and 
insulin, compared to undifferentiated hESCs (n = 3).  B) Flowcytometry analysis for c-peptide on hESC-
derived mature cells on TCP. Secondary antibody only was used as negative control. C)  Immunostaining 
analysis for c-peptide on hESC-derived mature cells on TCP. 
Before encapsulation of DE cells, differentiation in 2D was confirmed by analysis of DE markers 
by qRT-PCR (Figure 2.3A), flow cytometry (Figure 2.3B) and immunohistochemistry (Figure 
2.3C). Encapsulated mature cells were maintained for 7 days in basal maturation media (B27, 




Figure 2.3. Definitive endoderm characterization prior to encapsulation.   
A) Gene expression by qRT-PCR at the definitive endoderm stage on tissue culture plastic for SOX17, 
FOXA2, CXCR4 and CER compared to undifferentiated hESCs (n = 3). B) Flow cytometry analysis at the 
definitive endoderm stage for SOX17. Secondary antibody only was used as negative control. C) 
Immunostaining at the definitive endoderm stage for FOXA2. Scale bar is 50 µm.  Primary AB - 1:200 goat 
anti-human SOX17 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Secondary AB - 1:2000 donkey 
anti-goat Alexafluor 488 (Life Technologies). 
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2.3.2 Encapsulation of predifferentiated hESC results in low yield of viable cells 
2.3.2.1 Viability and Proliferation.  
In order to encapsulate the hESC-derived cells, undifferentiated (UD) or pre-differentiated 
hESCs at each stage of differentiation were harvested and dispersed as single cells in 1.1% 
alginate with 0.2% gelatin and added drop-wise to a bath of CaCl2 (Figure 2.4). This resulted in 
uniform capsules with encapsulated cells, which were washed and further continued in culture in 
relevant media depending on the stage of encapsulation. 
 
Figure 2.4. Schematic showing the process of calcium alginate encapsulation of hESCs 
The viability of encapsulated MAT cells was analyzed on days 1, 3 and 7 post-encapsulation, 
using the LIVE/DEAD assay. Figure 2.5A show images from days 1 and 7. Viable cells 
fluoresce green by metabolically converting calcein-AM to calcien, while the dead cells 
fluoresce red by diffusion of ethedium-homodimer-1 into the cell due to the permeability of 
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apoptotic cells. Day 1 bright field and fluorescent images confirm the presence of live cells in the 
alginate capsule, indicating successful encapsulation of the hESC derived islet-like cells. 
Apoptotic single cells were also observed in the alginate capsules, which are expected due to the 
increased stress on the cells during harvesting and encapsulation. The hESC derived mature cells 
are, however, not strongly proliferative. Hence the number of viable cells in the alginate capsules 
remains unchanged throughout the 7 days of culture. Consequently, colony formation was not 
observed and the yield of the viable encapsulated cells was low. 
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Figure 2.5. Characterization of encapsulated predifferentiated hESCs.  
A) LIVE/DEAD assay on days 1 and 7 after encapsulation of hESCs after MAT on TCP. B) LIVE/DEAD assay on 
days 1 and 14 after encapsulation of hESC-derived DE cells. C) Gene expression on islet-like cells, 7 days post 
encapsulation, for PDX1, glucagon, and insulin, compared to UD hESCs (n = 3).  D) Gene expression by qRT-PCR 
at the mature stage on cells encapsulated at the DE stage, for PDX1, Glucagon, MAFA, and Insulin. The results 




P<0.01 (n = 3). Scale bar is 450 µm. 
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Next, DE cells were harvested and encapsulated as mentioned previously, and the 
subsequent PP and MAT differentiation stages were followed under encapsulation. Viability of 
encapsulated DE cells was analyzed at the end of each stage of the differentiation, after 
encapsulation. Figure 2.5B shows that although beyond day 7, cellular aggregation into small 
colonies was observed; the size of these colonies did not increase appreciably by the end of 
maturation as show by the LIVE/DEAD images on day 14. Although the yield of the viable cells 
is higher compared to encapsulating mature cells, the overall yield of viable cells is still low. 
2.3.2.2 Effect of Encapsulation on hESC Maturation  
The encapsulated MAT cells were further analyzed for mature pancreatic markers after 7 days of 
culture to verify if the encapsulated cells maintained their differentiated phenotype. 
Differentiated cells analyzed at the point of encapsulation showed strong upregulation of PDX1 
(51), glucagon (5635), and insulin (9.5x10
5
). This condition was used as a positive control. Upon 
culture under encapsulation the cells still retained their maturation markers: PDX1 (~3), MAFA 
(~19), glucagon (~1309), and insulin (~4.8x10
5
) (Figure 2.5C). However, the strength of 
upregulation was reduced with culture: expression of PDX1, glucagon, and insulin showed 
respectively 18.6, 4.3, and 19.6 fold lower upregulation after 7 days under encapsulation. This 
indicates that, while it is feasible to encapsulate hESC derived islet-like cells, the cells tended to 
lose their mature phenotype upon encapsulation. 
Analysis of the encapsulated DE cells after pancreatic induction showed strong 
upregulation of PDX1 gene expression, a crucial transcription factor in pancreatic development. 
The encapsulated hESC-derived DE cells were further matured into islet-like cells, and analyzed 
for the gene expression of more mature pancreatic islet markers. As illustrated in Figure 2.5D, 
maturation of encapsulated cells resulted in strong upregulation of many of the mature markers: 
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PDX1 (~2500 fold), glucagon (~2.5x10
5
 fold), MAFA (~14 fold), and insulin (~2.5x10
6
 fold) 
compared to UD hESCs. PDX1 and insulin expression were respectively 50 and 2.8 fold higher 
upon encapsulation, compared to 2D tissue culture plastic controls. These results indicate the 
enhanced pancreatic potential of the hESC-derived DE cells upon encapsulation. However, 
although encouraging as a differentiation platform, the above configuration is restrictive for 
cellular yield. 
2.3.3 Encapsulation of undifferentiated hESCs results in high viability and strong islet-
specific maturation  
The above analysis indicated the difficulty in encapsulating pre-differentiated hESCs, but it 
established the positive attribute of encapsulation on differentiation. Hence in the next step we 
evaluated the feasibility of encapsulating undifferentiated (UD) hESCs and conducting all the 
stages of differentiation under encapsulation. UD hESCs were pretreated with Y-27632 for two 
hours, harvested, and encapsulated in alginate. Upon encapsulation, the cells were further 
propagated for 4 days in mTesR1 with Y-27632, followed by 2 days in only mTeSR1, to allow 
colony formation. After propagation, the encapsulated cells were induced towards differentiation 
according to the previously described protocol (Figure 2.1A). 
2.3.3.1 Viability and Proliferation  
Viability and proliferation of UD encapsulated cells were assessed by LIVE/DEAD and 
AlamarBlue assays throughout the differentiation protocol. Some apoptotic single-cells were 
observed immediately after encapsulation (Figure 2.6A), but the apoptotic cell population did not 
increase even after 23 days of encapsulation. Unlike previous encapsulation configurations, 
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small cell colonies were visible after the propagation stage, which continued to grow into large 
viable colonies by the end of maturation. The vast majority of the cells in the individual colonies 
remained viable after maturation, although some apoptotic cells were observed on the periphery 
of colonies towards the end of maturation. Figure 2.6B shows proliferation of encapsulated 
hESCs, represented as fluorescence intensity per capsule. Proliferation of encapsulated cells 
progressively increased up to the end of pancreatic progenitor stage, and decreased slightly after 
maturation. These results clearly indicate a significant increase in the cellular viability and 
overall yield of mature cells by encapsulating UD hESC rather than pre-differentiated hESCs. 
 
Figure 2.6. Viability and proliferation of hESCs encapsulated at the undifferentiated stage.  
A) LIVE/DEAD viability assay on the first and last day of differentiation, for each stage after 
encapsulation. B) AlamarBlue proliferation assay on the first and last day of differentiation, for each stage 
after encapsulation (n = 3).  Scale bar is 450 µm. 
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2.3.3.2 Differentiation under Encapsulation  
Having confirmed high viability of the encapsulated hESCs, the next question is the 
differentiation potential of the encapsulated cells. Cellular differentiation was analyzed in detail 
after each stage of the induction protocol by using stage-specific markers. Gene expression 
analysis after DE induction of the encapsulated hESCs showed strong upregulation of the DE 
markers SOX17  (~400 fold), FOXA2  (~90 fold), CXCR4  (~72 fold), CER  (~175 fold) 
compared to UD hESCs (Figure 2.7A). All these DE markers were found to be upregulated  
under encapsulation, although the levels were not significant different from parallel 2D controls. 
Analysis of protein expression using immunostaining confirmed SOX17 and FOXA2 positive 
cells in the encapsulated cells (Figure 2.7B). These findings indicate successful induction of 
encapsulated hESCs to the DE stage.  
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Figure 2.7. Characterization of the definitive endoderm and pancreatic progenitor stage for hESCs 
encapsulated at the undifferentiated stage.  
A) Gene expression by qRT-PCR at the definitive endoderm stage for SOX17, FOXA2, CXCR4, and CER, 
compared to undifferentiated hESCs (n = 3). B) Immunostaining at the definitive endoderm stage for 
SOX17 and FOXA2. C) Gene expression at the pancreatic progenitor for PDX1 stage after encapsulation, 
compared to undifferentiated hESCs (n = 3). D) Immunohistochemistry at the pancreatic stage for PDX1. 
Scale bar is 50 µm. The results were considered significant if 
*
P<0.05.  
The next step was analysis of the pancreatic progenitor stage. Similar to DE, the PP stage 
also showed strong upregulation of PDX1 when encapsulated, showing approximately 3000 fold 
increase compared to UD hESCs (Figure 2.7C) which was folds higher than parallel 2D controls. 
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Immunofluorescence analysis showed colonies of encapsulated cells strongly positive for the 
PDX1 protein (Figure 2.7D), confirming differentiation to the PP stage. 
The encapsulated cells were further induced towards islet maturation as detailed in Figure 
2.1A. Maturation was achieved by notch inhibition by addition of DAPT for 7 days. At the end 
of the entire protocol the encapsulated cells were analyzed for mature pancreatic islet-specific 
markers. Gene expression analysis at the mature stage showed strong upregulation of the beta 
cells markers insulin (~8x10
5
 fold) and MAFA (14 fold), as well as the alpha cell marker 
glucagon (~3x10
4
 fold), compared to UD hESCs (Figure 2.8A). Unlike the previous stages, the 
strength of the mature markers under encapsulation was comparable to that of the control in 
conventional 2D cultures. The exception to this is PDX1 (800 fold), which was several folds 
stronger than parallel TCP controls, although this difference was not significant. Detailed 
immunostaining characterization of the encapsulated cells revealed cell colonies positive for 
PDX1, as well as MAFA, which has been implicated in the mechanism of glucose responsive 
insulin secretion (Figure 2.8B). Additionally, cells were positive for glucagon and somatostatin, 
as well as a considerable number of cells positive for c-peptide, all of which are hormones 
secreted by islets (Figure 2.8B).  
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Figure 2.8. Characterization of mature islet-like cells, encapsulated as undifferentiated hESCs.  
A) Gene expression of the mature markers PDX1, glucagon, MAFA, and insulin, compared to 
undifferentiated hESCs (n = 3). B) Immunohistochemistry at the mature stage for PDX1, Glucagon (GLU), 
MAFA, Somatostatin (SST), and C-Peptide.  Scale bar is 50 µm. 
While some of the cells were polyhormonal, expressing both c-peptide and glucagon as 
shown in Figure 2.9A, there were distinct populations of cells expressing single hormones 
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(Figure 2.9B). Thus differentiation of encapsulated UD cells shows a high cellular yield as well 
as efficient differentiation to mature pancreatic phenotype, as indicated by gene and protein 
expression of mature pancreatic islet markers. 
 
Figure 2.9. Pancreatic islet Hormone localization.  
A) Co-staining of UD encapsulated hESCs at the mature stage for c-peptide and glucagon. The white arrow 
shows a cell which is polyhormonal. B) Co-staining of UD encapsulated hESCs at the mature stage for c-
peptide and glucagon showing single hormone positive cells. The white arrow is directed at a cell which is 
positive for the single hormone c-peptide.  
2.3.3.3 Intracellular C-peptide and Glucagon content and release  
As a final analysis of the maturation of hESC derived islet-like cells, we measured the 
intracellular protein content and protein secretion of the islet-specific hormones c-peptide and 
glucagon, shown in Figure 2.10. Mature insulin is produced by post translational cleavage of 
proinsulin into insulin and c-peptide. Thus, intracellular c-peptide content is analogous to 
intracellular insulin, and is a measure of avoiding any artifacts arising from insulin in the culture 
media. Quantification of the intracellular c-peptide and glucagon protein content was performed 
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using Luminex based Magpix assay. The encapsulated UD hESCs were found to contain 0.39 pg 
c-peptide/µg total-protein, which was 20 fold higher than the 2D controls, containing 0.019 pg c-
peptide/µg total-protein. Similarly, the encapsulated UD hESC showed 0.085 pg glucagon/µg 
total-protein, while 2D showed 0.006 pg glucagon/µg total protein (Figure 2.10A). 
 
Figure 2.10. Intracellular protein quantification and glucose sensing.  
A) Intracellular c-peptide and glucagon content at the mature stage for UD encapsulated hESCs, measured 
by MagPix analysis. B) Gene expression analysis of the glucose sensing molecules KIR6.2 and SUR1 
(subunits of KATP channel) and glucokinase (GCK) at the mature stage for UD encapsulated hESCs. C) 
Released c-peptide in response to basal conditions (low glucose) and after stimulation with high glucose 
(16.7 mM), 100 mM tolbutamide, and 30 mM KCl for 1 and 3 hours respectively, measured by MagPix 
analysis. The results were considered significant if 
*
P<0.05 (n = 2). 
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After confirming the ability of hESC-derived cells to synthesize islet-specific hormones, 
we wanted to evaluate the mature functionality of the cells in sensing and responding to 
extracellular glucose with enhanced insulin/c-peptide release. The presence of potassium channel 
KATP required for c-peptide release was confirmed by the upregulation of the KATP subunits genes 
KIR6.2 and SUR1 (Figure 2.10B). Glucokinase, a key molecule involved in sensing glucose 
levels, also showed an upregulation in gene expression (Figure 2.10B). Finally, we analyzed the 
release of c-peptide in response to stimulation for 1 and 3 hours with physiologically relevant 
high glucose concentration (16.7), tolbutamide, and KCl. Upon stimulation for 1 and 3 hours, the 
mature islet-like cells released 0.008 and 0.031 pg c-peptide/µg total-protein into the media, 
respectively (Figure 2.10C). Stimulation resulted in approximately 1.5 fold and 3.9 fold higher c-
peptide release over the basal conditions for 1 and 3 hour stimulation, respectively. Thus it can 
be construed that hESC differentiation under alginate encapsulation promotes both hormone 
synthesis and release in response to stimulation. 
2.3.3.4 Enhanced differentation is likely due to increased pSmad/pAKT ratio  
Since encapsulated differentiation of hESCs enhanced its maturation over the conventional 2D 
tissue culture plastic control, we further investigated the cause of these enhancements. Our initial 
hypothesis was the extracellular matrix (ECM) and cell adhesion (CAM) molecules in the 
encapsulated cell clusters are mediating this process. Hence we first analyzed the global gene 
expression of ECM and CAM molecules for both the 2D cultures and encapsulated cultures at 
the DE and PP stage using the Extracellular matrix and Adhesion molecule array. This array 
profiles genes important for cell-cell adhesion, cell-matrix adhesion, and various ECM 
molecules. Figure 2.11A shows the results for this gene array represented as a heatmap, for 
CAM, ECM and molecules categorized as both CAM and ECM (BOTH). The heatmap 
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represents relative gene expression of encapsulated cells at DE and PP stage, compared to the 2D 
control evaluated at DE and PP stage, respectively. Overall we observed that most of the tested 
molecules were either unchanged at the DE stage or down regulated, while the PP stage showed 
a more prominent downregulation of the tested molecules under encapsulation. There were only 
few molecules which were consistently upregulated under both DE and PP condition, of which 
MMP7 had the highest upregulation. MMP15 was strongly upregulated in PP stage, but was 
unchanged at DE. Of the CAM molecules, VCAM1, NCAM1, ITGA8 and ITGA4 were strongly 
upregulated at the DE stage but were downregulated at PP.   
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Figure 2.11. Characterization of enhanced differentiation for cells encapsulated as UD hESCs.  
A) ECM and adhesion molecule gene array by qRT-PCR at the DE and PP stage, compared to cells 
differentiated on TCP. B) Protein expression of key molecules in the TGFβ pathway, and molecules which 
with this pathway by MagPix analysis after DE stage (n = 3). C) Western blot analysis for β-catenin after 
DE differentiation.  MFI is normalized to GAPDH.  D) pSMAD3/pAKT and pSMAD2/pAKT after DE 






Next we wanted to evaluate the primary signaling pathways mediating the process of 
differentiation. We concentrated on the DE stage since DE differentiation is critical in achieving 
successful maturation of the hESCs into functional cell types. Since DE induction was achieved 
through the activation of TGFβ and WNT pathway we measured the expression of the primary 
effectors of these pathways. For TGFβ pathway we focused primarily on expression of key 
SMAD molecules by Luminex-based MagPix assay, and for WNT pathway we measured 
expression of β-catenin by western blot analysis. Quite interestingly, we found the expression 
level of the key effectors of the pathways; pSMAD2, pSMAD3 (Figure 2.11B) and β-catenin 
(Figure 2.11C) were lower under encapsulation. Consistent with the other molecules, the 
expression of pAKT and pERK were also found to be lower under encapsulation than in 2D 
cultures (Figure 2.11B). However, low expression of these crosstalk molecules from parallel 
pathways will be indicative of less influence of negative feedback. In order to quantify this 
effect, we evaluated the ratio of pSMAD2 and pSMAD3 with pAKT. It was consistently 
observed that pSMAD/pAKT ratio was significantly higher under encapsulation compared to 
TCP cultures (Figure 2.11D). This indicates that the increased differentiation observed under 
encapsulation could be due to an increased ratio of pSMAD2/3 /pAKT. 
2.4 DISCUSSION 
In this chapter we are presenting a detailed procedure for obtaining hESC derived encapsulated 
islet-like cells which can be directly implanted for treatment of the autoimmune disease, type 1 
diabetes. The presented study will address the shortage for donor islets by providing a platform 
for high throughput and directly implantable regenerative cell source. Deriving functional islet-
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like cell types from pluripotent stem cells has the potential for creating a major transformative 
impact in cell therapy. Hence this has been an intensely researched area over the past decade, 
with multiple studies including our own, investigating pathways for efficient differentiation of 
hESCs to islet-like cell types on conventional TCP culture configuration [40, 42, 43]. In contrast 
to those studies, the current report specifically focuses on deriving encapsulated islet-like cells 
from hESC. The criteria for useful encapsulation will be high insulin per bead which needs (i) 
adequate maturation of the encapsulated cells and (ii) high yield of viable encapsulated cells. 
In our previous study we have reported a stage-wise differentiation protocol for 
differentiating hESCs to mature islet-like cell types [87]. In the current study, we further 
extended our 2D protocol to evaluate for the first time the feasibility and configuration for 3D 
encapsulation of hESC derived cell types. The first logical extension of our 2D protocol to a 3D 
system was to fully differentiate hESCs to mature islet-like cells in 2D, followed by harvesting 
and encapsulation of these differentiated mature cells. Our results demonstrated that 
encapsulated cells were initially viable, but their viability decreased with continuous culture. It is 
known that the proliferation rate of hESCs progressively reduces with differentiation, and 
typically the cells are not proliferative after maturation. Hence the cell loss upon encapsulation 
could not be recovered by the proliferation of the live cells. Furthermore, the encapsulated cells 
appeared to lose the mature phenotype, as exhibited by the rapid down-regulation of mature gene 
expression of the encapsulated cells. It is difficult to conclude if the encapsulated cells are going 
through dedifferentiation, or if the more mature cells are prone to apoptosis, while the surviving 
cells are a less differentiated sub-population. Alternatively, the disruption of the ECM 
microenvironment and cell-cell contact formed during the 23 day differentiation protocol during 
the harvesting step could have led to the low viability of encapsulated cells. Previous studies 
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have also shown that dissociation of islet clusters leads to loss of cell function and apoptosis[90], 
possibly indicating that our hESC-derived islet-like cells require cell-cell contact similar to 
primary islets. Additionally, previous work with islet-like maturation of hESCs by implantation 
of PPs using the Theracyte device has shown that colony formation is required for development 
of insulin producing cells, while single cell suspensions failed to develop into insulin secreting 
cells [91, 92]. Thereby an encapsulation strategy ensuring adequate cell-cell contact and cell-
cluster formation will be required to ensure functionality upon complete maturation of hESC. 
With the failure to maintain the phenotype of mature cells upon encapsulation, we 
considered encapsulation of a partially differentiated hESC population which still retains 
proliferative potential. The hESCs are still proliferative in the DE stage, but proliferation slows 
down considerably during the induction of the PP stage. Hence we next explored encapsulating 
pre-differentiated DE cells, followed by further pancreatic induction under encapsulation. When 
we encapsulated hESC-derived DE cells, we saw moderately better viability immediately after 
encapsulation compared to encapsulation of mature cells. The cells also grew into small cell 
colonies upon maturation and proliferation of encapsulated DE cells was highest immediately 
after encapsulation, but decreased by the end of maturation. This was expected because mature 
cells are known to show little or very slow proliferation [93]. This, combined with normal 
apoptosis during differentiation, could explain the decrease in proliferation by the end of 
maturation. It is unlikely that diffusion limitations from encapsulation was causing any cell 
death, since the alginate capsule is very porous, and the encapsulated cell aggregates are fairly 
small in size (~ 350um in diameter). Although DE encapsulated cells show adequate induction to 
the mature stage, as well as improved viability, the yield of viable cells is still very low. The 
transplantation of these encapsulated islet-like cells is volume limited. A low yield of 
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encapsulated viable cells requires an increased volume of capsules to meet insulin requirements. 
Therefore, it is likely that the number of capsules needed to return to normoglycemia would be 
too high of a volume for the implantation site. It may be possible to enhance the yield of viable 
cells by increasing the seeding density. However, compensating for cell death by increasing 
seeding density may restrict the translational potential of this platform. 
In our next configuration we therefore explored the encapsulation of undifferentiated 
hESC and performing the entire maturation under encapsulation. Our results indeed indicate that 
when undifferentiated hESCs were encapsulated and differentiated to mature islet-like cell types, 
the yield of viable cells was greatly improved. Distinct viable colonies were visible at the end of 
maturation, a result which was never achieved by encapsulating predifferentiated cells. This 
could be attributed to the propagation of the encapsulated cells before induction of 
differentiation, which could have been permissive to colony formation and establishment of cell-
cell contact prior to differentiation. Similar to encapsulation of DE cells, we saw a peek in 
proliferation when encapsulating UD hESCs at the end of the PP stage and proliferation 
decreased by the end of the maturation stage. This decrease in proliferation can be attributed to 
slower proliferation of maturing cells and cells undergoing apoptosis during the differentiation 
process.  Additionally, encapsulated UD hESCs at the mature stage show upregulation of the 
gene PDX1, as well as the mature markers glucagon, MAFA, and insulin, confirmed by 
immunostaining. These results therefore unequivocally demonstrate that alginate encapsulation 
and differentiation of UD hESC results in adequate islet-like differentiation, as well as a higher 
yield of viable cells.  While encapsulation of hESC-derived PP cells have been previously 
proposed as a strategy for implantation [94], our results indicate the difficulty of encapsulating 
partially differentiated cells. Thus from a purely differentiation stand-point it is advantageous to 
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perform the entire differentiation under encapsulation. However, from the standpoint of 
implantation, it will be advantageous to minimize the period of in-vitro culture under 
encapsulation, prior to implantation. This is to minimize the presence of contaminating antigens 
from encapsulated dead cells during culture and differentiation. Hence we propose the strategy of 
decapsulating the differentiated hESCs after maturation, followed by its re-encapsulation in 
ultrapure, endotoxin free alginate. These alginate capsules will be further modified with a 
polycation coating, followed by an alginate coating [18, 84] and implanted immediately. 
Since encapsulation and differentiation of UD hESCs appear to meet the requirements of 
adequate mature differentiation and high yield of viable cells, we conducted further 
characterization of these cells by analysis of intracellular c-peptide levels to seek further insight 
into possible mechanisms. C-peptide was measured to avoid any artifacts arising from insulin in 
the media. Protein quantification using MagPix showed that the encapsulated UD hESCs 
expressed intracellular c-peptide (0.39 pg/µg total-protein) and glucagon (0.019 pg/µg total-
protein). Although a previous study with primary mouse islets showed a c-peptide content of 
9.93 ng/µg total protein [95], considering the present results are obtained with hESCs, this is 
indeed an encouraging step towards functional islet-like cell types from hESCs in 3D culture. 
Gene expression analysis showed that the required machinery necessary for glucose stimulated 
insulin release was present by upregulation of the KATP subunits SUR1 and KIR6.2 as well as 
glucokinase. Additionally, the cells were stimulated for 1 hour and 3 hours to determine c-
peptide secretion. Upon stimulation, encapsulated UD hESCs at the mature stage secreted 1.5 
fold and 3.9 fold higher c-peptide over the basal conditions for 1 and 3 hour stimulation, 
respectively. It is worth noting that, although gene expression for insulin was similar between 2D 
controls and encapsulated cells, intracellular c-peptide protein was much higher in encapsulated 
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cells after maturation. However, it is unclear if differentiation under encapsulation is recruiting 
more islet-like cells or if the differentiated cells are eliciting higher levels of gene and protein. 
This enhancement could be attributed to the 3D environment provided by the alginate 
encapsulation forcing cell-cell contact, and is thus more closely mimicking the native 
environment cells would experience in vivo [96]. To investigate this further, we analyzed the 
gene expression levels of ECM and CAM molecules using a PCR array previously used to 
analyze the dynamics of embryoid body differentiation [97]. We expected to observe higher 
levels of CAM expression when comparing traditional 2D culture with our 3D alginate system, 
since the alginate hydrogel confines the differentiating hESCs. However, the gene array revealed 
that a large majority of the genes profiled were downregulated with respect to the 2D 
configuration for both ECM and CAM molecules at both the DE and PP stage. While most of the 
genes were downregulated, ITGA4, ITGA8, were upregulated at the DE stage, and MMP7 as 
well as MMP15 were however upregulated at the PP stage. ITGA4 is one of the integrins which 
encode the subunits of heterodimeric integrin’s receptors that bind fibronectin and vitronectin, 
which are important matrix proteins during DE differentiation [98]. MMP15 has been shown to 
be highly expressed in the mature pancreas and MMP7 to a lesser extent [99]. Next we evaluated 
the expression pSMAD3 and β-catenin, key molecules which directly influence DE 
differentiation in the TGFβ and WNT pathways respectively. Surprisingly, the expression of both 
β-catenin and pSMAD3 was lower in encapsulated cells than in cells on 2D, even though the 
resultant differentiation initiated by these signaling pathways was significantly higher in 
encapsulated cells. Hence we analyzed the parallel signaling pathways since the effect of 
crosstalk has been recently shown to be dominant in differentiating hESCs [100]. pAKT is 
known to be a strong negative regulator of SMAD3 [101, 102] hence we analyzed the levels of 
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pAKT which was seen to be weaker under encapsulation. It is thus likely that even though the 
levels of pSMAD2/3 are higher in 2D cultures, the available proteins for nuclear translocation 
and hence gene transcription is lower from negative interaction with pAKT. For a more 
quantitative evaluation we next evaluated the ratio of pSMAD2/pAKT and pSMAD3/pAKT both 
of which were significantly higher under encapsulation compared to 2D cultures. Hence we 
hypothesize that even though the expression levels of key protein molecules is lower under 
encapsulation, the signaling cascade is more effective because of reduced negative interactions, 
as judged by the high levels of pSMAD3/pAKT and pSMAD2/pAKT ratio. This indicates that 
under encapsulation more SMAD complex is available for translocation to the nucleus which 
helps influence the differentiation. While pSMAD/pAKT ratio has been implicated to be critical 
in TGFβ-induced apoptosis in various different cells types [101], we report its importance in 
determining the differentiation potential of hESCs towards the DE cell type.  
2.5 CONCLUSIONS 
This research clearly shows that the configurations (stage) in which cells are encapsulated 
affects their viability/differentiation, and therefore their transplantation potential. We have 
shown that encapsulation of mature islet-like cells or hESC-derived DE cells resulted in a low 
yield of viable cells after maturation. Although encapsulation of hESC-derived DE cells showed 
adequate cellular maturation, encapsulation of UD hESCs was the preferred configuration since 
it distinctly showed adequate differentiation along with a high yield of viable cells. In fact, we 
have shown that differentiation of encapsulated UD hESCs resulted in a stronger expression of 
primary maturation markers and enhanced hormone synthesis compared to parallel 2D cultures. 
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This suggests that encapsulation and mature differentiation of UD hESC has the highest 
transplantation potential for treatment of type 1 diabetes. Furthermore, our analysis indicated that 
the high levels of pSMAD/pAKT ratio obtained upon encapsulation appear to be the primary 
mediator for differentiation further validating the promising therapeutic benefits of encapsulation 
of hESCs in alginate. 
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3.0  CAPSULE STIFFNESS REGULATES THE EFFICIENCY OF PANCREATIC 
DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS 
The content of this chapter is taken from Richardson Thomas, Barner Sierra, Candiello Joseph, 
Kumta Prashant N., and Banerjee Ipsita. Capsule Stiffness Regulates the Efficiency of Pancreatic 
Differentiation of Human Embryonic Stem Cells. Acta Biomaterialia. Volume 35, 15 April 2016, 
Pages 153-165 
3.1 INTRODUCTION  
 
In  chapter 2 of this work, we showed the successful derivation of insulin producing β-cells from 
hPSCs encapsulated in calcium alginate capsules, towards a directly transplantable T1D 
treatment option [103]. Interestingly, we even observed significant enhancement in pancreatic 
maturation of hPSCs when differentiated under encapsulation, which renders calcium alginate 
capsules as an attractive platform for differentiation, in addition to immune protection. While 
calcium alginate has been extensively used in hPSC literature, it is limited in its in-vivo 
applications because calcium ions can be easily displaced by monovalent cations, such as 
sodium, resulting in weakening of the capsules over time [104, 105]. Alginate is composed of 
mannuronic (M) and guluronic (G) acid, which forms a 3D network when divalent cations bind 
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with the G residues of two adjacent polymer chains [9]. While calcium is commonly used for cell 
encapsulation, other divalent cations such as strontium and barium can also be used. In 
comparison to calcium, barium binds to alginate with a much higher affinity, resulting in more 
robust capsules [10, 36]. Thus barium alginate (BAlg) capsules have been extensively used for 
encapsulation of islets for T1D treatment [15, 19, 106-108]. However, BAlg has been less 
explored for pluripotent stem cell encapsulation, with few reported studies in adult stem cells 
[109-112]. The only successful study with hESCs is by  Dean et al., who showed that hESCs 
encapsulated in BAlg could survive and differentiate when transplanted in mice for a period of 
four weeks [113]. Thus, the favorable mechanical properties of BAlg capsules warrant 
investigation of its potential for hESC encapsulation and differentiation. 
The effect of insoluble physical cues, such as substrate stiffness or extracellular matrix 
(ECM) molecules, on stem cell differentiation is well-established [57, 114-116]. In the context of 
endoderm specific differentiation, our group has demonstrated the feasibility of driving early 
germ layer differentiation of mESCs by modifying the properties of alginate and fibrin 
substrates, in the absence of chemical inducers [117-120]. Hence even though pancreatic 
differentiation of encapsulated hESCs will be directed by chemical cues, it is likely that capsule 
properties will affect the fate of encapsulated cells. However, information on the effect of 
physical cues on stem cell differentiation is largely lacking in the context of pancreatic 
differentiation. The physical properties of alginate capsules can be modulated by changing the 
alginate (M/G ratio) and/or cation (Ca, Ba, Sr) type and concentration [30, 36]. As a general rule 
of thumb, increasing cation concentration will increase the stiffness of the resulting capsule by 
higher crosslinking of G residues; these effects are further enhanced by cations such as barium 
which have higher binding affinity [36, 37]. All of these can affect the fate and response of 
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encapsulated cells [61, 62, 121]. Hence, while engineering an encapsulation system for hPSCs, it 
is necessary to evaluate the effect of substrate properties on the fate of encapsulated cells.  
The objective of this chapter was to investigate, for the first time, the use of BAlg 
encapsulation for pancreatic differentiation of hESCs, and determine how BAlg properties 
influence growth and subsequent differentiation of encapsulated hESCs. Overall it was observed 
that the efficiency of chemical induction was largely dependent on the properties of 
encapsulating substrate, even though diffusion was never restrictive within the capsules. Cell 
growth was observed to be favorable under the low stiffness regime, and was highly suppressed 
under high stiffness conditions. Interestingly, the effect of differentiation was more complex and 
differed based on stage of differentiation, possibly due to the complexity of the interaction of 
physical cues with non-linear signaling pathways.  Increased alginate capsule stiffness appeared 
to promote TGFβ signaling during the definitive endoderm (DE) stage, which enhanced DE 
differentiation. However, increased substrate stiffness also promoted sonic hedgehog signaling at 
the pancreatic progenitor (PP) stage, which suppressed PP differentiation. Overall, cell growth 
and hESC-PP differentiation was found to be favorable in the stiffness range of approximately 4-
7 kPa. 
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3.2  MATERIALS AND METHODS 
3.2.1 Human embryonic stem cell culture 
Undifferentiated (UD) H1 hESCs (WiCell) were maintained on hESC-qualified Matrigel (BD 
Biosciences) coated tissue culture plastic for 5-7 days in mTeSR1 (StemCell Technologies) at 
37°C and 5% CO2 before passaging. Experiments were performed with p55-p85 hESCs. 
3.2.2 Barium alginate encapsulation of hESCs 
A single cell suspension of UD hESCs was encapsulated by modifying our previous 
encapsulation protocol with the use of BaCl2 [103]. hESCs were incubated with 10 µM Y-27632 
(Millipore) for two hours and harvested with Accutase (Life Technologies) to obtain single cells. 
Cells (1x10
6 
cells/ml) were suspended in filtered 1.1% (w/v) low viscosity alginate (Sigma-
Aldrich) with 0.2% (v/v) gelatin (Sigma-Aldrich) and added drop wise to a solution of BaCl2 
(Sigma-Aldrich) with 10 mM HEPES (Sigma-Aldrich) using a 22 gauge needle. The alginate 
used for encapsulation consisted of 39:61 guluronic to manuronic acid residues and an endotoxin 
content of approximately 88 EU/g [89]. hESCs were encapsulated using 10, 15, 20, 50 or 100 
mM BaCl2. Alginate capsules were incubated for 6-8 min in the BaCl2 solution. Capsules were 
washed three times with DMEM/F12 and suspended in mTeSR1 with 10 µM Y-27632 for 4 day, 
followed by 2 days in mTeSR1 alone to allow for colony formation, prior to differentiation.   
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3.2.3 Barium alginate capsule characterization 
Alginate disks were formed using a 1.7 cm diameter mold, and crosslinked with 10, 15, 20, 50, 
and 100 mM BaCl2. AFM force indentation measurements were performed using the MFP-3D 
Atomic Force Microscope (AFM, Asylum Research, CA, USA). The generated force 
measurements were analyzed using the MFP3D software (Asylum Research) built on IgorPro 6 
(Wavemetrics) based on previously described models [122]. For all measurements a 100 micron 
silicon nitride cantilever (Veeco Systems) with a spring constant of ~0.6 N/m was functionalized 
with a glass silica sphere (radius 3.5 microns) at the apex. Figure 3.1 shows a schematic of AFM 
micro indentation using a spherical tip.  
 
Figure 3.1. Schematic of AFM microindentation for hydrogel stiffness measurements 
Young’s modulus is proportional to is proportional the hydrogel displacement, δ, determined by 
the equation δ = x - d. Where x is cantilever position, and d is the cantilever deflection. The 
hydrogels were maintained in saline after formation to ensure their hydrated state. The stiffness 
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of each alginate gel was measured at n = 3 random locations and approximately 16 force curves 
were taken over a 4x4 grid at each location on each sample.  
Diffusivity was examined by first forming alginate capsules using 10, 20, and 100 mM 
BaCl2 without cells. 1 ml of alginate was used to form capsules for each BaCl2 concentrations, 
and was loaded with 2 mg of bovine serum albumin (BSA, (Sigma-Aldrich)). The capsules were 
suspended in 2 ml of 0.9% saline, and the supernatant was sampled for released BSA over 24 
hours. BSA was measured using the BCA total protein assay (Thermo Scientific) according to 
manufacturer’s instruction, and analyzed using a Synergy 2 multi-mode Microplate Reader 
(BioTek, Winooski, VT, USA). 
3.2.4 Differentiation of encapsulated hESCs 
The stage-wise induction protocol for the pancreatic differentiation of hESCs was identical to 
our previous study, ending at the pancreatic progenitor stage instead of the maturation stage [44]. 
First, DE was induced using 100 ng/ml ActivinA (R&D Systems, Minneapolis, MIN) with 25 
ng/ml Wnt3A (R&D Systems) for 4 days. Afterwards, PP was induced with 0.2 µM KAAD-
cyclopamine (CYC) (Millipore) for 2 days and 0.2 µM CYC with 2 µM retinoic acid (Sigma-
Aldrich) for 2 days.  All differentiation media was made using DMEM/F12 (Life Technologies), 
supplemented with 0.2% BSA and 1xB27® (Life Technologies). 
3.2.5 Cell viability  
LIVE/DEAD (Life Technologies) viability assay was performed according to manufacturer’s 
instructions. Encapsulated cells were incubated with 2 µM ethidium homodimer-1 and 1 µM 
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calcein-AM in DMEM/F12 for 25 min at room temperature. Capsules were washed three times 
with DMEM/F12 before fluorescent imaging. Viable cells fluoresce green by metabolically 
converting calcein-AM to calcein and apoptotic cells fluoresce red by diffusion of ethidium-
homodimer1 into the cell because of the permeable membrane of apoptotic cells. 
 
3.2.6 Image analysis 
The stock LIVE images from LIVE/DEAD analysis were processed using Metamorph. Briefly, 
the processing steps included thresholding to eliminate background, after which the image was 
binarized to create a black and white mask; filtered to detect the edges of the individual colonies, 
forming a mask or outline.  From the mask, using Integrated Morphometry Analysis, data was 
generated for each colony within each image, measuring the area of the colony.  This image 
processing was done on images taken on 5 capsules, each day for each condition.  
3.2.7 hESC proliferation and death 
Cell proliferation was measured using AlamarBlue (Life Technologies) assay according to 
manufacturer’s instructions. Cells were incubated in the Alamarblue solution for 4 hours (1:10 
v:v dilution). Cell death was measured by analysis of released lactate dehydrogenase (LDH), 
using the CytoTox 96® Non-Radioactive Cytotoxicity assay according to manufactures 
instruction. LDH released from dead/dying cells in the supernatant was analyzed every other 
days. Absorbance was measured using a Synergy 2 multi-mode Microplate Reader. To quantify 
cell death, dilutions of lysed cells were prepared to quantify LDH signal per cell, to create a 
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standard curve. Cell death measurements were presented as number of dead cells. Fluorescence 
intensity of the supernatant was measured using a Synergy 2 multi-mode Microplate Reader.   
3.2.8 qRT-PCR for gene expression analysis 
Cells were decapsulated with 100 mM EDTA (Sigma) and washed twice with PBS before lysis. 
mRNA was isolated using the NucleoSpin RNA II kit (Macherey-Nagel, Bethlehem, PA). cDNA 
was obtained using ImpromII Reverse Transcription (Promega, Madison, WI). Each PCR 
reaction contained 5 µl SYBR Green Master Mix (Agilent, Santa Clara, CA), 2 µl nuclease free 
H2O, 2 µl primer, and 1µl cDNA. Samples were normalized to the house keeping gene GAPDH 
and analyzed relative to UD hESCs using the ΔΔCt method. Gene expression was measured with 
quantitative polymerase chain reaction (qRT-PCR) using an MX3005P system (Agilent). 
3.2.9 MagPix for TGFβ pathway signaling analysis 
The TGFβ pathway was analyzed using the MILLIPLEX MAP TGFβ Signaling Pathway 
Magnetic Bead 6-Plex (Millipore) for pSMAD2, pSMAD3, pERK1/2, and pAKT as well as total 
TGFβII and SMAD4 according to manufactures instruction. Briefly, 25 µl of each control and 
sample was incubated with 25 µl of a 1x beads solution over night at 4°C. After incubation, the 
beads were washed twice and incubated with 1x detection antibody for 1 hour in the dark, 
followed by 1x streptavidin-PE for 15 min. Fluorescence intensity was measured using the 
xMAP (Luminex, Austin, TX) machine. The total protein was measured using a BCA total 
protein kit, according to manufactures instruction.  
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3.2.10 Immunostaining  
Encapsulated cells were fixed with 4% formaldehyde for 20 min and cryopreserved with 30% 
sucrose for 24 hours before embedding in OCT for cryo-sectioning. H&E staining was done to 
determine the gross morphology of the colonies for each encapsulation condition. For 
immunostaining, blocking was done with 10% donkey serum in PBS for 1 hour. Primary 
antibody staining was done overnight at 4°C, followed by addition of the secondary antibody for 
45 minutes at room temperature. For primary antibodies, we used goat anti-SOX17 (1:200 
dilution, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-FOXA2 (1:200 dilution, Santa 
Cruz), and goat anit-PDX1 (1:50 dilution, R&D Systems). Secondary antibodies used were: 
donkey anti-rabbit Alexafluor 555 (1:500 dilution), anti-goat Alexafluor 555 (1:500 dilution). 
Finally, slides were covered with hardening mounting medium containing DAPI (Vectashield, 
Vector laboratory). Slides were washed three times with PBS in between each step of the 
staining protocol. Primary and secondary antibodies and dilution details are located in the SI 
methods.  
3.2.11 Statistical analysis 
Data were presented as mean ± SD. Statistical significance between two groups was determined 
using the two tailed Student T-test for two group comparisons. Statistical significance comparing 
multiple groups was determined using one-way ANOVA, with Tukeys or Games-Howell post 
hoc testing for homogeneous or inhomogeneous variance, respectively. Probability values at P < 
0.05(*) and P < 0.01 (**) indicated statistical significance. 
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3.3 RESULTS 
3.3.1 Barium alginate stiffness, and not diffusion, affects encapsulated hESCs  
The mechanical properties, namely stiffness, of organs can vary in a wide range: 1 – 10 kPa in 
soft tissue like brain or muscle, while hard tissue such as collagenous bone is on the order of 100 
kPa [57]. Hence we first identified the range of cation concentrations which produces capsules in 
the range of 1 – 100 kPa, by varying barium concentrations (5 – 200 mM BaCl2). Alginate 
capsules were formed by drop-wise addition of alginate into the cation solution, resulting in 
capsules of 2.07±0.1 mm in diameter. Barium alginate capsules of this size have recently been 
shown to strongly resist fibrosis compared to traditionally used capsules of smaller diameter for 
up 175 days in immune competent mice, while supporting islet function and viability [108]. 
Resulting capsule stiffness was measured using atomic force microscopy (AFM) micro-
indentation to determine the Young’s Modulus. Capsules created with less than 10 mM BaCl2 did 
not form homogenous capsules (data not shown), while those created with greater than 100 mM 
BaCl2 were outside the desired stiffness range noted above. The Young’s modulus of the BAlg 
capsules progressively increased from 3.9±1.3 kPA in the lowest BaCl2 concentration (10 mM), 
to 73.3±22.4 kPA in the highest BaCl2 concentration (100 mM, Figure 3.2A). 
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Figure 3.2. Characterization of Barium alginate capsule.  
A) Alginate hydrogel elastic moduli (Pa) as  measured by AFM nano-indentation of alginate crosslinked 
with 10, 15, 20, 50, and 100 mM BaCl2. B) Schematic of alginate encapsulation of hESCs with the desired 
BaCl2 concentration. C) Brightfield images of hESCs encapsulated in alginate crosslinked with 10, 15, 20, 
50, and 100 mM  BaCl2 after propagation of undifferentiated hESCs for 6 days to allow colony formation. 
White arrows indicate colonies, which were minimal in the 50 and 100 mM barium alginate conditions. 
Scale Bar is 450  μm. D) BSA released from alginate capsules crosslinked with 10, 20, and 100 mM BaCl2 
over 24  hours.  The results were considered significant if *P<0.05. 
 The chosen range of capsule stiffness was next explored for encapsulating 
undifferentiated (UD) hESCs. Cells were suspended in 1.1% alginate with 0.2% gelatin and 
added to a solution of the desired BaCl2 concentration for crosslinking (Schematic in Figure 
3.2B). After 6 days of propagation, colony formation was minimal in the 50 and 100 mM BAlg 
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capsules, as compared to cells encapsulated in 10 – 20 mM BAlg capsules (colonies indicated 
with white arrows, Figure 3.2C). Since the density of crosslinking could also possibly modulate 
the diffusivity of the capsule to nutrients, growth factors, or small molecules in the media, we 
measured BSA diffusivity with changing alginate crosslinking. BSA was chosen for this study 
for its high molecular weight of 66.5 kDA, in comparison to key differentiation inducers: 
ActivinA (26 kDA), Wnt3A (40 kDA), CYC (0.4 kDA), and Retinoic Acid (0.3 kDA). Figure 
3.2D shows that there was insignificant difference in the release profiles of the BSA loaded BAlg 
capsules of different crosslinking densities after 24 hours. This indicates that for the range of 
BAlg used in this study, the encapsulated cells are unlikely to experience any difference in media 
exposure from diffusion limitations.  On the other hand, the effect of crosslinking on the 
resultant capsule stiffness was significant.  
3.3.2 Capsule stiffness suppresses the growth dynamics of encapsulated hESCs  
We next quantified the effect of varying BaCl2 concentration, and thereby BAlg capsule stiffness, 
on the viability and proliferation of encapsulated hESCs throughout differentiation. UD hESCs 
were encapsulated using 10, 15, 20, 50, and 100 mM BaCl2, propagated for 6 days, at which 
stage they form visible colonies. Following this, encapsulated cells were induced to differentiate 
to DE and subsequently to PP, following the protocol detailed in Figure 3.3A [44, 45, 103]. Cell 
viability was evaluated on days 1, 6, 10, and 14 after encapsulation using the LIVE/DEAD assay. 
As illustrated in Figure 2B, all the gel conditions show similar viable cells (green fluorescence) 
on Day 1 after BAlg encapsulation. However, by Day 6 after encapsulation, visible differences 
were apparent in the number of viable cells across each substrate condition. Softer capsules with 
lower BaCl2 concentration exhibited larger viable cell colonies and less apoptotic single cells 
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(red fluorescence). In contrast, stiffer BAlg capsules synthesized with higher BaCl2 
concentration showed visibly fewer viable cell colonies and more apoptotic single cells. This 
effect was more dramatic by the end of the PP stage on day 14, where capsules of 50 mM and 
100 mM BaCl2 conditions resulted in very small cell colonies. However, in some of the capsules 
under these conditions, the colonies grew rapidly in size with unusual morphology as early as 
day 10 of differentiation (indicated by white arrows, Figure 3.3B).  
 
Figure 3.3. Viability and cell growth dynamics of encapsulated hESCs throughout differentiation.  
A) Differentiation protocol for inductions of hESCs to PP cells. B) LIVE/DEAD assay of hESCs in 
response to barium alginate capsule stiffness. Scale bar is 450 μm. C) The LIVE images were processed 
using Metamorph for each encapsulation condition. Using Integrated Morphometry Analysis, data was 
generated for each colony within each image, measuring the area of the colony. 
 66 
Visible cracks were observed on the surface of these capsules, likely due to the non-compliance 
of the stiffer capsules, which results in cracking as the capsule swells (Figure 3.4). It is thus 
likely, that cracks also formed within the BAlg capsule, allowing for uninhibited growth.  
 
Figure 3.4. Alginate Bead Cracking.   
Brightfield images for hESC encapsulated in 100 mM BaCl2 on day 1, 6, 10, and 14 after encapsulation.  
Scale bar is 450. Cracks indicated with red arrows. 
To further characterize the dynamics of cell growth, the images from the LIVE/DEAD 
assay were quantified using Metamorph image analysis software. The colony area (μm2) of each 
live colony was measured, and the dynamics of average colony area for each capsule 
configuration was quantified (Figure 3.3C). In general, for all crosslinking conditions, the cell 
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colony size increased initially with propagation. The extent of the growth was, however, strongly 
dependent on the capsule property. For example, by day 6, cells encapsulated using 10 mM 
BaCl2 had a larger area as compared to the other conditions. Overall, increased BaCl2 
concentration resulted in a progressive decrease in cell colony size. This trend was apparent at 
the end of propagation stage and continued through the rest of the differentiation stages, with 
later stages showing an enhanced effect of substrate composition on colony size. An exception to 
this was the 100 mM BAlg condition, which had minimal growth in cell colonies all through the 
propagation and differentiation stages. As noted before, the 50 and 100 mM BAlg conditions 
showed some uninhibited growth, potentially from gel cracking, which are depicted as outliers 
(circled in black) in Figure 2C. These results clearly show that growth of encapsulated hPSCs is 
strongly determined by properties of encapsulating gel, with increased gel stiffness suppressing 
growth. 
Consistent with colony sizes, quantification of cell proliferation by the AlamarBlue assay 
also showed a strong dependence on substrate stiffness. As shown in Figure 3.5A cells 
encapsulated in softer capsules (10-20 mM BaCl2) are highly proliferative, and resulted in 
distinct colonies within the capsule. However, stiffer substrates (50, 100 mM BaCl2) were less 
supportive of proliferation and hence failed to give rise to cell colonies. Along with proliferation, 
cell death was measured using the LDH assay, to verify if changing capsule properties are having 
any toxic effect on the cells. As shown in Figure 3.5B, cell death was most predominant in Day 
1, immediately after encapsulation. Beyond that, cell death is somewhat suppressed for most of 
the conditions, while the cells remain highly proliferative as judged by AlamarBlue assay. It is 
important to note that cell seeding for all conditions was 1x10
6
 cells/ml, and the peak death 
observed was less than 2.5x10
5
 on day 1 for the 10 mM BaCl2 condition.  While this trend is 
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consistent across the softer gels, cells encapsulated in the stiffer gels remain somewhat static. 
They are neither proliferative, nor show significant cell death. Overall, the above results clearly 
show that BAlg capsules in the range of 10 – 20 mM BaCl2 (~4-7 kPa) are supportive of hESC 
proliferation and colony formation. While the stiffer gels were not necessarily toxic, they did not 
support sufficient colony growth to be a feasible option for encapsulation.  
 
Figure 3.5. Proliferation and cell death of encapsulated hESCs, in response to substrate stiffness.   
A) Cell proliferation measured by AlamarBlue assay, of encapsulated hESCs under each barium alginate 
condition during pancreatic differentiation. B) Cell death measured by the LDH assay, of encapsulated 
hESCs under each barium alginate condition during pancreatic differentiation. 
3.3.3 Increasing capsule stiffness supports DE differentiation, while suppressing PP 
differentiation 
Having confirmed cell viability and colony formation in BAlg capsules, we next evaluated the 
feasibility of differentiating the cells after encapsulation and growth. Encapsulated hESCs under 
each BAlg conditions were induced to DE and subsequent PP stage of differentiation following 
the protocol detailed in Figure 3.3A. Differentiation efficiency was analyzed by gene and protein 
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expression for both DE and subsequent pancreatic commitment. Figure 3.6A, B compares the 
efficiency of germ layer commitment across varying capsule stiffness, which shows a distinct 
biphasic response. Mesendodermal markers EOMES and CER both showed an initial increase in 
expression with increased capsule stiffness (Figure 3.6A), reaching a peak upregulation of 
~3800-fold at 50 mM BaCl2 for EOMES and ~6900-fold at 20 mM BaCl2 for CER. Further 
increase in substrate stiffness, however, resulted in a reduction in gene expression. A similar 
biphasic trend was also observed for the DE markers SOX17 and FOXA2, with peak 
upregulation of ~8400-fold at 50 mM BaCl2 for SOX17 and ~29500-fold at 20 mM BaCl2 for 
FOXA2 (Figure 3.6B). Hence BAlg capsules crosslinked with 20–50 mM BaCl2 (~7–22 kPa) 
exhibited the most significant upregulation of mesendoderm and DE markers. However it is 
worth noting that even the lowest observed gene expression at 10mM BaCl2 is still substantial 
differentiation as judged by the strong upregulation of relevant genes. Further analysis of SOX17 
and FOXA2 protein expression by immunostaining confirmed the strong presence of cell 
colonies with significant expression of these proteins in 10, 15, and 20 mM BaCl2 (Figure 3.6C).  
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Figure 3.6. Increased substrate stiffness enhances DE stage differentiation.  
A) Relative gene expression of the mesendodermal genes EOMES and CER for each barium alginate 
condition at the DE stage, relative to UD hESC. B) Relative gene expression of the DE genes SOX17 and 
FOXA2 for each barium alginate condition at the DE stage, relative to UD hESCs. C) Immunostaining of 
hESCs encapsulated with 10, 15, and 20 mM BaCl2 at the DE stage, for SOX17 and FOXA2. Scale bar is 
75 μm. The results were considered significant if *P<0.05, **P<0.01. 
 71 
Having confirmed germ layer commitment, the next step was to analyze the effect of 
substrate stiffness on pancreatic commitment. We first looked at HNF4α, which is a marker of 
the primitive gut tube, and is expressed in pancreatic development between the DE and PP 
stages. Interestingly, consistent with the DE makers, gene expression of HNF4α increased as 
BAlg capsule stiffness increased (Figure 3.7A), but lacked the biphasic nature and was highest 
under the stiffest condition tested: ~510-fold increase over UD hESCs at 100 mM BaCl2. Figure 
3.7B shows gene expression of PTF1A, a precursor to PDX1, which showed a similar increasing 
trend with BAlg capsule stiffness, from ~3-fold to ~3300-fold upregulation over UD hESCs. A 
crucial transcription factor for endocrine pancreatic development is PDX1, which is also 
necessary for β cell maturation. In contrast with the previous analysis, PDX1 gene expression 
showed strong inverse relationship with BAlg capsule stiffness (Figure 3.7C). The highest PDX1 
expression was obtained at 10 mM BaCl2 which resulted in ~3800-fold increase over UD hESCs. 
All of the other gel conditions tested had a significantly lower PDX1 gene expression (~370 – 
580 fold increase over UD hESCs).  
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Figure 3.7. Increased substrate stiffness suppressed PP stage differentiation.  
Relative gene expression of A) HNF4α, B) PTF1A, and C) PDX1 for each BAlg condition, at the PP stage.  
Gene expression was normalized to UD hESCs. The results were considered significant if *P<0.05, 
**P<0.01. D) H&E staining of hESC colonies encapsulated using each cation concentration, after the PP 
stage. Scale bar is 100 μm. Immunostaining for PDX1 E) and collagen 1 and laminin F) for hESCs 
encapsulated with 10, 15, 20, 50, and 100 mM BaCl2.  Scale bar is 50 and 75 μm, respectively.  
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We subsequently compared the morphology of PP colonies across the gel conditions. At 
the end of PP induction, the BAlg capsules were dissolved and the collected cell colonies were 
sectioned and stained with H&E to visualize the colony morphology for each BAlg condition 
(Figure 3.7D). Cells differentiated in the 10 and 15 mM BAlg capsules resulted in colonies 
which were visibly less dense in higher BaCl2 concentrations. The cell colonies within 10 and 15 
mM BAlg were found to have distinct cavities (indicated with black arrows) within the colonies, 
which was significantly reduced at 20 mM condition and completely absent in 50 and 100 mM 
BAlg capsules. As indicated earlier, 50 and 100 mM BAlg capsules resulted in either small 
restricted colonies or in some cases, large elongated colonies. 
Pancreatic differentiation was next confirmed by immunostaining of colony sections for 
PDX1. Consistent with the gene expression analysis, cells encapsulated in the 10 mM BaCl2 gel 
were strongly positive for the protein PDX1 (Figure 3.7E). While PDX1 protein expression was 
also detected in 15 mM and 20 mM conditions, the number of PDX1 positive cells decreased 
significantly with increasing gel stiffness. In the stiffest gels formed with 50 or 100 mM BaCl2, 
no detectable cells were positive for the protein PDX1. Hence, while higher stiffness was 
conducive for mesendoderm and DE differentiation, the lower stiffness BAlg capsule was more 
supportive of endocrine pancreatic differentiation, as shown by high PDX1 gene and protein 
expression.  
Since ECM can play a significant role in modulating cell fate, we further analyzed the PP 
colonies across gel conditions for relevant ECM proteins. In particular, laminin and collagen 1 
are known to be important basement membrane and structural proteins in the pancreas, 
respectively [123-125] and were analyzed by immunostaining. Consistent with the differentiation 
data, the presence of ECM was more evident in lower stiffness gels (Figure 3.7F). Interestingly, 
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the ECM deposition appeared to be localized primarily around the cavities within the colony 
(indicated with white arrows). 
3.3.4 Capsule Properties impact signaling at both the DE and PP stage 
Our results showed that in spite of identical chemical induction, the differentiation potential of 
the encapsulated cells was significantly modified by the properties of the encapsulating substrate. 
Further, the effect of the substrate was specific to the stage of differentiation and not consistent 
throughout. Since signaling pathways are also known to have similar stage specific effect on 
differentiation, we hypothesized that substrate properties are modulating the efficacy of relevant 
signaling molecules. The TGFβ pathway is known to play a critical role in the process of 
endoderm and pancreatic differentiation. High activation is necessary for endoderm induction, 
while it is detrimental to pancreatic differentiation. Hence to analyze how substrate properties are 
affecting differentiation, we chose to measure the SMAD molecules, which are key effectors of 
the TGFβ pathway. However, the complex interactions between parallel pathways make it 
difficult to understand pathway behavior by analyzing molecules and pathways in isolation 
[126]. Hence we also measured pERK and pAKT which are known to have significant 
interaction with the TGFβ pathway. Using a Luminex-based MagPix assay, we measured the 
expression of relevant signaling molecules after the DE and PP stage in 10 and 20 mM BaCl2 
condition (Figure 3.8 and Figure 3.9). These conditions were chosen because they had the most 
contrasting effect between the DE and PP stage differentiation. We first focused on how gel 
stiffness influenced signaling at the DE stage (Figure 3.8A). Total TGFβRII levels were 
significantly lower in the 20 mM BAlg, while t-SMAD4 levels were insensitive to changes in 
response to capsule stiffness. Interestingly, the primary effectors of the TGFβ pathway, 
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pSMAD2/3, showed an opposite trend. While pSMAD2 was significantly lower in the 20 mM 
BAlg compared to 10 mM BAlg, pSMAD3 was significantly higher. The cross talk molecule 
pERK1/2 also showed significantly higher expression in the 20 mM BAlg, while pAKT, a 
negative regulator of the TGFβ pathway, showed significantly lower expression in this condition 
compared to 10 mM BAlg. To evaluate the level of negative regulation, we analyzed the ratio of 
pSMAD2/3/pAKT to estimate the level of available pSMAD2/3 which can influence 
differentiation (Figure 3.8B). While the ratio of pSMAD2/pAKT was not significantly different 
between the gel conditions, pSMAD3/pAKT was significantly higher in 20 mM BAlg. Both 
higher levels of pSMAD3 and higher pSMAD3/pAKT ratio in 20 mM BAlg condition, as 
compared to the 10 mM BAlg condition, indicates a larger pool of active pSMAD3 molecules 
are available to direct mesendoderm gene transcription. 
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Figure 3.8. Effect of substrate stiffness on TGFβ signaling at the DE stage.  
A) Expression of key signaling proteins of the TGFβ pathway, and key cross talk pathway molecules by 
Magpix analysis, after DE stage differentiation for hESCs encapsulated using 10 or 20 mM BaCl2. B) The 
ratios of pSMAD2/pAKT and pSMAD3/pAKT, which indicated the level of available pSMAD2/3. The 
results were considered significant if *P<0.05, **P<0.01. 
High TGFβ signaling activation is of paramount importance for DE induction; however, 
following DE specification, activation of this pathway is detrimental to pancreatic commitment 
[127]. In our experimental set-up, beyond the DE stage there was no exogenous activation of the 
TGFβ pathway. Even then we observed significant dynamics of the pathway molecules, the 
nature of which depended on the substrate properties (Figure 3.9A). Both 10 and 20 mM BAlg 
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conditions showed a significant increase in the receptor level and t-SMAD4 levels from DE to 
PP. However for 20 mM BAlg, the key signaling molecules pSMAD2/3 remained similar 
between DE and PP. This was surprising since the DE differentiation is conducted under high 
TGFβ stimulation and the PP stage is devoid of it. Even more surprising was the response of the 
10 mM BAlg condition. While pSMAD2 was significantly reduced from the DE to PP stage, as 
expected from the removal of ActivinA, pSMAD3 was significantly enhanced from DE to PP 
under the 10 mM BAlg condition. Furthermore, this increase in pSMAD3 is in disagreement 
with the enhancement of the PP stage differentiation we observe under the 10 mM condition, 
since SMAD molecules are known to interfere with PP induction [128]. pSMAD3 levels under 
10 mM BAlg at the PP stage is not only increasing from the corresponding DE stage, it is also 
higher than the 20 mM BAlg at the  PP stage. However, as mentioned earlier, it is difficult to 
conclude on the state of signaling by evaluating signaling pathways in isolation. Hence we also 
evaluated pAKT and pERK levels to characterize the signaling events in more detail (Figure 
7A).  We observed that both pERK and pAKT increased significantly from the DE to PP stage 
under both gel conditions. However, the difference was insignificant for both signaling 
molecules between the two conditions at the PP stage. These pathways alone do not explain the 
observed difference in differentiation. Hence, we analyzed the ratio between the key signaling 
molecules, in order to quantify the interaction. We observed that the pSMAD2/3/pAKT ratio was 
significantly suppressed when the cells were differentiated from DE to PP, in both the gel 
conditions with the exception of pSMAD2/pAKT for 20 mM BAlg (Figure 3.9B). This indicates 
that the availability of active pSMAD levels lower upon withdrawal of ActivinA, while moving 
from DE to PP. While this analysis explains the feasibility of PP differentiation, it does not 
explain the superior performance of the 10mM BAlg condition.  
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Figure 3.9. Effect of substrate stiffness on TGFβ signaling at the PP stage.  
A) Expression of key signaling proteins of the TGFβ pathway, and key cross talk pathway molecules by 
Magpix analysis, after PP stage differentiation for hESCs encapsulated using 10 or 20 mM BaCl2. B) The 
ratios of pSMAD2/pAKT and pSMAD3/pAKT, which indicated the level of available pSMAD2/3. The 
results were considered significant if *P<0.05, **P<0.01. 
We next specifically analyzed pathways which are being directly modulated for 
pancreatic induction. This includes inhibition of the sonic hedgehog (SHH) signaling pathway, 
the presence of which promotes liver bud formation [127]. Hence, we examined the substrate-
specific effect of SHH inhibition by measuring the gene expression levels of the SHH ligand and 
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GLI1, a transcription factor downstream of and activated by SHH. Comparing the two gel 
conditions at the PP stage, we observed that cells encapsulated in 10 mM BAlg capsules had 
lower expression of SHH and significantly lower expression of GLI1, compared to the 20 mM 
BAlg condition (Figure 3.10A). However, for both of these conditions, the gene expression of 
GLI1, was significantly higher at the PP stage than the corresponding DE stage, even when the 
signaling was suppressed with the inhibitor CYC (Figure 3.10A). A previous report has shown 
that the TGFβ pathway can activate SHH signaling through pSMAD3, independent of the SHH 
receptor smoothened [129]. Since we observed an increase in TGFβ signaling activation at the 
DE stage in the stiffer 20 mM BAlg conditions, we next wanted to examine if increased stiffness 
is activating SHH through the TGFβ pathway. We inhibited TGFβ signaling with the addition of 
Alk5i during the PP stage for the 20 mM BAlg condition. However, Figure 3.10B shows that in 
the presence of the TGFβ inhibitor, PDX1 expression decreased, while SHH and GLI1 
expression increased slightly. This indicates that the stiffer substrates are more strongly 
activating SHH pathway independent of TGFβ, and thus is detrimental to PP induction, even 
though these same conditions favored DE differentiation.  
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Figure 3.10. The effect of substrate stiffness on Sonic Hedgehog signaling.  
A) Gene expression of SHH ligand, and its downstream target GLI1 at the DE and PP stage for hESCs 
encapsulated with 10 or 20 mM BaCl2. Gene expression was normalized to undifferentiated hESCs. B) 
Gene express of PDX1, SHH, GLI1, at the PP stage for hESCs encapsulated using 20 mM BaCl2, with the 
PP stage media supplemented with the TGFβ receptor inhibitor Alk5i. Gene expression was normalized to 
hESCs encapsulated with 20 mM BaCl2 at the PP stage, which where differentiated without the Akl5 
inhibitor. The results were considered significant if *P<0.05. 
3.4 DISCUSSION 
The objective of this study was to evaluate the feasibility of using BAlg encapsulation for 
pancreatic differentiation of hESCs, and how capsule properties regulate growth and 
differentiation. These capsules can then be subsequently used for implantation for T1D 
treatment, where BAlg is expected to immunoisolate the cells within. For hPSC-derived β-cell 
therapy for T1D to reach fruition, high capacity biomanufacturing techniques are required to 
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generate the necessary cell numbers (~10
9
/patient). Hence, essential features to consider while 
engineering a platform for regenerative cell therapy for T1D are (i) supportive of cell growth (ii) 
supporting/promoting differentiation and (iii) amenable to immune protection, which has not yet 
been demonstrated. We observed that DE differentiation was enhanced as capsule stiffness 
increased; however, high capsule stiffness was not supportive of cell growth and proliferation. 
Low stiffness capsules were supportive of both cell growth, and pancreatic differentiation. 
Signaling pathways analysis showed that increasing capsule stiffness activated TGFβ signaling, 
which supports DE differentiation, and SHH signaling, suppressing PP differentiation. Hence in 
the current study we report for the first time, specific barium alginate configurations most 
supportive of growth and pancreatic differentiation of encapsulated hPSCs.  
In evaluating the growth and differentiation properties of barium alginate capsules, the 
parameter we modulated was the crosslinking concentration. Even though the encapsulated cells 
were continuously induced by specific growth factors and chemical inducers, we hypothesized 
that the substrate properties play a critical role in modulating cell fate, as has been well known in 
stem cell literature, [57, 58, 115]. In islet encapsulation studies, 20 mM BaCl2 capsules are the 
most ubiquitous, which results in a stiffness of 6.8 kPa. This is in a similar range as has been 
reported in mouse, 1.210±0.77 [117], and adult human pancreata, 1.4±2.1 kPa – 4.4 ±5.1 kPa 
[130]. Based on this, we selected a wide range of cation concentrations encompassing this range, 
where capsules made using 10 – 20 mM BaCl2 (~4 – 7 kPa) most closely mimicked the stiffness 
of the pancreas in vivo. As seen in previous reports, increasing BaCl2 concentration increases the 
young’s modulus, E (kPa), of the resulting alginate capsule [36, 37], which significantly affected 
both growth and differentiation of the encapsulated hESCs. Most significantly, BAlg capsules 
using 10-20 mM BaCl2 (first regime) was very supportive of cell proliferation, resulting in large 
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viable cell colonies by the end of the 14 day differentiation protocol. In contrast 50 - 100 mM 
BaCl2 (second regime) resulted in marginal proliferation into small colonies. Although gel 
stiffness increased as BaCl2 concentration increased in the first regime, it was not adverse to cell 
growth and differentiation. While in the second regime, the resulting stress from the capsule 
stiffness was too high to sustain healthy cell growth. It was not entirely clear if this poor viability 
was due to potential effects of barium toxicity [131], or from the high physical stress imparted by 
the capsule stiffness preventing cell proliferation. However, 1 day after hESC encapsulation, the 
highest cell death by the LDH assay was found in the lower barium concentration, which still 
showed 97% viability. Additionally, the high stiffness capsules were found to be cracking on the 
capsule surface and likely within the capsules, resulting in distinctly large and irregularly shaped 
cell colonies. This leads us to believe that the capsule was physically restraining the cells, and 
relieving the stress resulted in rapid cell growth in the cracked regions. The possibility of healthy 
cell growth in high barium capsule indicates the effects of barium toxicity in this system are 
minimal. This is further supported by the observation that better viability was observed in 100 
mM BAlg, compared to the 50 mM BAlg on day 14 in Figure 2B. Barium concentration was 
higher in 100 mM BAlg, but cracking of the gel resulted in cell overgrowth, and more viable 
cells than in 50 mM BAlg, containing less barium. However, barium may still be toxic to the 
body in future implantation studies. Matching the most supportive capsule stiffness found in this 
study using a combination of calcium and low barium concentration, as done previously for islet 
encapsulation [132], may be useful in mitigating potential barium toxicity in the body. Taken 
together, this indicates that within the stiffness range of approximately 4 – 7 kPa, it is possible to 
maintain healthy growth and high expansion of hESCs, while beyond this range is not amenable 
to cell growth.  
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While the effect of stiffness was clear on cell viability and expansion, the effect of 
stiffness on pancreatic differentiation was much more complex. We evaluated the most 
supportive capsule properties to obtain PP cells, since implantation of PP cells have been widely 
reported to be successful in reinstating glucose homeostasis in diabetic mice upon implantation 
[133-136].  While the higher stiffness capsules are much stiffer than most soft tissue, it was not 
obvious how stiffness would influence differentiation in the presence of chemical differentiation 
factors. Remarkably, during both the DE and PP stage, alginate stiffness significantly influenced 
differentiation, even though the soluble chemical cues were identical and there were no diffusion 
limitations. Even minimal change in stiffness (1.7 fold) between 10 and 20 mM BaCl2 
significantly affected differentiation. Similarly, Wilson et al. have shown that endoderm 
differentiation of alginate encapsulated mESC aggregates can be significantly increased by a 
minimal decrease in capsules stiffness (1.4 – 1.7 fold) [31]. In our study, both DE and early 
pancreatic differentiation had a positive correlation with BAlg stiffness, showing increased 
stiffness enhanced differentiation. However, mesendoderm and endoderm differentiation had a 
slight bi-phasic behavior, with reduced differentiation in the high range, which was not observed 
in the pancreatic progenitor markers. The effect of stiffness on the key pancreatic endocrine 
transcription factor PDX1 was in complete contrast to the early markers. Increased gel stiffness 
strongly suppressed PDX1 expression, with the highest expression being at 10mM BaCl2 (3.9 
kPa). While this is completely opposite to the early pancreatic markers tested, an explanation can 
be that increased higher elastic moduli is suppressing or delaying differentiation and maintaining 
a progenitor pool. This is supported by the increase in gene expression with increased stiffness of 
HNF4α, a primitive gut tube marker involved in early pancreatic development, and PTF1A, a 
precursor to PDX1. Narayanan et al. have shown an approximately 10% increase in insulin and 
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PDX1 gene expression in hESC after pancreatic differentiation on 2D hyaluronic acid gels of 
stiffness 2.1 kPA compared to controls [137]. While this study only investigated a narrow 
stiffness range with only three gel stiffness’s (1.3, 2.1, and 3.5 kPa) in 2D, it confirms that a 
delicate balance must be struck between physical and chemical cues.  
The inconsistent effect of capsules stiffness on differentiation at the DE and PP stage is 
clearly indicative of the complex interactions between biophysical properties and signaling 
pathways. The mechanism of such interactions is still lacking in the context of stem cell 
differentiation, while understanding such interactions will significantly enhance the efficiency of 
engineering substrates for hPSC differentiation. To better understand such interactions, we 
evaluated the expression of key molecules of the TGFβ pathway, as well as key cross talk 
molecules. TGFβ is a critical signaling pathway in hPSCs; however, its effects are specific to the 
stage of differentiation. Low level TGFβ signaling is required for maintenance of pluripotency 
and self-renewal of hESCs, and high TGFβ signaling induces DE differentiation [126]. While 
high levels are needed for DE differentiation, as mentioned previously, continued activation of 
TGFβ is detrimental to further pancreatic differentiation. From our analysis of the effect of 
capsule stiffness on SMAD molecules, it is possible that the increased substrate stiffness is 
promoting DE stage differentiation by increased TGFβ signaling activation. Previous work with 
UD hESCs [138, 139] and chondrocytes [140] have shown changes in substrate mechanical 
properties can result in TGFβ signaling activation. Thus it is clear that physical stimuli imparted 
on the encapsulated cells can influence differentiation by modulating the signaling pathways. In 
analyzing the 10 and 20 mM BAlg conditions we observed a decrease in pSMAD2 levels in 20 
mM from 10 mM BAlg, with a corresponding increase in pSMAD3 expression. However, since 
there is significant cross talk between pathways, parallel signaling pathways must also be 
 85 
examined. Specifically the PI3K pathway acts as a negative regulator of the TGFβ pathway 
through sequestration of the R-SMADs by pAKT. Hence we measured the ratio of R-
SMADs/pAKT as an estimate of R-SMADs available for gene transcription. While 
pSMAD2/pAKT was not significantly different, pSMAD3/pAKT was significantly higher in the 
20 mM BAlg conditions, indicating higher TGFβ activity by less negative regulation by the PI3K 
pathway. This trend follows previous reports for prostatic epithelial cells and human embryonic 
kidney cells, which have shown that pAKT suppresses TGFβ signaling specifically through 
suppression of SMAD3 phosphorylation, and not SMAD2 [141, 142]. Additionally, we also 
examined pERK1/2 expression, a primary effector of the MAPK pathway. We observed 
significantly higher pERK1/2 expression in the 20 mM BAlg conditions. DE stage differentiation 
is induced by activation of the WNT pathway with Wnt3A, in addition to the TGFβ pathways. 
Singh et al. have shown that pERK promotes DE stage differentiation by inhibition of the WNT 
pathway inhibitor, Gsk3β [126]. This indicates that the increase in DE stage differentiation as 
substrates stiffness increased may be due to higher TGFβ and WNT signaling through a decrease 
in pAKT and GSK3β, respectively.  
While it is clear that increased substrate stiffness supports DE stage differentiation, the 
effect of stiffness on PP stage is more variable. Previous reports have shown that beyond DE 
commitment, TGFβ signaling must be suppressed for subsequent pancreatic induction [127, 143, 
144]. However analysis of the PP cells for signaling molecules revealed that even after removal 
of the TGFβ ligand (Activin) and further PP induction, the TGFβ pathway still remained active 
in a non-intuitive substrate dependent manner. The ratios of both pSMAD2/3/pAKT decreased 
from the DE to PP stage, indicating reduced levels of active pSMAD2/3 after the removal of 
ActivinA at the PP stage. However, this does not explain the superior PP stage differentiation at 
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lower capsule stiffness. Hence, we investigated the direct signaling pathways inducing PP 
differentiation; namely, retinoid signaling activation and sonic hedgehog (SHH) inhibition. 
Lopez-Carballo et al. have shown than retinoic acid treatment of human neuroblastoma cells 
activated PI3K signaling and resulted in increased AKT phosphorylation [145]. Induction of PP 
stage by addition of retinoic acid may serve to suppress TGFβ signaling by the PI3K pathway, in 
addition to retinoid signaling activation. Inhibition of SHH signaling is achieved by addition of 
CYC, which inhibits SHH through the receptor smoothened [146]. Even in the presence of the 
CYC, we saw an increase in SHH ligand and its downstream transcription factor GLI1, after PP 
stage differentiation in 20 mM BAlg, as compared to 10 mM BAlg. Dennler et al. showed that 
even in the presence of CYC, TGFβ induced expression of GLI1 and GLI2 specifically through 
SMAD3, in multiple human cell types [129]. Importantly, this activation of SHH signaling by 
TGFβ was independent of the SHH receptor. Our results clearly show an increase in TGFβ 
signaling in response to increased substrates stiffness at the DE stage. However, upon inhibition 
of TGFβ at the PP stage with Alk5i in the 20 mM BAlg condition, we did not observe a rescue of 
PDX1. It is thus unlikely that the increase in SHH in 20 mM BAlg is TGFβ mediated. This 
indicates the possibility that higher capsule stiffness is strongly increasing SHH signaling to the 
point where CYC cannot fully inhibit SHH, which has not been previously demonstrated. 
Abnormal hedgehog (HH) signaling is common in many human cancers, and can involve “non-
classical” HH signaling activation independent of the “classical” ligand-smoothened HH 
activation [147]. As we have seen in our differentiation studies; this results in the ineffectiveness 
of HH signaling inhibitors like CYC.  It is possible that the increase in substrate stiffness is 
activating “non-classical” SHH signaling, independent of the ligand-receptor binding.   
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3.5 CONCLUSIONS 
In the present study we evaluated the feasibility of adopting BAlg capsules as a unifying 
platform for hPSC growth, differentiation and implantation. Since BAlg is well studied for islet 
transplantation, we focused our study on its usefulness for hPSC encapsulation and pancreatic 
differentiation. Our results clearly indicate the excellent performance of BAlg capsules in 
supporting growth and pancreatic differentiation of encapsulated hPSCs, highlighting its 
potential as a single platform for hPSC scale-up, differentiation and final implantation. However, 
it also highlights the importance of considering capsule synthesis as an important parameter. Cell 
growth and differentiation were strongly dependent on the stiffness of the substrate. We 
determined that capsule stiffness of approximately 4 to 7 kPa was most supportive of cell 
proliferation, while ~3.9 was best for pancreatic differentiation. Analysis of the signaling 
pathway indicated increased stiffness strengthens TGFβ signaling, driving DE differentiation. 
However, it also strengthens SHH signaling, which is detrimental to PP differentiation. Future 
implantation studies will first require investigation of the perm-selectivity of the barium alginate 
capsules with changing stiffness to determine the exact capsule parameters which support 
viability, differentiation, and immunoisolation from the patient immune system.  
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4.0  DECOUPLING THE EFFECT OF MULTIPARAMETRIC PERTUBATIONS ON 
HUMAN PLURIPOTENT STEM CELLS DURING PANCREATIC DIFFERENTIATION 
4.1 INTRODUCTION 
Stem cell fate is known to be sensitive to its local microenvironment, both chemical and physical 
in nature. In the previous chapter we showed that the pancreatic differentiation of hPSC was 
highly sensitive to alginate capsule stiffness. However, there could be other factors affecting cell 
fate as well. Given the complexity of stem cell response to environmental parameters, it will be 
important to evaluate cell response to multiple combinatorial perturbations, in isolation and 
conjugation. Such combinatorial perturbations are best enabled by high throughput screening 
platforms, which also minimize the cost of materials, time of experimentation, and physical 
space. The sensitivity of stem cells to various environmental factors has inspired the 
development of high throughput platforms. This approach has been used in 2D for screening 
physical stimuli such as material stiffness [148], topography [149, 150], and ECM protein or 
peptide composition [151-153] on stem cell attachment, growth and differentiation.  However the 
complexity of stem cell response limits the information gathered from single perturbations and 
necessitates combinatorial perturbations. For example, Gobba et al. developed a microengineered 
hydrogel microarray which can vary substrate stiffness while being functionalized with protein 
combinations, which was used to test MSC differentiation [154]. The advent of 3D culture of 
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stem cells has initiated the development of array platforms supportive of 3D cell culture.  Ranga 
et al. utilized nanoliter-dispensing technology to synthesize over 1000 unique environments to 
simultaneously probe the effect of matrix elasticity, degradability, and signaling proteins on 
mESC self-renewal and proliferation [155]. Yang et al. developed a 3D combinatorial ECM 
hydrogel platform to identify optimal ECM combinations which support linage specific 
differentiation of hESCs [156].  Thus, the use of 3D array platforms permits the analysis of the 
effects of combinatorial stimuli on cells in an environment which can closely mimic in vivo 
organogenesis. However, many of these high-throughput techniques mentioned above require 
special robotic setups, which cannot be achieved commonly in the laboratory setting. While 
these techniques provide a rich multitude of data, our primary interest in this study was to 
conduct a small number of specific perturbations in a laboratory set-up.   The Jonathan Dordick 
group developed a simple alginate-based array platform, originally for the purpose of 
toxicological studies in 3D [157], and later utilized to track mESC fate to quantify the expression 
of key proteins in 3D [158]. While this platform also utilized robotic techniques, the simplicity is 
particularly attractive. We have adapted this platform for bench-scale screening without the use 
of robotics, and further modified it to perturb the physical microenvironment. This array 
platform was originally built for chemical perturbations, while in our work we have modified the 
system to induce combinatorial physical perturbations, and was achieved using simple laboratory 
tools.  
Encapsulation for 3D culture of hPSCs seems to be a promising avenue to meet both 
biomanufacturing goals and immune protection in a single platform. However, the signals used 
to drive differentiation not only include soluble chemical cues, but also include insoluble 
physical cues. Previous work has clearly indicated that stem cell fate is highly sensitive to its 
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chemical, as well as physical microenvironment. More specifically for pancreatic differentiation, 
we have shown in the first part of Aim2 (Chapter 3) that encapsulation will influence stem cell 
fate.  Microenvironment can constitute soluble chemicals/growth factors, interactions with 
extracellular matrix (ECM) proteins, cell-cell contact, or physical stimuli such as stiffness or 
tension. In 2006, Engler et. al. showed that culture of mesenchymal stem cells (MSC) on 
substrates of stiffness matching those of tissues in the body resulted in tissue stiffness specific 
differentiation of the MSCs [57]. In our earlier work from our lab, we demonstrated the effect of 
substrate properties using fibrin and alginate on the differentiation of mouse embryonic stem 
cells (mESCs) [117, 118]. More recently, covered in the preceding chapter of this dissertation, 
we demonstrated the feasibility of pancreatic differentiation of hESCs within alginate capsules; 
and as expected, pancreatic maturation within the capsules was sensitive to alginate capsule 
properties [159].  Cell-cell contact, especially in 3D cellular aggregates, is another important 
insoluble cue which can influence hPSC differentiation. Lee et al. showed controlling hPSC 
colony size could control specification to mesoderm (1200 μm in diameter) or endoderm in the 
presence of soluble differentiation factors, linking cellular organization to hPSC differentiation 
[160]. Recently, Toyoda et al. have shown that the pancreatic induction of hPSCs was correlated 
with increasing cell density in 2D, and was further improved in aggregate culture [161]. Thus 
clinical translation of encapsulated hPSCs will require a thorough evaluation of optimum 
parameters supporting hPSC growth and differentiation [10, 162, 163]. In this chapter, which 
constitutes the second part of Aim 2, we evaluated the sensitivity of proliferation and 
differentiation of encapsulated hPSCs to both cell culture configuration and substrate mechanical 
properties, through the development and use of a 3D alginate array platform. 
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Conceptually, the alginate array immobilizes individual alginate beads to the culture 
surface, enabling convenient imaging and analysis of the same. Our objective here was to 
investigate the effect of alginate properties and encapsulated culture configurations on the 
propagation and pancreatic differentiation of hPSCs. This simple alginate array platform allowed 
for multiparametric perturbations and quantitative imaging. As this alginate array generated a 
rich complex data set, the use of a simple linear statistical model allowed us to decouple the 
complex interactions between the stem cells and the effect of their microenvironment. Thus, in 
combination with statistical modeling, this allowed us to identify the sensitivity of stem cell 




4.2.1 Human embryonic stem cell culture 
Undifferentiated (UD) H1 hESCs (WiCell) were maintained on hESC-qualified Matrigel (BD 
Biosciences) coated tissue culture plastic for 5–7 days in mTeSR1 (StemCell Technologies) at 
37°C and 5% CO2 before passaging. Experiments were performed with p55-p85 hESCs. 
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4.2.2 Alginate array formation and hESC encapsulation 
Fabrication of the 3D alginate array was done by adopting an approach developed previously by 
Fernadez et al [158]. The 3D alginate array was created by coating the culture surface with 
nitrocellulose (Fisher), followed by spotting 0.5 – 5 µl of a   BaCl2-poly-(l-lysine) (PLL) mixture 
in the desired array configuration using a Eppendorf Repeater Plus pipette. The BaCl2-PLL spot 
was allowed to dry, after which the alginate solution was added directly to the dried spot, 
resulting in alginate hydrogel crosslinking and attachment to the culture surface. To vary alginate 
crosslinking, the barium concentration in the BaCl2-PLL mixture was varied from 10 – 500 mM. 
For hESC encapsulation, hESCs were treated with 10 μm Y-27632 (R&D Systems, 
Minneapolis, MIN) for 2 hours prior to harvesting by Accutase (Invitrogen) treatment for 5-7 
min at 37°C and 5% CO2. For encapsulation of single cells, 3 or 5x10
6 
cells/ml were suspended 
in 1.1% (w/v) low viscosity alginate (Sigma-Aldrich) with 0.2% (v/v) gelatin (Sigma-Aldrich), 
and was spotted onto the dried BaCl2-PLL spots as described above. hESC aggregates were 
formed by culturing the Y-27632-treated single cell suspension of hESC in low adherence 30 
mm dishes on a plate shaker set at 55 rpm, at 37°C and 5% CO2. Cells were seeded at 1x10
6
 
cells/ml, using 2 ml of media in each 30 mm dish. Aggregate formation was allowed to proceed 
for 2 day on the plate shaker before collecting and encapsulating the alginate array, as described 
above. The resulting aggregates from one 30 mm dish were suspended in 1 ml of alginate for 
encapsulation in the array. 
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4.2.3 hESC differentiation 
The stage-wise induction protocol for the pancreatic differentiation of hESCs was identical to 
our previous study, ending at the pancreatic progenitor stage instead of the maturation stage 
[164]. Encapsulated single cells were propagated for 4 days in mTeSR1 with 10 μm Y-27632 
followed by 2 days in mTeSR1 alone. Preformed aggregates were allowed to acclimate to the 
hydrogel for 2 days in mTeSR1 prior to starting differentiation. First, DE was induced using 
100 ng/ml ActivinA (R&D Systems) with 25 ng/ml Wnt3A (R&D Systems) for 4 days. 
Afterwards, PP was induced with 0.2 μM KAAD-cyclopamine (CYC, Millipore) for 2 days and 
0.2 μM CYC with 2 μM retinoic acid (Sigma–Aldrich) for 2 days. All differentiation media was 
made using DMEM/F12 (Life Technologies), supplemented with 0.2% BSA (Sigma) and 
1xB27® (Life Technologies). 
4.2.4 Atomic Force Microscopy 
The alginate array was formed as described previously, crosslinked with 10, 50, 150 200, and 
500 mM BaCl2. AFM force indentation measurements were performed using the MFP-3D 
Atomic Force Microscope (Asylum Research, CA, USA). The hydrogels were maintained in 
saline after formation to ensure their hydrated state. The stiffness of each alginate gel was 
measured at n = 3 random locations and approximately 16 force curves were taken over a 4 × 4 
grid at each location on each sample. 
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4.2.5 Viability 
LIVE/DEAD (Life Technologies) viability assay was performed according to manufacturer’s 
instructions. 
4.2.6 DNA and protein immunostaining and quantification using LICOR 
Encapsulated cells in the alginate array were fixed with 4% formaldehyde for 20 min. Cells were 
permeabilized with 0.1% Triton-X 100 (Sigma-Aldrich) for 5 mins prior to blocking with 10% 
donkey serum in for 1 hr. For primary antibodies, we used we used goat anti-Ki67 (1:100, Santa 
Cruz Biotechnology), goat anti-SOX17 (1:400 dilution; R&D Systems), rabbit anti-FOXA2 
(1:400 dilution; R&D Systems), goat anit-PDX1 (1:200 dilution; R&D Systems), and rabbit anti-
Nkx6.1 (1:400 dilution; R&D Systems). Primary antibody staining was done overnight at 4°C, 
followed by addition of the anti-goat or anti-rabbit IR-conjugated secondary antibodies (1:800; 
LI-COR) for 1h at room temperature. DNA was stained by addition of Draq5 (1:5000, Fisher) 
during the secondary antibody staining step. Encapsulated cells were washed three times with 
0.9% saline in between each step of the staining protocol. The entire array was imaged at the 
same time using Odyssey CLx (LI-COR) machine. Protein and DNA expression were quantified 
using the LI-COR Odyssey and Image Studio software. 
4.2.7 Regression analysis 
To relate the expression of markers representing proliferation and pancreatic differentiation to 
cation concentration and seeding configuration, linear regression analysis was performed [165]. 
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] = Intercept + βCC + βC2C
2 +  βC3C
3  … (1.1) 
 
Here, C denotes cation concentration. The model parameters, Intercept and βC
i’s are estimated by 
applying the training data on the model and performing optimization to minimize the error 
between the true response and predicted response. The process is repeated for each culture 
configuration and marker separately. A linear least squares error model was selected. The data 
used for training the model was obtained from the individual experimental repeats using a 
bootstrapping approach. The technique generates large datasets from a small number of 
experimental replicates, using sampling with the replacement technique [166, 167]. Each such 
surrogate dataset was selected to contain the same number of cation concentration values (total 
of 5) and configuration types (total of 3). The regression analysis was performed on each 
individual bootstrap dataset and the model parameters and their p-values were recorded. The 
final distribution of the p-values and the coefficients was monitored for convergence. Only those 
models where the R squared values ranged from 0.5 to 0.95 were taken in the final distribution of 
p-values and coefficients and for the current analysis, 1000 such bootstrap datasets were 
sufficient to make the final conclusions. 
To evaluate relative importance of configuration and cation concentration 
simultaneously, configuration was added into the equation to get a multiple linear regression 






] = Intercept + ∑ (βCiC
i)3i=1 + ∑ (βconfigiConfigi)
3
i=2     + ∑ (βC×configiC × Configi)
3
i=2  … (1.2) 
 
In Equation 1.2, the configuration variables are binary. The variables config 2 and 3 take values 
of 0/1 or 1/0 or 0/0 simultaneously to represent one configuration at a time. Note that config 1 is 
chosen as the reference (when config 2 and config 3 are null) and therefore does not explicitly 
appear as a variable in this equation, but is absorbed by the intercept term. This schema, hence, 
captures the relative influence of config 2 and config 3 over config 1.  Concentration terms occur 
in two forms: one by itself (third order polynomial) and one as a bi-linear term with 
configuration. All coefficients are estimated in a similar manner as discussed above for Equation 
1.1, except that the bootstrap data is now sampled to include all configurations and cation 
concentrations together for a chosen marker. 
4.3 RESULTS 
4.3.1 3D alginate array formation  
The alginate array was constructed by first coating the culture surface with nitrocellulose (Figure 
4.1A), a negatively charged coating. This was followed by depositing a barium (Ba
2+
) chloride-
PLL mixture in the desired array configuration (Figure 4.1B), where positively charged PLL 
ionically interacts with negatively charged nitrocellulose. Once this coating has dried, 
the alginate-cell solution was spotted directly on top of the BaCl2 (Figure 4.1C).  
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Figure 4.1. Schematic of 3D alginate array fabrication and characterization.  
(A) The culture surface is coated with nitrocellulose. An example is shown for fabrication in a well of a 6-
well plate. (B) Next, a BaCl2-poly-(L-lysine) (PLL) mixture is spotted onto the nitrocellulose coated 
surface in the desired array configuration. In this study, a 5x5 array was predominantly used. (C) Finally, 
the cell-alginate solution is added directly onto the dried BaCl2-PLL spot, resulting in crosslinking of the 
alginate and attachment to the culture surface by ionic interaction between the alginate, PLL, and 
nitrocellulose. (D) The alginate array was formed using 10, 50, 100, 150, 200, mM BaCl2 for alginate 
crosslinking. The resulting alginate hydrogel elastic moduli (Pa) was measured by AFM micro-indentation. 
The Ba
2+
 crosslinks the alginate, forming a cell-encapsulating hydrogel, and the PLL serves to 
ionically adhere the alginate to the nitrocellulose, and thus the culture plate. An example of 
5x5 arrays in three wells of a six-well plate can be seen in Figure 4.1 C.  We next evaluated the 
feasibility of modifying the stiffness of the alginate within the array by modulating the BaCl2 
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(cation) concentration. In Chapter 3 of this work, we identified a stiffness range of approximately 
3 – 6 kPa to be ideal for cell growth and pancreatic differentiation [159]. To encompass this 
stiffness range, we formed the alginate array with varying barium concentrations within the same 
array, ranging from 20 mM - 500 mM Ba
2+
. Measurement of the alginate spot stiffness within 
the alginate array, using atomic force microscopy (AFM) micro-indentation (Figure 4.1D), 
shows that the Young’s Modulus increased from 819 ± 151 Pa for 10 mM Ba2+ to 3821 ± 63 Pa 
for 200 mM Ba
2+
. As expected, the Young’s Modulus of the alginate spots increased with 
increased cation concentration. Hence, this simple platform allows for synthesis of alginate spots 
with varying physical properties within the same array. This will enable a convenient procedure 
to evaluate cell response, both short and long term, to physical stimuli 
 
4.3.2 3D alginate array characterization 
A critical component of a high throughput platform for studying cell response is the successful 
integration of appropriate imaging, analysis, and quantification techniques to measure cell 
response. Our current objective is the quantitative analysis of viability and phenotype of hESCs 
encapsulated within the array, primarily using immunostaining. Since this system requires 
analysis of cell aggregates suspended in an alginate hydrogel, and not adherent cells, the imaging 
technique requires sufficient penetration into both the hydrogel and cell aggregates. For this 
purpose, we integrated the LICOR Odyssey scanner, which utilizes a near infrared wave length 
to detect and quantitatively measure the fluorescence intensity in immunostained samples. The 
LI-COR near-infrared fluorophores enhance penetration depth, and dramatically reduce 
autofluorescence. This system is often used for small animal imaging, and is thus well suited for 
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imaging and analysis of encapsulated cell aggregates [168-170]. Therefore, we first needed to 
determine the optimal volumes for the array spots to ensure adequate signal intensity, without 
exceeding the detection limits of the LICOR scanner. hESCs were encapsulated in the array at 
1x10
6
 cells/ml using 0.5 - 5 μl of the barium (10 mM)/PLL and alginate solutions (Figure 4.2A). 
 
Figure 4.2. Alginate array parameter selection and characterization.  
(A) Cells were encapsulated in the array at 1x10
6
 cells/ml using 0.5 - 5 µl of the cation and alginate. (B) 
DNA was stained with DraQ5, and imaged using the LICOR Odyssey and (C) quantified using the Image 
studio software. The dashed line represents the expected MFI and the solid line is the experimental DNA 
MFI. Data was represented as both MFI and cell number/array volume. (D) Schematic of the detection 
limits of the LICOR Odyssey in the 3D alginate array system. (E) Spot diameter and depth. (F) DNA 
quantification within the alginate array using the volume of 1 µl, as hESC seeding density is increased. 
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 This resulted in increasingly larger alginate spots, with a corresponding increase in cell number, 
while retaining the same cell density. Cells within each spot were stained using DRAQ5, which 
stains cell DNA and is proportional to cell number, and was quantified using the LI-COR 
Odyssey and Image Studio software (Figure 4.2B). Figure 4.2C shows that an increase in the 
array volume resulted in an increased fluorescent signal up until an array volume of 2 μl. When 
we compared the quantified MFI (solid line) with the expected MFI based on cell number 
(dashed line, Figure 4.2C), there was close correspondence between the two, up until array 
volume of 2 μl. An increase in array volume above 2 μl resulted in a decrease in the measured 
MFI from the expected values, indicating these spots were too large for the LICOR scanner to 
fully penetrate (Figure 4.2D). The LI-COR Odyssey Imager scans over 6 logs of linear dynamic 
range with no image saturation, it is thus likely that the differences between quantified and 
expected MFI were from hydrogel penetration. Thus, for the remainder of this work, the array 
volume was restricted to 1 μl in order to obtain reliable MFI values from the LICOR Odyssey 
scanner (Figure 4.2C). These volumes resulted in alginate spots with diameter and height of 1600 
and 300 µm, respectively (Figure 4.2E).  
Next, we wanted to determine the range of cell density over which the LI-COR Odyssey 
retains accuracy in quantification. (Figure 4.2F). Cell number should not be so high as to saturate 
the signal, but not so low that the signal is below the detection limit. hESCs were encapsulated at 
a density of 1, 3, and 5x10
6
 cells/ml, stained with DRAQ5 and quantified using the LI-COR 
Odyssey and Image Studio software. As expected, the MFI values increased  by a factor of 2.8 ± 
0.9 and 4.6 ± 1.6, as seeding density was increased by a factor of 3 and 5, respectively. Thus, 
seeding densities between 1-5x10
6
 cells/ml were used for the remainder of this study. 
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4.3.3 hESC growth and viability in the alginate array during pancreatic differentiation 
The array platform is specifically developed to quantitatively track the effect of 
microenvironment on stem cells, in a high throughput manner. In the current application, we 
chose to evaluate the effects of cell density, cell culture configuration and substrate stiffness on 
hESC fate. Toyoda et. al. have shown that culture configuration influences the pancreatic 
induction of human pluripotent stem cells (hPSCs): pancreatic induction increases with cell 
density in adherent cultures, and the effect was further enhanced in aggregate cultures [161]. In 
our previous reports we have shown that substrate properties can strongly modulate pancreatic 
differentiation [117, 118, 159, 171]. Our objective here is to adapt the array platform to enable 
simultaneous perturbation of both substrate stiffness and culture configurations and evaluate its 
effect on viability, growth, and proliferation of hESCs during pancreatic differentiation. In this 
work, culture configuration refers to encapsulating hESCs in the array starting as single cells 
(SC) or as preformed aggregates (Agg) formed using stirred suspension. Figure 4.3 shows a 
schematic of the experimental plan.  
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Figure 4.3. Schematic of encapsulation in the 3D alginate array when varying barium concentration 
and culture configuration.  
(A) The array configuration used for cell viability, proliferation and differentiation experiments. hESCs 
were encapsulated as single cells, at 3 or 5x10
6
 cells/ml, or as preformed aggregates. (B) Propagation and 
stage-wise differentiation protocol for differentiation of hESCs to pancreatic progenitor cells. (C) 
Schematic of tools used for analysis in the 3D alginate array for cell viability (fluorescent imaging) and 
high throughput protein and DNA analysis (LICOR Odyssey scanner). 
Undifferentiated (UD) hESCs were encapsulated in the array as single cells (seeding density of 3 
(SC3) or 5x10
6
 cells/ml (SC5)) or preformed UD aggregates, using 20 – 500 mM BaCl2 to 
crosslink the alginate (Figure 4.3A). Encapsulated single cells were propagated for 6 days, at 
which point they started forming small colonies. The encapsulated aggregates were allowed to 
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stabilize for 2 days post encapsulation and prior to induction of differentiation, which didn’t 
result in significant changes in aggregate size. Encapsulated hESCs were first differentiated to 
the definitive endoderm (DE) stage, followed by further differentiation to the pancreatic 
progenitor (PP) stage (Figure 4.3B). Throughout the differentiation protocol, cell viability and 
protein expression were analyzed directly on the array (Figure 4.3C). Figure 4.4 illustrates cell 
viability by LIVE/DEAD staining performed at the end of the DE and PP stages, for each culture 
configuration, with simultaneous variation in the alginate substrate properties.  
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Figure 4.4. hESC viability in response to alginate crosslinking and culture configuration. 
LIVE/DEAD assay after the DE and PP stage for encapsulated single cells, at 3 and 5x10
6
 cells/ml, and 
aggregates, indicating cell viability in response to increasing crosslinking. Scale bar is 450 μm.  
For each condition, the alginate crosslinking concentration was found to significantly affect 
hESC viability and its colony forming capability. This effect is most significant with 
encapsulated single cells. SC3 showed viable cell colonies after DE differentiation when 
encapsulated in 10 mM BAlg. However, the number and size of viable colonies decreased as 
alginate crosslinking was increased. This similar trend was observed to continue through PP 
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stage; with the surviving cell colonies growing larger with subsequent differentiation to the PP 
stage. Hence, more viable cells were observed at the PP stage (over DE stage) for high 
crosslinking conditions. SC5 showed a similar trend as observed in the SC3 configuration at the 
DE and PP stages, with the exception that more cells were observed in each stiffness condition, 
given that the starting population was approximately 1.7 fold higher.  
Encapsulation of preformed aggregates, in contrast to single cells, showed good viability 
after the DE and PP stage for each BAlg condition. Further, the aggregate size was fairly 
insensitive to the substrate properties and maintained similar sized colonies throughout. 
However, the aggregates did not grow appreciably over time, when differentiated from the DE to 
PP stage, which also contrasts with the behavior of encapsulated single cells. While cell growth 
was low when encapsulating hESC as aggregates, cell death was also minimal, as judged by the 
relative absence of red DEAD stains. Single cell encapsulation, on the other hand, resulted in 
significant cell death, both immediately after encapsulation as well as over propagation and 
differentiation. Overall these results indicate that while encapsulation of single cells showed 
higher expansion potential for surviving cells compared to preformed aggregates, they are more 
prone to cell death under encapsulation.  
4.3.4 Quantitative analysis of growth and proliferation in the alginate array during 
pancreatic differentiation 
In order to further confirm this finding, we next quantified cell growth and proliferation by 
staining for DNA and Ki67 for each of the tested conditions, at both the DE and PP stages. DNA 
and Ki67 staining was done using LICORs near-infrared fluorophores, and quantified using the 
LICOR Odyssey scanner. Figure 4.5 compares cell growth, determined by amount of total DNA 
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present, and cell proliferation by KI67 staining, at the DE and PP stage for each configuration 
and crosslinking combination.  
 
Figure 4.5. Quantification of DNA and cell proliferation as alginate crosslinking and culture 
configuration is varied.  
(A) Quantification of DNA and Ki67 protein expression after DE differentiation for single cells 
encapsulated at 3 or 5x10
6
 cells/ml and preformed aggregates; encapsulated using 10, 50, 100, 200, and 500 
mM BaCl2. (B) Quantification of DNA and Ki67 protein expression after PP stage differentiation for single 
cells encapsulated at 3 or 5x10
6
 cells/ml and preformed aggregates; encapsulated using 10, 50, 100, 200, 
and 500 mM BaCl2. Ki67 expression of each array spot was normalized the cellular DNA content within 
the array spot. Each crosslinking and culture configuration condition represents the average of n=5 array 
spots.  
 107 
At the DE stage, DNA staining showed an increase in MFI with an increase in cell seeding 
density from 3 to 5x10
6
 cells/ml (Figure 4.5A). For both the conditions, though, an increase in 
crosslinking concentration decreased the overall DNA content. The DNA content of the 
aggregate configuration was similar to that of the SC3 configuration, and did not change 
considerably with changes in substrate properties. Analysis of cell proliferation after DE 
differentiation by Ki67 staining showed that the SC3 configuration possesses higher proliferative 
potential, compared to SC5, irrespective of substrate condition. At both seeding densities, the 
Ki67 expression increased slightly as stiffness was increased, with the exception of the SC3 
configuration in the 500 mM BAlg spots, which showed a sharp increase in expression. The 
aggregate configuration showed lower Ki67 expression than both single cell configurations, 
which did not change appreciably as alginate stiffness increased.  
At the PP stage, the trends in DNA content were similar to that observed at the DE stage 
(Figure 4.5B). As expected, the DNA content was higher at the PP stage for both single cell 
configurations, since the cells continued to grow in culture. For the aggregate configuration, 
however, the DNA content remained similar between the DE and PP stage. Ki67 expression at 
the PP stage for both single cell configurations decreased as compared to the DE stage, 
indicating that the cells become less proliferative with differentiation. We observed only a slight 
decrease in Ki67 expression in the aggregate configuration at the PP stage as well, compared to 
the DE stage. Additionally, at the PP stage the aggregate configuration showed little to no 
change in Ki67 expression as substrate stiffness increased, similar to what was observed at the 
DE stage. These results confirm the qualitative trend that was observed in the LIVE/DEAD 
images seen previously. Additionally, these results indicate that while alginate stiffness did affect 
proliferation, culture configuration had a larger impact on proliferation. 
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Next, a regression analysis was performed to quantify the effect of substrate properties on 
proliferation of hPSCs in the array. The cation concentration was chosen as the independent 
variable, and the proliferation marker as the response variable. In the regression equation, non-
linear dependence on the cation concentration is modeled in the form of higher order polynomial 
relationships (up to third order), but each such non-linear term is linear in the regression 
coefficients. Regression coefficients denote the strength of the contribution of the corresponding 
regression term to the marker level (see Methods section 2.7 for more details). In addition to 
these regression coefficients, p-values of the F statistic are calculated and these denote the 
statistical significance of including the particular regression term in the overall equation. Data 
from Figure 5 was used to train the regression model (see Equation 1.1).  
As a first step, regression analysis was performed to find the importance of cation 
concentration in determining the marker levels for each culture configuration separately. Due to 
experimental variability, it is necessary to check for robustness of the regression estimates. 
Therefore, regression analysis was repeated on multiple datasets (chosen from data for the same 
culture configuration and response marker) obtained by resampling of the original experimental 
‘repeats’ using a bootstrapping with replacement algorithm (see Methods for further details) 
[172]. At the end of the analysis, the distributions of regression coefficients and p-values of each 
term in the regression equation (over bootstrapped datasets) were collected and used for 
comparison. From this analysis, the sensitivity of proliferation to cation concentration was 
determined at both the DE and PP stage, and evaluated for each culture configuration. Figure 4.6 
shows the regression coefficients for the proliferation marker Ki67.  
 109 
 
Figure 4.6. Significance of cation concentration in determining proliferation for each culture 
configuration.  
(A) DE stage and (B) PP stage. Shown here are the intercept and regression coefficients, with the 
coefficients scaled by appropriate order mean concentration (Co = 172 mM). The mean and median of the 
distributions in the violin plot are shown as red crosses and green squares. The p-values of the F-statistic 
are given for the significant terms. *P < 0.05 and # 0.01 < P < 0.1 
Only those bootstrap samples for which the R squared values ranged from 0.5 to 0.95 are shown 
(the number of such samples ranged from 50 to 95% of 1000 bootstrap samples). The x-axis 
includes the intercept, first order, second order and third order terms for the DE (Figure 4.6A) 
and PP stage (Figure 4.6B) for each configuration. Note that the terms for each order are 
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multiplied by an average concentration (Co = 172 mM) of the right order, so that they are in the 
same units and are comparable. Overall, it is found that coefficients for most terms are close to 
zero except for the SC3 configuration at the DE stage (p-value < 0.05). Here, the first order and 
second order terms are more important than the third order. This sensitivity is also apparent in 
the experimental data where SC3 was seen to have enhanced proliferation with increased 
crosslinking. 
4.3.5 Pancreatic differentiation in the alginate array 
We next evaluated the sensitivity of hESC differentiation on substrate conditions and culture 
configuration influenced. We have previously reported that increasing substrate stiffness 
enhances DE differentiation, and suppresses PP differentiation in bulk alginate capsules, formed 
by dropwise addition of alginate into a cation solution [159]. In the current report, synthesis of 
the alginate array system allows us to investigate such effects with finer resolution, along with 
inducing multi-parametric perturbations by simultaneously varying stiffness and culture 
configuration. Encapsulated hESCs were first induced to the DE stage (Figure 4.3B), and 
differentiation was evaluated by SOX17 and FOXA2 protein immunostaining. Figure 4.7A 
presents the protein expression levels quantified using the LICOR Odyssey platform, and 
normalized to DNA.  
 111 
 
Figure 4.7. Analysis of DE and PP stage differentiation as alginate crosslinking and culture 
configuration is varied.  
(A) Quantification SOX17 and FOXA2 protein expression after DE differentiation for single cells 
encapsulated at 3 or 5x10
6
 cells/ml and preformed aggregates; encapsulated using 10, 50, 100, 200, and 500 
mM BaCl2. (B) Quantification PDX1 and Nkx6.1 protein expression after PP stage differentiation for 
single cells encapsulated at 3 or 5x10
6
 cells/ml and preformed aggregates; encapsulated using 10, 50, 100, 
200, and 500 mM BaCl2. Ki67 expression of each array spot was normalized the cellular DNA content 
within the array spot. Each crosslinking and culture configuration condition represents the average of n=5 
array spots. 
Overall, both SOX17 and FOXA2 were observed to have a similar response to the exposed 
perturbations. SC5 showed a slight increase in SOX17/DNA (~1 – 1.7) and FOXA2/DNA (~0.8 
– 1.1) as substrate stiffness was increased. The same trend was observed for SC3, however, the 
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expression of SOX17 and FOXA2/DNA was higher for each stiffness, as compared to SC5. 
Interestingly, cells encapsulated as preformed aggregates showed considerably higher expression 
of SOX17/DNA and FOXA2/DNA, as compared to cells encapsulated as single cells. However, 
aggregates showed an increase in SOX17/DNA expression as stiffness increased up to the 100 
mM BAlg condition, and then began to decrease as stiffness was further increased. While 
FOXA2/DNA was significantly higher in aggregates compared to single cells, the trend in 
protein expression as stiffness was increased was less clear. 
Having confirmed germ layer commitment, we next analyzed the sensitivity of pancreatic 
differentiation to perturbations in substrate and culture configurations. Pancreatic differentiation 
was analyzed by quantifying the expression levels of PDX1 and Nkx6.1 proteins, both vital 
markers of the progenitor population required for downstream β cell commitment. As illustrated 
in Figure 4.7B, while SC5 showed higher expression of PDX1/DNA as compared to SC3, 
pancreatic differentiation of single cells was insensitive to changes in substrate properties. 
Similarly, expression of Nkx6.1/DNA for SC3 and SC5 showed slight variations as stiffness was 
increased, but essentially remained unchanged as stiffness increased. Unlike that seen with 
PDX1, SC3 showed higher Nkx6.1/DNA expression as compared to SC5. Consistent with DE 
differentiation, preformed aggregates showed significantly higher pancreatic phenotype as 
compared to single cell encapsulation. Additionally, PDX1/DNA expression in encapsulated 
aggregates was more sensitive to substrate conditions: it increased as stiffness was increased up 
to the 100 mM BAlg condition, and then decreased as stiffness was further increased. 
Nkx6.1/DNA expression for preformed aggregates was significantly higher than both SC3 and 
SC5, consistent with the expression of DE stage makers and with PDX1 expression. Similar to 
PDX1, Nkx6.1 expression for preformed aggregates was also sensitive to substrate properties, 
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but the nature was slightly different. While PDX1 peaked around 100 mM concentration, 
NKX6.1 expression was highest at 10mM concentration and dropped beyond that with 
increasing crosslinking. Taken together, these results indicate that differentiation is sensitive to 
both culture configuration and substrate properties during each stage of pancreatic 
differentiation.  
In order to evaluate this sensitivity using quantitative metrics, we next performed a 
statistical analysis to quantify the importance of substrate properties on the differentiation of the 
encapsulated hPSCs. Again, the cation concentration was chosen as the independent variable, but 
now the differentiation markers were chosen as the response variables. This includes SOX17 and 
FOXA2 protein expression at the DE stage, and PDX1 and Nkx6.1 protein expression at the PP 
stage. Figure 4.8 shows the regression coefficients for the differentiation markers at the DE and 
PP stages.  
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Figure 4.8. Significance of cation concentration in determining differentiation for each culture 
configuration.  
(A-B) DE stage and (C-D) PP stage. The mean and median of the distributions in the violin plot are shown 
as red crosses and green squares. The p-values of the F-statistic are given for the significant terms. *P < 
0.05 and # 0.01 < P < 0.1 
 115 
Again, only those bootstrap samples for which the R squared values ranged from 0.5 to 0.95 are 
shown. For the DE markers SOX17 (Figure 4.8A) and FOXA2 (Figure 4.8B), the influence of 
substrate properties are more pronounced in the aggregate configuration than the other 
configurations. However, the p-values over the bootstrap samples are in a wider range (0.01 < p-
value < 0.1). Similar observations can be made for the PP stage markers PDX1 (Figure 4.8C) and 
Nkx6.1 (Figure 4.8D). There is a minor effect of concentration in the SC3 configuration at the 
DE stage.  
4.3.6 Statistical analysis to identify best predictors of proliferation and differentiation 
The above analysis shows a somewhat disparate effect of substrate properties on proliferation 
and differentiation. While cation concentration most significantly affected the proliferation of 
SC3 cells, for differentiations the aggregate cultures were most sensitive to substrate properties. 
Thus in order to resolve the combined effect of multiple parameters (substrate properties and 
culture configuration) on proliferation and differentiation, a multiple regression with two 
independent variables was performed (Equation 1.2). Cation concentration was chosen as a 
continuous variable as done in Figures 6 and 8. Culture configuration being a categorical 
variable was encoded as follows: aggregates as ‘config 1’, SC3 as ‘config 2’ and SC5 as ‘config 
3’. During regression, a simple coding scheme was used with ‘config 1’ as the reference level 
with respect to which the regression coefficients were calculated. Therefore, the regression 
model measures the influence of deviation of config 2 and 3, from this reference level. In the 
reduced form, the model equation contains third order polynomials to describe the dependence 
on cation concentration (substrate effect), linear terms for culture configurations and bi-linear 
terms for interaction between cation concentration and culture configuration. To compare the 
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relative importance of configuration vs. cation concentration, the p-values of the regression terms 
will be used. The violin plots in Figure 4.9 show a distribution of coefficients of each regression 
term for the proliferation and differentiation markers, each term brought to the same units.  
 
Figure 4.9. Influence of configuration and stiffness in determining proliferation and differentiation.  
(A) Proliferation marker at DE and PP stage, (B) DE stage markers, (C) PP stage markers. The mean and 
median of the distributions in the violin plot are shown as red crosses and green squares. The p-values of 
the F-statistic are given for the significant terms. *P < 0.05 and # 0.01 < P < 0.1 
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Figure 4.9A shows the coefficients for the proliferation marker Ki67 at DE and PP stage. 
Overall, the configuration terms are found to be most important (Intercept and config 2 and 3) at 
both stages. Additionally, the interaction of config 2 and concentration shows a secondary 
importance at the DE (also seen from Figure 4.6). This term was less significant at the PP stage. 
Overall, these results also indicate that the contributions of each term to the proliferation marker 
are reduced after the DE stage. 
For the differentiation markers SOX17 and FOXA2 at the DE stage, and PDX1 and 
Nkx6.1 at the PP stage (Figure 4.9B and C), the configuration terms were again important (p-
value < 0.05), while the concentration terms showed a range of significance values (0.01 < p-
value < 0.1). The interaction between config 2 and concentration was still seen for SOX17 in a 
number of regression models, but this interaction was lost for other differentiation markers. 
Overall, this indicates that culture configuration is the primary determinant of the average 
expression of the proliferation and differentiation markers, while cation concentration (and hence 
stiffness) fine-tunes the expression around the average levels. 
4.4 DISCUSSION 
The objective of this study is to quantitatively evaluate the effect of combinatorial perturbations 
of cell microenvironment on the pancreatic differentiation of hESCs, conducted in a 3D 
configuration. The implementation of a high-throughput alginate-based 3D microarray platform 
allowed simultaneous variation of both hydrogel crosslinking, as a well as culture configuration 
(in this study, single cells or preformed aggregates). Translation of hPSCs to clinic for 
regenerative cell therapy will require its large scale propagation, along with functional 
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differentiation. In addition, encapsulation in a retrievable device is a necessity in current clinical 
trials, in particular for diabetes therapy [173]. Hence, in our 3D alginate array platform we 
evaluated the sensitivity of hESC proliferation and differentiation on encapsulation and substrate 
parameters. By integrating regression analysis with quantitative imaging, we identified that 
proliferation and differentiation were sensitive to substrate stiffness in the array at lower seeding 
densities, while cell aggregates were not. When simultaneously varying cell density, cell culture 
configuration, and substrate stiffness, we identified that hESC proliferation and differentiation 
were most strongly sensitive to configuration. Thus, in the current study, we report the variations 
of alginate crosslinking and culture configuration which are most amenable to proliferation and 
pancreatic differentiation of hESCs. 
The alginate array is constructed by first spotting a barium/PLL solution in the desired 
array configuration onto nitrocellulose coated tissue culture plastic. The solution is allowed to 
dry before spotting the cell-alginate solution directed on top of the cation spot. The physical 
stimuli imparted on the cells were directly controlled by the barium concentration used. We have 
previously identified the range of barium alginate stiffness, specifically 4-7 kPa, which was 
supportive of hESC growth and pancreatic differentiation in alginate hydrogel capsules [159]. 
Reproduction of the same stiffness range in the current array platform required higher Ba
2+
 
concentrations as compared to the alginate capsules. For example, in capsules, crosslinking with 
10 mM BaCl2 results in approximately 4 kPa stiffness, while 150 mM BaCl2 was necessary to 
achieve this same stiffness in the array. This difference in cation concentration needed to match 
the alginate stiffness in the two platforms are likely due to differences in gelation kinetics: while 
alginate capsules are formed by external gelation, the alginate array is primarily by internal 
gelation. For example, we have previously reported the alginate hydrogel stiffness to be ~1 kPa 
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for a 1.0% alginate crosslinked with 48 mM CaCO3 using internal gelation [117]; while Morch et 
al. have shown that alginate of the same type and concentration, crosslinked with 50 mM CaCl2 
resulted in hydrogels of ~10 kPa [36]. Since different gelation methodologies could result in the 
different hydrogel stiffness, in the current study we chose to adjust the cation concentration in 
order to reproduce the desired stiffness range conducive to hESC growth and pancreatic 
differentiation.  
The primary advantage of the array platform is it allows simultaneous perturbation of 
multiple parameters. We first used the platform to evaluate the effect of hydrogel crosslinking 
and culture configuration on the viability and growth of hESCs during pancreatic differentiation. 
Encapsulation of single cells, both 3 and 5x10
6
 cells/ml, and aggregates showed high viability 
after pancreatic induction. Encapsulated single cells grew into large viable cell colonies by the 
end of differentiation; however, for both SC3 and SC5, the number of viable cells decreased with 
increasing alginate crosslinking. This same trend was observed in our previous report using 
alginate capsules [159]. Interestingly, however, the viability of encapsulated preformed 
aggregates was unaffected by alginate crosslinking. This suggests that formation of preformed 
hESC aggregates prior to encapsulation resulted in a more robust starting population for 
differentiation. Encapsulation of single cells showed considerable cell death after encapsulation 
and during differentiation; however, both single cells and aggregates conditions showed good 
viability by the end of pancreatic differentiation. This suggests that single cells are more 
sensitive to encapsulation conditions and differentiation, even in the presence of Y-27632, while 
aggregates were more robust.  
Cell proliferation potential during pancreatic differentiation within the array was 
analyzed by Ki67 staining after the DE and PP stage, and quantified using the LICOR Odyssey 
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scanner. Overall, it was observed that under all tested conditions the cells were more 
proliferative at the end of DE stage, compared to the PP stage. This is expected, since as hPSCs 
undergo differentiation and approach maturation, their proliferative potential begins to decrease. 
However, comparison across the tested conditions showed distinct differences. At the DE stage, 
as substrate stiffness was increased, Ki67 expression increased for both the SC3 and SC5 
conditions, albeit only slightly for SC5. A similar trend was observed at the PP stage for both 
single cell conditions, while the aggregate condition showed no change in Ki67 expression as 
stiffness was increased. Although our platform is in 3D, a number of studies on 2D substrates 
have similarly shown that cell proliferation increases as substrate stiffness is increased [174-
177].  While expression of the proliferation maker increased with stiffness, cell growth was 
deceased as stiffness increased, as shown by a decrease in DNA content, due to the hydrogel 
physically inhibiting cell expansion. Similar results have been seen in alginate encapsulated 
breast cancer cells [178], neural stem cells [179], and hESC-derived pancreatic cells [159]. The 
importance of substrate stiffness on hESC proliferation during pancreatic differentiation was 
better resolved using a regression analysis. While studying the influence of cation concentration 
(hence, substrate stiffness), it was seen that the proliferation marker was not affected 
significantly by the cation concentration, except in the SC3 conditions at the DE stage. Since the 
relationship of Ki67 with hydrogel crosslinking in the SC3 condition was significant, it indicates 
that fine-tuning the stiffness will be beneficial at lower cell densities, with increasing stiffness 
favoring proliferation, especially at the DE stage. This relationship comes without loss of DE 
differentiation potential; however, cell number is decreased from the physical inhibition of 
growth as crosslinking increases.  At the PP stage, increasing cation concentration will not be 
beneficial for increasing proliferation. 
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While differentiation was influenced by substrate stiffness at both the DE and PP stages, 
the trends were less clear. At the DE stage, while SOX17 and FOXA2 expression in the SC5 
condition were not sensitive to changes in substrate stiffness, they were sensitive to changes in 
substrate stiffness in the SC3 condition.  For the aggregate condition, while the trend was not 
clear for FOXA2 expression, SOX17 expression increased as stiffness increased until the 100 
mM condition, after which it began to decrease. However, the regression analysis showed that 
the effect of crosslinking on differentiation at the DE stage was only significant in the SC3 
condition for SOX17. Similarly, the regression analysis identified that the effect of substrate 
stiffness on differentiation at the PP stage was only significant in the aggregate condition, while 
the single cell conditions were not. PDX1 expression increased until the 100 mM condition, after 
which expression decreased. Nkx6.1 was highest at the lowest stiffness condition of 10 mM, 
after which the expression deceased and reached steady state by the 100 mM condition. Schaffer 
et al. showed that the delineation between endocrine and exocrine cells during beta cell 
development is controlled in part by the expression of Nkx6.1 and PtF1a [180]. High expression 
of Nkx6.1 results in the repression of Ptf1a, leading to endocrine commitment. Previously, for 
alginate encapsulation of hESCs, we saw an increase in Ptf1a expression as alginate stiffness was 
increased [159]. Thus, the decrease in Nkx6.1 expression as alginate stiffness is increased could 
indicate a commitment to the exocrine pancreas as stiffness is increased.  This is further 
supported by the decrease in PDX1 expression after the 100 mM conditions,  as PDX1 
expression has been shown to decrease as the exocrine pancreas develops [180]. However, in the 
presence of experimental variability, the influence of hydrogel crosslinking to pancreatic 
differentiation was only significant in the aggregate condition, within the alginate array platform.   
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While only slight effects were observed to be significant when considering only substrate 
stiffness, performing a multiple regression analysis on both substrate stiffness and configuration 
identified the significant contributions to proliferation and differentiation. Conditions with lower 
seeding density were more proliferative for all alginate crosslinking conditions and at all stages 
of differentiation. Wu et al. observed that hPSC proliferation was decreased as cell density was 
increased in adherent cultures [181]. Similarly, while not in hPSCs, Stephan et al. showed that 
Ki67 expression was decreased in adult human intervertebral disc cells encapsulated in alginate, 
as seeding density was increased [182]. From the LIVE/DEAD images, the higher seeding 
density of the SC5 condition, resulted in slightly larger aggregates by the end of the DE stage 
compared to SC3, and considerably larger aggregates by the end of the PP stage. When 
encapsulated single cells undergo expansion, they form small cell aggregates within the alginate 
hydrogel. As these cells continue to grow, the propensity for aggregate coalescence is higher in 
the SC5 condition since more cells are present and more densely packed in the hydrogel, 
resulting in the larger aggregates observed after PP induction. Hence, the higher seeding density 
led to larger aggregates during culture, which in turn may have caused the decrease in 
proliferation, as seen by lower Ki67 expression. Interestingly, however, encapsulation of 
preformed aggregates showed lower Ki67 expression than either single cells condition at both 
the DE and PP stages, for all stiffness conditions. Nelson et al. have shown that endothelial and 
smooth muscle cell proliferation in 2D was inhibited by decreasing cell spreading as cells 
become crowded [183]. Gray et al. have shown that endothelial cell proliferation was increased 
when in contact with only one other cell, but was inhibited when in contact with two or more 
cells [184]. Thus, is it is possible that preaggregation of the hESCs prior to encapsulation, 
resulted in locally minimal cell spreading, which in turn limited the proliferative capacity within 
 123 
the hydrogel. Combined with the physical inhibition of cell growth imparted by the hydrogel 
stiffness, cell proliferation of preformed aggregates was minimized.  
Similar to what was seen with proliferation, culture configuration significantly influenced 
the differentiation potential at both the DE and PP stages, and while the effect of crosslinking 
was present, it was weak. Differentiation was most sensitive to changes in culture configuration, 
while alginate crosslinking had a secondary effect in certain cases. At the DE stage, the SC3 
condition showed higher SOX17 and FOXA2 protein expression as compared to the SC5 
condition for all stiffness conditions. However, SOX17 and FOXA2 expression in preformed 
aggregates was significantly higher than both the SC3 and SC5 conditions. This suggests that 
formation of tight cell-cell contacts from pre-aggregation prior to encapsulation may be 
promoting differentiation. This is supported by Tang et al., who have shown in 2D that the extent 
of mesenchymal stem cell osteogenic and adipogenic differentiation increases as cell-cell contact 
was increased [185]. While encapsulation of single cells in the SC3 and SC5 conditions 
eventually form aggregates as well, aggregates form primarily from confined single cell division, 
thus forcing cell aggregation over time as cells proliferate.  This indicates that formation of 
hESC aggregates prior to encapsulation is more supportive of differentiation at the DE stage than 
when cells form aggregates from single cells through cell proliferation. The same trends were 
observed at the PP stage as that seen at the DE stage. Encapsulation of preformed aggregates 
showed higher PDX1 and Nkx6.1 protein expression, as compared to either the SC3 or SC5 
conditions, suggesting that preformed aggregates as the starting population are more supportive 
of differentiation. Toyoda et al. have shown that an increase in cell density supported pancreatic 
differentiation of hESCs in adherent culture, and that aggregation of cells strongly enhanced 
pancreatic bud differentiation [161]. While we did not see the strong increase in differentiation 
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as cell density was increased in our 3D alginate array, we have observed a similar effect of cell 
aggregates strongly supporting differentiation. In future, we could focus efforts on finding 
optimal culture configurations for hPSC proliferation and differentiation in large scale 
biomanufacturing, while using hydrogel properties which are most supportive of bioreactor 
culture. 
4.5 CONCLUSIONS 
The objective of this chapter was to use alginate-based 3D microarray platform, to 
simultaneously evaluate the effect of culture configuration and alginate crosslinking on the 
directed differentiation of hESCs to the pancreatic lineage. While the effect of hydrogel 
crosslinking was shown to be minimal on proliferation of hESCs encapsulated as single cells, the 
effect was significant in the aggregate configuration. Encapsulation of single cells in the array 
showed higher growth and proliferation than aggregates during differentiation. However, single 
cells were more susceptible to apoptosis as compared to aggregates. Finally, the pancreatic 
differentiation of hESCs was sensitive to both crosslinking and culture configuration, although it 
was more strongly sensitive to the latter. While slight changes in pancreatic differentiation were 
observed as crosslinking in the array was varied, cells encapsulated as aggregates showed 
significantly higher levels of differentiation as compared to cells encapsulated as single cells. 
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5.0  ENGINEERED PEPTIDE MODIFIED HYDROGEL PLATFORM FOR 
BIOMANUFACTURING OF HUMAN PLURIPOTENT STEM CELLS 
5.1 INTRODUCTION 
Having demonstrated in Aims 1 and 2 that alginate hydrogel capsules provided a permissive and 
supportive environment for hPSC propagation and differentiation to pancreatic islet cell types, 
our next step was to consider large scale expansion for clinical translation. A vital step in the 
path to clinical translation of laboratory scale scientific advances in hPSCs is to implement 
reproducible, scalable culture and differentiation protocols.  The primary criterion for hPSC scale 
up platforms is the maintenance of high viability and proliferation without compromising 
pluripotency and differentiation potency. However, a critical requirement for hPSC survival and 
proliferation is maintaining cell-cell contact, failing which results in dissociation induced 
apoptosis.  This requirement significantly restricts options for scalable cultures, which has 
inspired novel avenues for hPSC scale-up. 
With maintenance of cell-cell contact being critical for hPSC survival, these cells are 
commonly cultured and propagated as colonies on adherent 2D substrates. The most commonly 
used method employs propagation on tissue culture plastic coated with Matrigel, an animal 
derived ECM protein cocktail [186]. However, being animal derived and expensive, this limits 
the scalability for use in cellular therapy applications [70]. Suspension culture systems, on the 
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other hand, are intrinsically better suited for scalable cultures because of geometric scalability. 
Current methods of suspension cultures of hPSCs include microcarrier culture [187, 188] and 
cell aggregate culture [189, 190]. Microcarrier culture offers the unique advantage of scaling up 
adherent hPSCs. While uniquely suited for hPSCs, this platform possesses a high propensity for 
undesirable cell clustering, along with problematic separation of cells from the carrier. Currently 
the most promising scalable platform is aggregate-based suspension culture of single cell 
inoculation with ROCK inhibition, which supports long-term cell survival in an undifferentiated 
state [191-198]. Key challenges with the current suspension cultures are (i) maintaining 
homogeneity of cell aggregates and (ii) accounting for the uncontrolled shear stress on the 
surface of aggregates. Specifically, the response of hPSCs to shear stress varies with cell lines, 
hence reducing the versatility of the platform [198, 199].  Overcoming these shortcomings will 
be highly critical in establishing a robust and controlled stem cell biomanufacturing platform.  
Maintaining tight cell-cell contact is indispensable for hPSC survival and proliferation; 
the absence of which results in ROCK pathway activation, actomyosin hyperactivation, and 
ultimately dissociation induced apoptosis. ROCK inhibition is by far the most commonly used 
procedure for single cell hPSC cultures, however, this only partially rescues the dissociation 
induced apoptosis [200].  Specifically, hPSCs treated with ROCK inhibitor can still result in over 
50% cell death upon dissociation [78]. The Rho/ROCK signaling cascade is initiated by 
dissociation of the transmembrane glycoprotein E-cadherin, a primary homophilic adhesion 
molecule responsible for hPSC survival [79] (Figure 5.1). 
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Figure 5.1: Schematic of E-cadherin binding between two hESCs.  
A) E-Cadherin protein. B) Trans dimerization of E-Cadherin in the presence of cell-cell contact. C) 
Dissociation induced apoptosis of hESCs. 
Hence, an alternative strategy to improve cell viability is to directly target E-cadherin [201]. To 
this end, the extracellular domain of E-cadherin has been successfully used to replace Matrigel in 
adherent cultures of hPSCs [202].  Recently, there has been extensive advancement in designing 
xeno-free, chemically defined substrates for 2D adherent cultures of hPSCs. A highly promising 
avenue has been to replace Matrigel with recombinant proteins such as laminin [68], a primary 
constituent of Matrigel, or vitronectin [69]. While this approach to produce hPSCs will comply 
with FDA regulations for cell therapy applications, the production of xeno-free recombinant 
proteins is highly expensive. This again places more limitations on transitioning hPSC culture to 
large scale applications due to the enormous cost. Therefore, there has been attempts to design 
synthetic peptides to replace the bioactive region of full protein; mimicking the bioactive regions 
of integrin’s with synthetic peptides has recently been successfully shown in 2D adherent 
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cultures of hPSC [203-205]. However, it is not obvious how critical integrin junction is for hPSC 
viability. In this study we have accordingly designed synthetic peptides to mimic E-cadherin, 
primarily because it is critical for hESC survival. We have designed a biomimetic alginate 
substrate which mimics the role of E-cadherin during cell-cell binding.  Alginate was chosen as 
the support substrate since it has been previously demonstrated to be suitable for hPSC 
propagation and differentiation. Additionally, alginate is easily modified with peptides using 
simple water soluble carbodiimide chemistry [206]. Our ultimate goal is to synthesize a 
biomimetic hydrogel for cell encapsulation for propagation in the large scale bioreactor setting; 
in this work we evaluated the E-cadherin mimicking peptides in 2D adherent culture. To this 
end, while informing optimal parameters for a future 3D platform, the 2D E-cadherin mimicking 
substrate developed in this chapter has commercial potential to replace current animal-derived 
substrates. 
E-cadherin dimerizes through completion of a trans interaction between adjacent EC1 
domains which contains either a ‘bulge’ region consisting of a conserved HAV peptide sequence 
or ‘groove’ regions through the ADT sequence [207-209] (Figure 5.1A). These and other 
sequences, based on overlapping dimers of various EC1-5 domains, have resulted in a variety of 
sequences that result in binding of E-cadherin of various cell types [207, 210, 211]. The EC1 
domain has been previously shown to be the primary E-cadherin subunit involved in cell-cell 
contact [212, 213]. Thus, we focused on this region to mimic E-cadherin binding using short 
synthetic peptides. We used peptide sequences based on the active domain of the bulge and 
groove region of the EC1 domain for production of our biomimetic E-cadherin mimicking 
alginate hydrogels (Table 1). 
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Table 1. E-cadherin mimicking peptides and sequences. 
 
Previous work using these peptide sequences has focused on sequestration of E-cadherin binding 
sites to increase intracellular porosity [207, 214-216]. On the other hand, N-cadherin-derived 
HAV peptide enhanced MSC chondrogenesis in conjunction with methacrylated hyaluronic acid 
[217]. The same substrate was recently shown to enhance osteogenesis of hMSCs [218]. The 
HAV motif from the EC1 domain of N-cadherin is highly conserved across other types of 
cadherin’s, and thus as previously mentioned, the same HAV domain is also present in the EC1 
domain of E-cadherin. However, these peptides have never been evaluated for use with 
pluripotent stem cells.  
We hypothesized that the extracellular E-cadherin domain of hPSCs will bind to the 
synthetic peptides of the biomimetic alginate to retain single-cell viability and clonogenicity. 
Hence, the objective of this study was to functionalize alginate hydrogels with synthetic peptides 
mimicking E-cadherin and evaluate peptide performance in promoting cell attachment, viability, 
maintaining pluripotency, and differentiation potential. We observed that alginate conjugated 
with HAV and ADT based peptides supported initial cell attachment and hPSC propagation. 
Cells propagated on the peptide modified substrates maintained good pluripotency and 
differentiation potential, as shown by gene and protein analysis. 
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5.2 MATERIALS AND METHODS 
5.2.1 hPSC Culture 
Undifferentiated (UD) H1 hESCs (WiCell) were maintained on hESC-qualified Matrigel (BD 
Biosciences) coated tissue culture plastic for 5–7 days in mTeSR1 (StemCell Technologies) at 
37°C and 5% CO2 before passaging. Experiments were performed with p55-p85 hESCs. 
5.2.2 Thin Alginate Hydrogel formation and peptide conjugation 
The alginate hydrogels were formed prior to peptide attachment. The culture well was coated 
with a thin layer of 1.1% (w/v) low viscosity alginate (Sigma-Aldrich) with 0.2% (v/v) gelatin 
(Sigma-Aldrich), which was allowed to dry overnight. 20 mM BaCl2 was used to rehydrate and 
simultaneously cross link the alginate in a thin hydrogel covering the bottom of the culture well. 
Peptide conjugation was done using water soluble carbodiimide chemistry [206]. Alginate 
hydrogels were activated by incubating with 20 mM/10 mM EDC/NHS in buffer containing 0.3 
M 2-(N-morpholino) ethanesulfonic acid (MES) and 0.1 M NaCl, for 15 min. The peptides were 
then added and incubated overnight at 4ºC to allow for peptide conjugation to the carbonyl 
groups of the alginate hydrogel. After conjugation, peptide modified hydrogels were washed 
with 0.9% saline prior to seeding cells. 
Confirmation of peptide conjugation to the alginate hydrogels was done using the BCA 
assay, according to manufacturer’s instructions. Briefly, peptide conjugated alginate hydrogels 
were incubated with BCA reagent at 60ºC for 30 min. The resulting supernatant absorbance 
analyzed using a Synergy 2 multi-mode Microplate Reader (BioTek, Winooski, VT, USA). 
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5.2.3 Cell Attachment 
For cell attachment studies to the peptide modified hydrogels, hESC were first labeled with DiD 
according to manufactures instruction, a fluorescent lipophilic dye, which is incorporated in the 
cell membrane.  hESC were treated with 10 μm Y-27632 (R&D Systems, Minneapolis, MIN) for 
2 hours prior to harvesting by Accutase (Invitrogen) treatment for 5-7 min. For cell attachment, 
studies were performed in a 48 well plate, seeded with 50,000 cells/well. Cell attachment was 
analyzed 24 hours after seeding. First, total cell number per well was quantified using the LI-
COR Odyssey scanner and Image Studio software to obtain the total possible MFI. Dead and 
unattached cells were washed away and the number of attached cells per well was again 
quantified using the LI-COR Odyssey scanner Image Studio software.  Cell attachment data was 
presented as percent attachment by normalizing the attached cell MFI to the total cell MFI for 
each peptide and peptide concentration. 
5.2.4 LIVE/DEAD Assay 
LIVE/DEAD (Life Technologies) viability assay was performed according to manufacturer’s 
instructions. 
5.2.5 Cell Expansion 
To determine cell expansion, cellular metabolism was assayed on cells attached to alginate 
conjugated with 50 µg/ml of each peptide using the CellTiter 96 ® AQueous One Solution Cell 
Proliferation Assay (MTS) after 1 and 6 days of culture, according to manufacturer’s 
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instructions. Briefly, cells were incubated with the MTS solution at a 1:5 v/v dilution for 3 hours 
at 37ºC. Absorbance intensity of the supernatant at 490 nm was measured using a Synergy 2 
multi-mode Microplate Reader. Fold expansion was determined by normalizing the day 6 
absorbance by the day 1 absorbance, for cells grown on each peptide-conjugated alginate 
substrate. 
5.2.6 Directed Differentiation 
hESC seeded on the peptide modified alginate hydrogels were propagated for 4 days in mTeSR1 
with 10 µm Y-27632 prior to DE induction. DE was induced using 100 ng/ml ActivinA (R&D 
Systems) with 25 ng/ml Wnt3A (R&D Systems) for 4 days. 
5.2.7 Quantitative Reverse Transcriptase Polymerase Chain Reaction 
mRNA was isolated using the NucleoSpin RNA II kit (Macherey-Nagel, Bethlehem, PA). cDNA 
was obtained using ImpromII Reverse Transcription (Promega, Madison, WI). Each PCR 
reaction contained 5 µl SYBR Green Master Mix (Agilent, Santa Clara, CA), 2 µl nuclease free 
H2O, 2 µl primer, and 1µl cDNA. Samples were normalized to the house keeping gene GAPDH 
and analyzed relative to UD hESCs using the ΔΔCt method. Gene expression was measured with 
quantitative polymerase chain reaction (qRT-PCR) using an MX3005P system (Agilent). 
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5.2.8 Immunostaining 
Cells were fixed with 4% formaldehyde for 20 min, and were permeabilized with 0.1% Triton-X 
(Sigma) in 0.9 % saline for 5 min.  A blocking step with 10% donkey serum in 0.9 % saline was 
done for 1 hour. For primary antibody staining, we used goat anti-Nanog (1:200 dilution, Cell 
Signaling, Danvers, MA). The incubation time for primary antibodies was done overnight at 4°C. 
Cells were incubated with the secondary antibody for 45 min at room temperature. For secondary 
antibody staining, we used anti-goat Alexafluor 488 (1:500 dilution). Cells were washed three 
times with 0.9 % saline (5-10 min) before mounting on slides with hardening mounting medium 
containing DAPI (Vectashield, Vector laboratory). Imaging was done using a Nikon A1 confocal 
microscope. 
 
5.2.9 Statistical Analysis 
Statistical significance comparing multiple groups was determined using one-way ANOVA, with 
Tukeys or Games-Howell post hoc testing for homogeneous or inhomogeneous variance, 
respectively. Probability values at P < 0.05(*) and P < 0.01 (**) indicated statistical significance. 
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5.3 RESULTS 
5.3.1 Substrate Design and Characterization 
A thin alginate hydrogel was created by first coating tissue culture wells with a 1.1% alginate 
solution, allowing this coating to dry, and finally rehydrating the dried alginate using 20 mM 
BaCl2 (Figure 5.2A).  
 
Figure 5.2. Schematic of peptide conjugated alginate hydrogel and characterization.  
A) Schematic of alginate hydrogel formation in a well plate. B) Carbodiimide chemistry was used to 
activate the carboxylic acid groups on alginate, forming a peptide bond with the N-terminus of the desired 
peptide. C). BCA protein assay analysis confirming the attachment of the peptides to alginate. 
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The BaCl2 crosslinks the alginate as it is being rehydrated, which resulted in a thin alginate 
hydrogel that covered the entire culture surface, thus preventing cells from getting underneath 
the gel between the tissue culture plastic and hydrogel. Peptide conjugation was achieved by first 
activating the alginate hydrogel using 20/10 mM EDC/NHS (Figure 5.2B). The EDC activates 
the carbonyl groups of the alginate back bone, forming an unstable o-Acylisourea intermediate. 
This intermediate is stabilized by the addition of the NHS, forming a reactive sulfo-NHS ester 
group on the carboxylic acid groups of the alginate substrate, allowing for peptide bond 
formation with the N-terminus of the e-cadherin peptides.  
Peptide conjugation to the alginate hydrogel was confirmed using the BCA assay (Figure 







. This chelates the BCA reagent, and thus, in the presence of the peptide-
conjugated hydrogels, results in a colorimetric detection of the attached peptides, quantified 
using absorbance spectroscopy. The presence of the conjugated peptide was represented as the 
absorbance from each peptide conjugated hydrogel, normalized to the absorbance of the alginate 
hydrogel alone. A similar level of absorbance was detected for each peptide and ranged from 1.6 
to 2.2-fold increase in absorbance as compared to alginate alone, for HAV10 and ADT6 
conjugated hydrogel respectively. 
5.3.2 hESC Attachment to Peptide Conjugated Alginate hydrogel 
Having confirmed peptide conjugation to the alginate hydrogel, our first step was to analyze cell 
attachment to each peptide conjugated substrate. Peptide concentration during conjugation was 
varied from 0 µg/ml (EDC/NHS activation of alginate alone) to 500 µg/ml. hPSCs were treated 
with Y-27632 prior to harvesting, and seeded as single cells on the alginate conjugated with 
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HAV10, ADT10, HAV6, and ADT6. As steric hindrance could significantly influence cellular 
access to the peptide, both a short (6 amino acids) and long (10 amino acids) variant of peptides 
mimicking the bulge (ADT) and groove (HAV) regions of E-cadherin, were examined. Prior to 
seeding, cells were labeled using DiD, a lipophilic fluorescent dye, which is incorporated into the 
cell membrane. After 1 day, cell attachment was quantified for each tested condition using the 
LI-COR Odyssey scanner. Percent cell attachment was determined by scanning the signal for 
total seeded cells (prior to wash) and attached cells (post-wash) and normalizing the attached cell 
MFI to the total cell MFI, for each peptide and peptide concentration (Figure 5.3A).  
 
Figure 5.3. Cell attachment to e-cadherin peptide modified alginate.  
(A) Percent cell attachment after 1 day, determined by normalizing attached cell MFI by total cell MFI. 
Cell attachment was analyzed for each peptide, conjugated at 0 – 500 µg/ml. (B) LIVE/DEAD analysis for 
cell attached to each peptide modified hydrogel, conjugated with 50 µg/ml.  
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For each peptide, as concentration was increased, cell attachment correspondingly increased. 
Cell attachment to the HAV10 and ADT6 substrates peaked at the 50 µg/ml condition, after 
which attachment decreased slightly or was unchanged. Cell attachment to the HAV10 
conjugated substrate was essentially unchanged from the control, until a sharp increase in 
attachment was observed at the 50 µg/ml condition. Cells attached to the ADT10 substrate 
continuously increased as peptide concentration was increased, and showed the highest cell 
attachment among all peptides, at all concentrations except 50 µg/ml. Interestingly, while the 
HAV6 conjugated substrate only showed higher cell attachment than the HAV10 substrate at 
concentrations less than 100 µg/ml, at the highest concentration of 500 µg/ml it showed higher 
cell attachment than HAV6 and HAV10 and was on par with ADT10. Figure 5.3B shows 
representative day 1 LIVE/DEAD images of cells attached to alginate conjugated with 50 µg/ml 
for each peptide. While cells were plated as single cells, upon attachment and interaction with 
the E-cadherin mimicking substrates, they quickly began to form small, rounded colonies when 
in contact with peptide modified alginate. Thus, hPSCs showed a concentration dependent 
attachment to peptide modified alginate, and each peptide performed similarly when considering 
cell attachment. While there was quantitative differences in cell attachment in individual 
peptides, cell morphology appeared similar in all the tested conditions. 
5.3.3 hESC Viability and expansion potential after propagation 
Having confirmed and quantified initial cell attachment, we next wanted to evaluate how the E-
cadherin mimicking substrates support hPSC propagation. Cell viability and morphology were 
analyzed after 6 days of propagation using the LIVE/DEAD assay, on each of the peptide 
modified alginate hydrogels, again conjugated with 0.1 – 500 µg/ml of each peptide (Figure 5.4).  
 138 
 
Figure 5.4. Cell viability and morphology after 6 days of propagation for each peptide, conjugated at 
0 – 500 μg/ml.  
White arrows indicate apoptotic single cells observed on the periphery of some colonies after propagation. 
High cell viability was observed on all peptides and no dependence of viability on 
peptide concentration was observed. For the most part, apoptotic colonies were not observed 
after the 6 days of propagation, however a small number of apoptotic cells were observed on the 
periphery of colonies in some conditions. Additionally, a small population of apoptotic single 
cells was observed, which appeared to have shed off the colonies during culture, or died initially 
during the seeding step.  For each peptide, at all concentrations tested, the colony size increased 
during the 6 days propagation period, and retained the characteristic round and uniform hPSC 
colony morphology. However, the colonies appeared to have slightly “domed” or “pancake”-like 
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morphology, as shown by darker regions in the center of the colony in the microscopy images, 
indicating that the hPSC colonies were thicker in the center as compared to the edges. While 
little to no difference in colony size or diameter was observed when comparing across each 
peptide, colony size did appear to change in response to peptide concentration. For the most part 
though, larger colonies were observed at the lower peptide concentrations, and as concentration 
was increased, there appeared to be a higher occurrence of small colonies, although larger 
colonies were still observed.  
Since high cell expansion is necessary to generate clinically relevant numbers of hPSCs, 
we next quantified the expansion potential of hPSCs grown on each peptide. Expansion potential 
was determined by normalizing cell number after 6 days of propagation, by day 1 cell number 
using MTS. Figure 5.5 shows hPSC expansion potential on alginate modified with 50 µg/ml of 
each peptide.  
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Figure 5.5. Day 6 hPSC expansion potential on recombinant e-cadherin, or alginate conjugated with 
each peptide. n=3, results were considered significant if *P<0.05, **P<0.01. 
The highest expansion was observed with hPSCs grown on HAV10 substrates, showing an 
approximately 23-fold expansion. Interestingly, while still high, cells propagated on recombinant 
E-cadherin protein showed only a 10-fold expansion over 6 days of propagation. ADT10 
conjugated alginate also showed higher expansion than E-cadherin, with an approximately 14 
fold expansion. HAV6 and ADT6 showed a similar trend as the longer peptides, although 
expansion was lower in magnitude, with a 16 and 11-fold expansion, respectively. Taken 
together, it is clear that the E-cadherin mimicking substrates can support hPSC proliferation, and 
high expansion potential.  
 141 
5.3.4 hESC Pluripotency on Peptide Modified Substrate 
Having confirmed the substrates supported attachment and propagation of hPSCs, our next step 
was to analyze the maintenance of hPSC pluripotency after propagation. hPSC pluripotency is 
the ability to become any cell type in the body, and along with self-renewal, is the defining 
characteristic of hPSCs. The maintenance of pluripotency is required for the downstream of 
hPSC for differentiation into any functions cell type, for cell therapy applications. As cell 
attachment and propagation did not change considerably when alginate was conjugated with 
peptide concentrations higher than 50 µg/ml, this condition was chosen to evaluate hPSC 
pluripotency for each peptide. hPSCs were seeded on alginate conjugated with 50 µg/ml of 
HAV10, ADT10, HAV6, or ADT, and propagated for 6 days. Again, cell morphology was 
similar across each peptide, and appeared to have similar morphology to the typical hPSC colony 




Figure 5.6. hPSC pluripotency after propagation on the peptide modified alginate substrate.  
(A) Phase contrast images of hPSC morphology after 6 days of propagation on alginate modified with 50 
μg/ml of HAV10, ADT10, HAV6, or ADT6. (B) Gene expression analysis of OCT4 and Nanog. n=3, 
results were considered significant if *P<0.05, **P<0.01. (C) Nanog immunostaining of hPSC colonies 
propagated on each peptide conjugated substrate. 
Pluripotency was first analyzed by qRT-PCR for gene expression of OCT4 and Nanog, and was 
shown relative to cells propagated on Matrigel (Figure 5.6B). Cells propagated on HAV10 
substrates showed an approximately 2-fold down regulation of OCT4 compared to Matrigel 
controls; however, expression of Nanog was slightly upregulated. On the other hand, cells 
cultured on HAV6 showed a 2 and 1.5 fold upregulation of OCT4 and Nanog, respectively, 
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compared to Matrigel. The ADT10 modified substrate had the highest upregulation of 
pluripotency markers, which showed a 3 and 1.5-fold upregulation of OCT4 and Nanog 
respectively, compared to Matrigel. Cells propagated on ADT10 showed significantly higher 
expression of OCT4, as compared to cells on HAV10. Similarly, ADT6 also retained good 
pluripotency with expression of OCT4 and Nanog on par with Matrigel, as showed significantly 
higher OCT4 expression compared to HAV10. Next, maintenance of pluripotency was 
confirmed by protein immunostaining for Nanog (Figure 5.6C). Cells positive for Nanog were 
observed in hPSC colonies propagated on each of the peptide modified substrates. Thus, it is 
clear that hESCs grown on each E-cadherin mimicking substrate retained high pluripotency, 
which were comparable to, and even higher, than the Matrigel control. 
5.3.5 hESC Differentiation Potential 
Having confirmed that hPSCs maintained high pluripotency after being propagated on the E-
cadherin mimicking substrates, the next question was if the differentiation potency was also 
maintained. To evaluate differentiation potential, cells were induced toward the definitive 
endoderm (DE) germ layer. Differentiation was analyzed after hPSCs were propagated on 
alginate modified with each of the peptides, and subsequently induced to the DE stage. Figure 
5.7A shows gene expression analysis of SOX17 after DE induction, which showed a strong 
upregulation for cells grown on HAV10 (~15000-fold) and ADT10 (~13700-fold), as compared 




Figure 5.7. Differentiation potential of hESCs propagated on e-cadherin peptide mimicking 
substrates.  
hPSCs were induced to the definitive endoderm stage using chemical induction. qRT-PCR was used to 
analyze the relative gene expression of SOX17 and FOXA2 for cell grown on each peptide conjugated 
hydrogel. n=3, results were considered significant if *P<0.05, **P<0.01. 
Although still highly upregulated, expression of SOX17 on the shorter peptides HAV6 and 
ADT6 showed an upregulation of 5900 and 3400-fold respectively, compared to undifferentiated 
controls. While cells grown on the Matrigel controls showed a 25000-fold upregulation of 
SOX17, cells grown on the HAV10 and ADT10 peptide modified substrates showed no 
statistical difference compared to Matrigel. Likewise, gene expression analysis of FOXA2 
showed a similar trend, although of a lower magnitude, with fold increases of 497, 409, 355, and 
174 for HAV10, ADT10, HAV6, and ADT6, respectively. Again, however, there was no 
statistical difference between cells differentiated on Matrigel, as compared to HAV10 or ADT10 
based substrates. These findings indicate successful induction of hESC to the DE stage, 
confirming cells propagated on the peptide modified substrates retained differentiation potency. 
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5.3.6 Cell Attachment and Pluripotency using Peptide combinations 
In analysis performed thus far, specific peptide has specific advantages. For example, while 
ADT10 appeared to support the highest initial cell attachment, and retained the highest 
pluripotency’s, HAV10 showed the highest expansion potential and level of differentiation. 
Hence, we next examined if attachment, viability, and pluripotency further improved by 
conjugating alginate with a combination of peptides. Thus, Alginate was conjugated with 
HAV10 + ADT10, HAV10 + ADT6, ADT10 + HAV6, or ADT6 + HAV6, using 50 µg/ml for 
each peptide. Single cell hPSCs were seeded on each substrate, and attachment and cell viability 
were evaluated after 1 day (Figure 5.8).  
 
Figure 5.8. Day 1 hPSC attachment to alginate modified with HAV and ADT peptides. 
(A) Day 1 attachment on alginate conjugated with 50 µg/ml of each peptide individually. (B) Day 1 
attachment to alginate conjugated with combination of each peptide, each conjugated at 50 µg/ml. (C) 
LIVE/DEAD images of cell attached to alginate conjugated with peptide combination. Scale bar is 450 µm. 
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Both attachment and cell viability for each peptide combination was similar to that seen 
when individual peptides were conjugated alone. Specifically, cell attachment ranged from 0.38 - 
0.48 % attachment for individual peptides, and similarly, cell attachment with peptide 
combinations ranged from 0.35 – 0.5 %. Thus, conjugation of peptide combination did not 
significantly alter attachment from single peptides.  
While cell attachment was not changed considerably by conjugating alginate with peptide 
combinations, it did have an effect on hPSC pluripotency. Previously, we observed that OCT4 
expression was down regulated compared to Matrigel on HAV10 substrates, while OCT4 
expression was actually upregulated on and ADT10 substrates. Interestingly, when HAV10 and 
ADT10 were combined, OCT4 expression was upregulated by 2-fold compared to Matrigel 
controls (Figure 5.9).  
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Figure 5.9. hPSC pluripotency after propagation on alginate modified with combination of HAV and 
ADT peptides. 
All other peptide combinations showed OCT4 expression to be on par with the Matrigel controls. 
Similarly, each peptide combination showed Nanog expression to be on par with the Matrigel 
control, with the exception of the HAV6 + ADT6 conditions. When the peptides were combined 
during conjugation, the resulting Nanog expression was slightly down regulated, while the 
peptides showed a slight upregulation when conjugated individually. Taken together, while cell 
attachment was unaffected by combining the peptide, an increase in pluripotency was observed 
with some combinations. 
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5.4 DISCUSSION 
The objective of this chapter was to incorporate synthetic peptides mimicking E-cadherin into a 
hydrogel substrate for the single cell culture of hPSCs. The use of a low cost synthetic peptide 
based substrate for hPSC culture can directly be used as a replacement for current expensive 
animal derived platforms, such as Matrigel. The use of E-cadherin based peptides has the 
potential to mitigate hPSC death occurring when these cells are cultured as single cells. This 
platform can then be further extended to 3D culture for biomanufacturing of hPSC in the 
bioreactor setting. Thus, the requirements for meeting these goals will be to develop a platform 
that (1) is low cost, (2) supports single hPSC attachment and viability, (3) maintains hPSC 
pluripotency, and (4), retains hPSC differentiation potential. In the synthesis of this platform, we 
have evaluated each of these criteria using 4 peptide sequences which mimic the EC1 domain of 
E-cadherin. We observed that each peptide supported both good initial attachment and viability, 
as well as hPSC propagation. While hPSCs maintained pluripotency and differentiation potential 
on most peptide-conjugated substrates, some dependence on peptide length and type was 
observed. Hence, in this chapter we have shown for the first time that E-cadherin mimicking 
synthetic peptides can be used for the culture and differentiation of hPSCs. 
 To evaluate this platform’s ability to promote single cell viability, our first step was to 
evaluate attachment as a function of peptide type and concentration. Previous reports have shown 
that synthetic peptides containing the bioactive regions of ECM proteins, such as laminin and 
vitronectin, support good hPSC attachment and pluripotency [204, 205, 219]. Additionally, the 
use of the full E-cadherin protein has successfully been used to replace Matrigel for hPSC 
propagation and self-renewal [220]. However, it was unclear if synthetic peptides mimicking 
only the EC1 domain of E-cadherin could also support hPSC attachment. Our findings showed 
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that alginate conjugated with each of the tested peptides supported single hPSC attachment. Cell 
attachment increased as peptide concentration was increased and was similar for HAV10, 
ADT10, HAV6, and ADT6 conjugated substrates. This is in contrast to a previous report which 
found that E-cadherin alone did not support single hPSC attachment and clonal expansion, but 
required a combination of E-cadherin with ECM, in this case, laminin fragments [221]. 
Similarly, while not shown with hPSCs, previous work with hMSCs showed that methacrylated 
hyaluronic acid hydrogels conjugated with a HAV containing N-cadherin peptide supported 
hMSC attachment, as well as chondrogenesis [217] and osteogenesis [218]. Again, these 
substrates engaged cell-cell contacts through the N-cadherin peptide and cellular cadherin’s, as 
well as integrin’s through the hyaluronic acid. It is unclear whether the N-cadherin peptide alone 
is responsible, or if a combination with integrin is necessary. In this work, however, attachment 
could occur without additional ECM components, and was dependent on peptide concentration, 
although only a slight dependence on peptide type and length was observed. 
 We next evaluated whether the combined conjugation of peptides from both the bulge 
and groove region of the EC1 domain of E-cadherin could improve cellular attachment. Our 
results showed that using a combination of HAV and ADT peptides, did not result in an increase 
in cell attachment, as compared to single peptides. These results are similar to previous reports, 
which have shown that a combination of peptides from the bulge and groove region did not 
increase the inhibition of tight intracellular cell-cell junctions on CaCo-2 and MDCK cells, as 
compared to individual peptide [222, 223]. However, these studies combined the peptides by 
linking them together, forming a single peptide with bioactive domains from both regions. In our 
system, we conjugated a combination of single HAV and ADT peptides to the alginate substrate. 
Additionally, the previous studies required the peptides to be in solution, as opposed to being 
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attached to the culture surface. However, taken together, our findings, as well as the previous 
reports, clearly indicate that engaging both the bulge and groove region is not required to invoke 
a cellular response. Thus, the use of fused HAV-ADT peptides, or a combination of single HAV 
and ADT peptides, did not enhance peptide performance, as compared to individual HAV or 
ADT peptides. 
 E-cadherin peptides supported good initial cell attachment, however supporting long term 
culture and high cell expansion is also required. Cells propagated for a period of 6 days showed 
good viability on each peptide modified substrate, however there appeared to be little to no effect 
of peptide concentration on hPSC propagation. hPSC expansion potential on the peptide-
modified alginate will provide insight as to how this system can perform when transitioned to 
large scale bioprocessing. Initial studies using Matrigel coated microcarriers achieved a 20-fold 
expansion of hPSCs [224, 225]. Here, we observed that hPSCs propagated on our substrate 
achieved an approximately 15-23-fold expansion, which was comparable to these previous 
studies. Interestingly, we observed that hPSC propagated on the full E-cadherin protein 
supported only a 10-fold expansion. Taken together, these results show that E-cadherin peptide-
modified substrates support high cell attachment, proliferation and cell expansion. 
 While supporting cell attachment is critical in evaluating peptide performance, the long 
term goal of this work will be to incorporate these peptides in alginate in the 3D setting, and thus 
ensuring cell-peptide interaction. The evaluation of pluripotency after propagation on the E-
cadherin peptide substrates is of critical importance for informing the optimal settings for future 
3D platforms. Nagaoka et al. showed that hPSCs passaged and cultured as colonies on human 
recombinant E-cadherin substrates maintained pluripotency and self-renewal [220]. Herein 
however, the hPSC starting population being plated on peptide-conjugated substrates consisted 
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of single cells and not colonies, which is more advantageous for large scale bioprocessing. 
Analysis of the pluripotency genes OCT4 and Nanog showed clear differences in peptide 
performance, which appeared to be dependent on peptide type and length. Specifically, OCT4 
and Nanog expression was down regulated 2-fold and upregulated 1.9-fold, respectively, on the 
HAV10 substrate. However, hPSCs propagated on the ADT10 substrates showed a 3.6 and 1.6-
fold upregulation of OCT4 and Nanog, respectively. Interestingly, while no effect was seen on 
cell attachment, cells propagated on alginate conjugated with a combination of HAV10 and 
ADT10, showed an OCT4 upregulated by 2.2-fold. Thus, the addition of ADT10 appeared to 
rescue the pluripotency of hPSCs propagated on HAV10 alone. This indicates that while both the 
bulge and groove region of E-cadherin was not required for cell attachment, it may be 
advantageous for maintenance of hPSC pluripotency.  
 Maintaining pluripotency is essential for large scale bioprocessing and production of 
clinically relevant cells number; however, the maintenance of good differentiation potential is 
also required for cell therapy applications. Previously, it has been shown that an acrylate surface 
modified with ECM based peptides not only supported hESC self-renewal, but also supported 
cardiomyocyte differentiation [219]. To evaluate the differentiation potential on our E-cadherin 
peptide modified substrate, we evaluated hPSC germ layer induction to the DE stage after 
propagation on alginate conjugated with each of the E-cadherin peptides. The DE layer gives rise 
to a number of functional cell types, such as insulin producing cells and hepatocytes, all of which 
are in high demand for cellular therapy [70]. The DE gene markers SOX17 and FOXA2 were 
highly upregulated on each of the four substrates; however, HAV10 and ADT10-conjugated 
substrates showed the best performance. While cells grown on Matrigel coated TCP showed 
slightly higher expression of the DE markers, the level of differentiation on E-cadherin peptides 
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was comparable to the gold standard control. This data supports similar findings in a previous 
report, although in mESCs, which found that a recombinant E-cadherin substrate supported 
endoderm differentiation [226]. Thus, it is clear that E-cadherin peptides can also strongly 
support directed differentiation of hPSCs. 
5.5  CONCLUSIONS 
Previous reports have indicated that cell-cell contact through E-cadherin is critical for hPSC 
viability and pluripotency. To that end, it has also been shown that recombinant E-cadherin 
protein can support hPSC colony attachment, pluripotency, and differentiation. However 
production of recombinant human E-cadherin is highly expensive and will serve as a major 
bottleneck in the translation from lab scale hPSC culture to large scale biomanufacturing. In this 
chapter, we showed that short, inexpensive, synthetic peptides derived from E-cadherin can be 
used in place of the full E-cadherin protein. Peptide-modified alginate substrates supported good 
initial cell attachment, viability after propagation, and have an expansion potential on par with 
recombinant E-cadherin. More importantly, however, hPSCs cultured on this substrate 
maintained high pluripotency and differentiation potential. Future studies will focus on 
incorporating the E-cadherin peptides into alginate capsules in 3D. Peptide functionalized 
hydrogel capsules will provide a controlled environment for hPSC survival, propagation, and 
differentiation, while isolating the hPSC colonies from external stresses associated with 
bioreactor hydrodynamics.   
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6.0  OVERALL CONCLUSIONS AND FUTURE WORK 
The overall goal of this work was to establish a directly transplantable 3D culture platform that 
would support hPSC proliferation and viability, good pancreatic differentiation, and have the 
capacity for immunoisolation. Having established alginate as a suitable platform for 
differentiation in Chapters 2-4, we further evaluated its modification to support single hPSC 
culture for large scale biomanufacturing applications in Chapter 5. We established that alginate 
could support the pancreatic differentiation of hPSCs, and then e-cadherin mimicking alginate 
substrates could also support single hPSC attachment, pluripotency, and differentiation. Taken 
together, this work shows the potential for alginate encapsulation to be a viable platform for 
large scale biomanufacturing of undifferentiated hPSCs, which can be directly differentiated 
after propagation. This has a great potential to alleviate current bottle necks in hPSC 
biomanufacturing for cell therapy applications 
6.1 AIM 1: ALGIANTE ENCAPSULATION AS A PLATFORM FOR THE 
PANCREATIC DIFFERENTIATION OF HPSCS 
Alginate encapsulation has been utilized for decades for the encapsulation of pancreatic islets 
because it supports islet viability, and can immunoisolate the encapsulated cells from the 
immune system post implantation [5, 12-22]. This eliminates the need for regular 
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immunosuppression, which ultimately leads to a more complete treatment and cure to T1D, and 
can provide better patient quality of life. Thus, our objective in Aim 1 (Chapter 2) was to 
evaluate alginate as a platform for the pancreatic differentiation of hPSCs, which then has the 
potential to be directly transplanted for T1D treatment. In this work, we established that while 
encapsulation of a predifferentiated DE population resulted in the best differentiation, the yield 
of viable cells upon mature differentiation was limited. However, encapsulation of 
undifferentiated hPSC resulted in a high cell viability, and enhanced the pancreatic 
differentiation of hPSC compared to the gold standard 2D Matrigel controls. 
In 2014, seminal work by the Melton lab established a new pancreatic differentiation 
protocol for hPSCs, capable of generating mature, functional glucose responsive β cells in vitro 
[46]. The protocol established in our lab (Figure 2.1A) when the work in Chapter 2 was 
completed, was adapted from a prior protocol by D’Amour [227]. Our protocol was also capable 
of generating glucose responsive β cells from hPSC in vitro; however, these cells were 
polyhormonal, indicating immaturity. Thus, future work related to AIM 1 will be to evaluate the 
pancreatic differentiation protocol established by Melton, under calcium alginate encapsulation. 
The key finding of this differentiation protocol was the generation of glucose responsive hPSC-
derived islets in vitro. Since we perceived a low level of glucose responsiveness using our 
differentiation protocol with alginate encapsulation, which we had not achieved in 2D culture, 
we can anticipate the observation of enhanced performance when using this updated 
differentiation protocol. While it will be important to demonstrate physiological levels of glucose 
responsiveness in vitro, the next step will be implantation of alginate encapsulated hPSC-derived 
islets in a mouse model.  
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In Aim 1, we have demonstrated that alginate encapsulation can improve the pancreatic 
differentiation of hPSCs, compared to 2D controls. In addition to our work, it has also been 
shown that alginate encapsulation enhanced the differentiation of hPSCs to midbrain dopamine 
neurons [55], and hESC-derived male germ-like cells [228], compared to traditional 2D culture.  
Additional future work for this Aim could include applying alginate encapsulation as a 
differentiation platform for other tissues-based functional cell types, such as thymus, liver, 
kidney, intestinal, or lung cells, to generate desirable cells for cell replacement therapy. 
6.2 AIM 2: THE EFFECT OF ALGIANTE CAPSULE PROPERTIES ON THE 
PANCREATIC DIFFRENTIATION OF HPSCS 
Stem cell differentiation is traditionally achieved by addition of soluble chemical factors 
in a stage wise fashion, mimicking stages of in vivo development. These chemical factors, 
including proteins and small molecules, modulate key signaling pathways, resulting in stem cell 
specification to the desired lineage. However, during embryonic development, both soluble and 
insoluble cues drive development and lineage specification [229]. Thus, countless studies over 
the last decade have shown that insoluble differentiation cues can also strongly influence stem 
cell differentiation in vitro [57, 114-120] . These insoluble cues include substrates stiffness, cell-
cell interactions, and cell-ECM interactions. In Aim 1 of this work, we clearly established that 
the pancreatic differentiation of hPSCs was significantly improved when done under alginate 
encapsulation, as compared to TCP. In Aim 2, we further investigated this by varying alginate 
crosslinking, and thus the resulting stiffness, and investigated how directed pancreatic 
differentiation was influenced. Interestingly, we observed a biphasic response to differentiation 
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as stiffness was increased, depending on the stage of differentiation. An increase in alginate 
stiffness supported DE stage differentiation; however, it suppressed differentiation at the PP 
stage. Signaling analysis identified that increased alginate stiffness enhanced TGFβ signaling, 
which is responsible for DE specification, but is also detrimental during downstream PP stage 
differentiation. 
The above results were for a single controlled perturbation; however, we further wanted 
to evaluate the effects of multiple simultaneous perturbations on the pancreatic differentiation of 
hPSCs. To enable this, in the second part of Aim 2 (Chapter 4) we designed  a 3D alginate array 
platform for the high throughput investigation of multiple simultaneous non-soluble 
differentiation cues on the directed pancreatic differentiation of hPSCs. We again varied alginate 
stiffness by varying crosslinking concentration, but in Chapter 4 we introduced the effect of 
culture configuration (cell-cell contact) by encapsulating cells as single cells or as preformed 
aggregates. Using statistical analysis, we identified that while cell proliferation and 
differentiation showed a slight dependence on alginate stiffness, they were more strongly 
influenced by culture configuration during directed differentiation. These studies are the first to 
demonstrate, to the best of our knowledge, the importance of insoluble differentiation cues 
during the pancreatic differentiation of hPSC. The general consensus in the field of hPSC 
differentiation is that the effect of insoluble cues is secondary to soluble cues, because key 
signaling pathways are being directly modulated by the added soluble factors. However, in this 
work, we have clearly shown that the insoluble differentiation cues can enhance the effect of 
soluble cues during pancreatic differentiation of hPSCs. Encapsulation offers clear advantages 
for implantation and large scale bioprocessing, and thus, balancing the effects of insoluble and 
soluble cues to identify synergistic ranges of both will be critically important. 
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For future work, it will be important to include additional insoluble cues utilizing the 
alginate array platform. Specifically, it has been previously shown that ECM proteins can 
strongly influence stem cell differentiation [151-153]. In our own lab, we have seen that the 
pancreatic differentiation of hPSCs was responsive to different organ derived ECM proteins 
(liver, heart, or pancreas). Evaluating the response of encapsulated hPSCs while varying the 
alginate stiffness, culture configuration, and ECM proteins in the alginate, will further inform 
optimal hydrogel setting to achieve optimal differentiation. Additionally, the establishment of the 
Melton protocol was developed using hPSC aggregates in suspension culture. While this 
platform included cell-cell contact, it will be interesting to determine if the current “gold-
standard” differentiation protocols by the Melton group can be further optimized if done in 
conjunction with multiple combinations of insoluble cues. This will yield the development of an 
effective in vitro differentiation protocol that more closely mimics pancreatic development, 
leading to potential higher yields of differentiated cells, and better functionality for cell therapy 
and drug testing. The alginate array platform developed in this work can be used to 
simultaneously vary both physical and chemicals differentiation factors. 
Additional future work for this Aim should include evaluating the effect of varying 
alginate composition and concentration, as well as cation type. Previous reports have shown that 
varying alginate composition, specifically G/M ratio [31], or concentration [61], can influence 
cell response. Although it has been established that increasing the G content of alginate, or 
alginate concentration will results in an increase in alginate stiffness after crosslinking, it will be 
interesting to decouple alginate stiffness and cation concentration. Specifically, if the same 
hydrogel stiffness is achieved separately by varying alginate composition/concentration, and 
keeping cation concentration constant, or keeping alginate composition/concentration constant 
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and increasing cation concentration, will the effect on proliferation and differentiation of 
encapsulated cells be the same. Additionally, in chapter 3 of this work, barium was chosen 
because it produces a more robust gel, which will maintain hydrogel integrity better than calcium 
alginate hydrogel after long term culture. However, barium has been shown to be toxic in the 
body, and thus minimizing barium concentration could improve future cell-therapy applicability. 
It has previously been shown that alginate cross linked with 50 mM CaCl2, in combination with a 
lower concentration of 1 mM BaCl2 supported islet encapsulation [132]. It will thus be 
interesting to evaluate if a combination of calcium and barium can be used to achieve optimal 
hydrogel stiffness for the pancreatic differentiation of hPSCs, while minimizing barium 
concentration.  
Finally, in Aim 2 we have focused on biomaterial properties which best support the 
pancreatic differentiation of hPSCs. However, in this work we were unable to further evaluate 
the in vivo applicability or biocompatibility of the selected optimal alginate stiffness. Vegas et al. 
have recently shown that hPSC-derived β-cells encapsulated in intriazole–thiomorpholine 
dioxide modified alginate, crosslinked with BaCl2, showed good biocompatibility and long-term 
glycemic control after implantation [230]. The hPSC-derived β-cells in this study were 
encapsulated after differentiation, and were not differentiated under encapsulation. However, our 
goal is to use alginate encapsulation as a differentiation platform, which is directly 
transplantable. The Vegas et al. study identified that barium alginate can support cell 
functionality and in vivo biocompatibility. However, as the alginate encapsulation parameters are 
varied to support differentiation, the effect on post implantation functionality and 
biocompatibility should be investigated. Specifically, it will be important to evaluate a range of 
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supportive alginate compositions, and balance which parameters support both good pancreatic 
differentiation, but also long term viability, functionality, and biocompatibility post implantation. 
6.3 AIM3: PEPTIDE MODIFIED ALGINATE FOR THE PROPAGATION AND 
DIFFERENTATION OF HESC 
Clinical translation of hPSC-derived functional cells requires the use of large scale culture 
techniques to meet clinically relevant cell numbers. The use of 3D cell culture techniques, in 
combination with bioreactors, has the potential to satisfy future biomanufacturing needs for 
hPSC therapy to achieve commercial success. However, current lab scale technologies being 
utilized for hPSC propagation require cells to be passaged as colonies to maintain cell-cell 
contact, and employ the use of highly expensive Matrigel to support cell attachment and 
pluripotency. While recent work has focused on developing xeno-free platforms by replacing 
Matrigel with synthetic human recombinant proteins, these techniques are still highly expensive. 
The use of short synthetic peptides which mimic the bioactive region of key ECM proteins have 
been shown to support hPSC propagation and self-renewal when cultured as colonies. However, 
for large scale bioprocessing, the use of hPSCs in a single cell format is highly advantageous. 
Additionally, treatment with ROCK inhibitor will support upwards of 50% viability after 
dissociation, but there is a significant loss of the starting population, severely limiting the 
commercial applicability of hPSC-based cell therapy. In the final Aim of this work (Chapter 5), 
our goal was thus to develop a low cost, xeno-free substrate, which can support single hPSC 
culture. Dissociation induced apoptosis is triggered by loss of cell-cell e-cadherin binding, thus 
we developed an alginate hydrogel based substrate, conjugated with synthetic e-cadherin-based 
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peptides which mimic cell-cell contact. In Chapter 5, we demonstrated that the peptide modified 
alginate supported cell attachment in a concentration dependent manner, propagation, and high 
expansion potential. Additionally, after propagation on the developed substrate, hPSCs retained 
good pluripotency and differentiation potency. 
While the ultimate goal of Aim 3 was to investigate peptide performance to inform 
optimal parameters for use in 3D, the developed 2D platform also has commercial potential. 
Successful translation from the lab scale protocols to the clinic requires that low cost xeno-free 
platforms are used from the initial conception of the work. Merely switching from Matrigel to a 
xeno-free platform immediately prior to clinical testing is problematic, as the use of animal 
derived products may cause cross contamination with animal pathogens [231]. Specifically, the 
efficiency of maintaining hPSC pluripotency and differentiation cannot be assumed to be 
equivalent on one substrate, versus another. The culture and development of hPSC differentiation 
protocols must be done considering the supporting substrate from the start, especially when the 
ultimate goal is transitioning from the lab setting to large scale bioprocessing. Thus, a low cost 
xeno-free platform for lab scale research, which can support single cell culture, is in high 
demand. For future work, additional analysis of hPSC expansion and maintenance of 
pluripotency over multiple serial passages will be required. Additionally, herein we have tested 
differentiation potency using simple DE germ layer commitment. Further in depth analysis, not 
only to mesoderm and ectoderm germ layers, but also to functional mature cell types, will be 
required for this platform to compete with Matrigel or recombinant protein-based substrates.  
Furthermore, although the work in Aim 3 focused on evaluation of e-cadherin peptides in 
2D, our ultimate goal is to develop a 3D platform for large scale biomanufacturing. As 
mentioned previously, current large scale biomanufacturing techniques for hPSCs primarily 
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includes cells grown on microcarriers, or as cellular aggregates, in the bioreactor setting. 
However, both of these approaches have significant draw backs, including susceptibility to cell 
over-aggregation and hydrodynamic shear forces imparted by the bioreactor. Thus, additional 
future work for Aim 3 should focus on using the findings in Chapter 5 to inform optimal 
parameters for the 3D peptide conjugated alginate platform. Alginate encapsulation will serve to 
protect the hPSCs from over-aggregation and hydrodynamic shear forces, and inclusion of the e-
cadherin peptide could significantly improve single cell viability, and thus promote cellular 
expansion potential. Determination of optimal parameters should include peptide sequence and 
length, as well as concentration. Initial work should focus on peptide conjugation to alginate in 
solution prior to hydrogel formation, including material characterization [206]. It should also 
focus on the in vitro performance on hPSC viability, expansion, pluripotency, and differentiation, 
under encapsulation in the developed hydrogel. Upon establishment of supporting each of these 
at the lab scale, the next step will be to incorporate the use of a bioreactor.  
Putatively, although alginate encapsulation will protect cells from over aggregation and 
hydrodynamic shear forces, the alginate parameters which support hPSC viability and expansion 
will need to be balanced with those that support capsule robustness in the bioreactor. Thus, 
future work concerning the use of peptide modified alginate in the bioreactor should determine 
alginate G/M ratio, cation chemistry and cation concentration supporting single cell viability and 
clonal expansion of encapsulated hPSCs. The objective should be to design alginate capsules that 
are suitable for withstanding the stress and hydrodynamic perturbations inherent in scaled up 
stirred suspension culture system. This will result in identification of key biophysical parameters 
necessary for alginate capsule structural stability in such systems.   
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Taken together in totality, the findings described in this dissertation represent a 
significant leap forward in the understanding of the application of biomaterial based hPSC 
propagation and differentiation platforms. We have shown alginate encapsulation supports strong 
hPSC pancreatic differentiation, but is highly sensitive to biomaterials parameters and culture 
configuration. The results of this dissertation thus strongly indicate that optimal parameters for 
hPSCs must be balanced with those parameters which support large-scale bioprocessing for cell 
therapy applications.  
 163 
BIBLIOGRAPHY 
[1] Daneman, D., Type 1 diabetes. The Lancet, 2006. 367(9513): p. 847-858. 
 
[2] Shapiro, A.M.J., et al., Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus 
Using a Glucocorticoid-Free Immunosuppressive Regimen. New England Journal of 
Medicine, 2000. 343(4): p. 230-238. 
 
[3] Efrat, S. and H.A. Russ, Making beta cells from adult tissues. Trends in endocrinology and 
metabolism: TEM, 2012. 23(6): p. 278-85. 
 
[4] O'Sullivan, E.S., et al., Rat islet cell aggregates are superior to islets for transplantation in 
microcapsules. Diabetologia, 2010. 53(5): p. 937-45. 
 
[5] Dufrane, D., et al., Six-month survival of microencapsulated pig islets and alginate 
biocompatibility in primates: proof of concept. Transplantation, 2006. 81(9): p. 1345-53. 
 
[6] Lim, F. and A.M. Sun, Microencapsulated Islets as Bioartificial Endocrine Pancreas. Science, 
1980. 210(4472): p. 908-910. 
 
[7] Scharp, D.W. and P. Marchetti, Encapsulated islets for diabetes therapy: History, current 
progress, and critical issues requiring solution. Advanced Drug Delivery Reviews, 2014. 
67-68: p. 35-73. 
 
[8] Beck, J., et al., Islet encapsulation: strategies to enhance islet cell functions. Tissue 
engineering, 2007. 13(3): p. 589-99. 
 
[9] Lee, K.Y. and D.J. Mooney, Alginate: Properties and biomedical applications. Progress in 
Polymer Science, 2012. 37(1): p. 106-126. 
 
 164 
[10] Wilson, J.L. and T.C. McDevitt, Stem cell microencapsulation for phenotypic control, 
bioprocessing, and transplantation. Biotechnology and bioengineering, 2013. 110(3): p. 
667-82. 
 
[11] S, M., S. Ja, and S. M, Regenerative Medicine and Tissue Engineering for the Treatment of 
Diabetes, in Tissue Engineering for Tissue and Organ Regeneration, D. Eberli, Editor 
2011, InTech: Rijeka. p. Ch. 19. 
 
[12] O’Sullivan, E., et al., Rat islet cell aggregates are superior to islets for transplantation in 
microcapsules. Diabetologia, 2010. 53(5): p. 937-945. 
 
[13] Lim, F. and A. Sun, Microencapsulated islets as bioartificial endocrine pancreas. Science, 
1980. 210(4472): p. 908-910. 
 
[14] Oshea, G.M. and A.M. Sun, Encapsulation of Rat Islets of Langerhans Prolongs Xenograft 
Survival in Diabetic Mice. Diabetes, 1986. 35: p. A82-A82. 
 
[15] Duvivier-Kali, V.F., et al., Complete protection of islets against allorejection and 
autoimmunity by a simple barium-alginate membrane. Diabetes, 2001. 50(8): p. 1698-
705. 
 
[16] Hoesli, C.A., et al., Reversal of diabetes by βTC3 cells encapsulated in alginate beads 
generated by emulsion and internal gelation. Journal of Biomedical Materials Research 
Part B: Applied Biomaterials, 2012. 100B(4): p. 1017-1028. 
 
[17] Scharp, D.W. and P. Marchetti, Encapsulated islets for diabetes therapy: History, current 
progress, and critical issues requiring solution. Advanced Drug Delivery Reviews, 
2013(0). 
 
[18] Steele, J.A.M., et al., Therapeutic cell encapsulation techniques and applications in diabetes. 
Advanced Drug Delivery Reviews, 2013(0). 
 
[19] Tuch, B.E., et al., Safety and Viability of Microencapsulated Human Islets Transplanted 
Into Diabetic Humans. Diabetes care, 2009. 32(10): p. 1887-1889. 
 
[20] Jacobs-Tulleneers-Thevissen, D., et al., Sustained function of alginate-encapsulated human 
islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 
diabetic patient. Diabetologia, 2013. 56(7): p. 1605-1614. 
 165 
 
[21] Li, N., et al., Engineering islet for improved performance by optimized reaggregation in 
alginate gel beads. Biotechnology and applied biochemistry, 2016. 
 
[22] Lacy, P.E., et al., Maintenance of normoglycemia in diabetic mice by subcutaneous 
xenografts of encapsulated islets. Science, 1991. 254(5039): p. 1782-4. 
 
[23] Nishimura, M., et al., Effects of encapsulated porcine islets on glucose and C-peptide 
concentrations in diabetic nude mice 6 months after intraperitoneal transplantation. 
Xenotransplantation, 2017. 
 
[24] Maiti, S., et al., Adipic acid dihydrazide treated partially oxidized alginate beads for 
sustained oral delivery of flurbiprofen. Pharmaceutical Development and Technology, 
2009. 14(5): p. 461-470. 
 
[25] Bouhadir, K.H., E. Alsberg, and D.J. Mooney, Hydrogels for combination delivery of 
antineoplastic agents. Biomaterials, 2001. 22(19): p. 2625-2633. 
 
[26] Silva, E.A. and D.J. Mooney, Effects of VEGF temporal and spatial presentation on 
angiogenesis. Biomaterials, 2010. 31(6): p. 1235-1241. 
 
[27] Chan, A.W. and R.J. Neufeld, Tuneable semi-synthetic network alginate for absorptive 
encapsulation and controlled release of protein therapeutics. Biomaterials, 2010. 31(34): 
p. 9040-9047. 
 
[28] Balakrishnan, B., et al., Evaluation of the effect of incorporation of dibutyryl cyclic 
adenosine monophosphate in an in situ-forming hydrogel wound dressing based on 
oxidized alginate and gelatin. Biomaterials, 2006. 27(8): p. 1355-1361. 
 
[29] Rabbany, S.Y., et al., Continuous Delivery of Stromal Cell-Derived Factor-1 From Alginate 
Scaffolds Accelerates Wound Healing. Cell Transplantation, 2010. 19(4): p. 399-408. 
 
[30] Huang, X., et al., Microenvironment of alginate-based microcapsules for cell culture and 
tissue engineering. Journal of bioscience and bioengineering, 2012. 114(1): p. 1-8. 
 
[31] Wilson, J.L., et al., Alginate encapsulation parameters influence the differentiation of 
microencapsulated embryonic stem cell aggregates. Biotechnology and bioengineering, 
2014. 111(3): p. 618-31. 
 166 
 
[32] Zimmermann, H., S.G. Shirley, and U. Zimmermann, Alginate-based encapsulation of cells: 
past, present, and future. Current diabetes reports, 2007. 7(4): p. 314-20. 
 
[33] Stabler, C., et al., The effects of alginate composition on encapsulated betaTC3 cells. 
Biomaterials, 2001. 22(11): p. 1301-10. 
 
[34] Siti-Ismail, N., et al., The benefit of human embryonic stem cell encapsulation for 
prolonged feeder-free maintenance. Biomaterials, 2008. 29(29): p. 3946-52. 
 
[35] Bohari, S.P., D.W. Hukins, and L.M. Grover, Effect of calcium alginate concentration on 
viability and proliferation of encapsulated fibroblasts. Bio-medical materials and 
engineering, 2011. 21(3): p. 159-70. 
 
[36] Morch, Y.A., et al., Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads. 
Biomacromolecules, 2006. 7(5): p. 1471-80. 
 
[37] Chan, E.S., et al., Effect of formulation of alginate beads on their mechanical behavior and 
stiffness. Particuology, 2011. 9(3): p. 228-234. 
 
[38] Balamurugan, A.N., et al., Prospective and challenges of islet transplantation for the therapy 
of autoimmune diabetes. Pancreas, 2006. 32(3): p. 231-43. 
 
[39] Bradley, J.A., E.M. Bolton, and R.A. Pedersen, Stem cell medicine encounters the immune 
system. Nature Reviews Immunology, 2002. 2(11): p. 859-871. 
 
[40] Segev, H., et al., Differentiation of Human Embryonic Stem Cells into Insulin-Producing 
Clusters. STEM CELLS, 2004. 22(3): p. 265-274. 
 
[41] Xu, X., et al., Endoderm and Pancreatic Islet Lineage Differentiation from Human 
Embryonic Stem Cells. Cloning and Stem Cells, 2006. 8(2): p. 96-107. 
 
[42] Baharvand, H., et al., Generation of insulin-secreting cells from human embryonic stem 
cells. Development, Growth & Differentiation, 2006. 48(5): p. 323-332. 
 
[43] D'Amour, K.A., et al., Production of pancreatic hormone-expressing endocrine cells from 
human embryonic stem cells. Nat Biotech, 2006. 24(11): p. 1392-1401. 
 167 
 
[44] Jaramillo, M., et al., Potential for pancreatic maturation of differentiating human embryonic 
stem cells is sensitive to the specific pathway of definitive endoderm commitment. PloS 
one, 2014. 9(4): p. e94307. 
 
[45] Jaramillo, M., et al., Endothelial Cells Mediate Islet-Specific Maturation of Human 
Embryonic Stem Cell-Derived Pancreatic Progenitor Cells. Tissue engineering. Part A, 
2014. 
 
[46] Pagliuca, F.W., et al., Generation of functional human pancreatic beta cells in vitro. Cell, 
2014. 159(2): p. 428-39. 
 
[47] Rezania, A., et al., Reversal of diabetes with insulin-producing cells derived in vitro from 
human pluripotent stem cells. Nature Biotechnology, 2014. 32(11): p. 1121-33. 
 
[48] Cogger, K. and M.C. Nostro, Recent advances in cell replacement therapies for the 
treatment of type 1 diabetes. Endocrinology, 2015. 156(1): p. 8-15. 
 
[49] Maguire, T., et al., Alginate-PLL microencapsulation: Effect on the differentiation of 
embryonic stem cells into hepatocytes. Biotechnology and Bioengineering, 2006. 93(3): 
p. 581-591. 
 
[50] Li, L., et al., Neural lineage differentiation of embryonic stem cells within alginate 
microbeads. Biomaterials, 2011. 32(20): p. 4489-4497. 
 
[51] Wang, N., et al., Alginate encapsulation technology supports embryonic stem cells 
differentiation into insulin-producing cells. Journal of Biotechnology, 2009. 144(4): p. 
304-312. 
 
[52] Siti-Ismail, N., et al., The benefit of human embryonic stem cell encapsulation for 
prolonged feeder-free maintenance. Biomaterials, 2008. 29(29): p. 3946-3952. 
 
[53] Dean, S.K., et al., Differentiation of Encapsulated Embryonic Stem Cells After 




[54] Chayosumrit, M., B. Tuch, and K. Sidhu, Alginate microcapsule for propagation and 
directed differentiation of hESCs to definitive endoderm. Biomaterials, 2010. 31(3): p. 
505-514. 
 
[55] Kim, J., P. Sachdev, and K. Sidhu, Alginate microcapsule as a 3D platform for the efficient 
differentiation of human embryonic stem cells to dopamine neurons. Stem Cell Research, 
2013. 11(3): p. 978-989. 
 
[56] Hunt, N.C., et al., 3D culture of human pluripotent stem cells in RGD-alginate hydrogel 
improves retinal tissue development. Acta biomaterialia, 2017. 49: p. 329-343. 
 
[57] Engler, A.J., et al., Matrix elasticity directs stem cell lineage specification. Cell, 2006. 
126(4): p. 677-89. 
 
[58] Zoldan, J., et al., The influence of scaffold elasticity on germ layer specification of human 
embryonic stem cells. Biomaterials, 2011. 32(36): p. 9612-21. 
 
[59] Discher, D.E., D.J. Mooney, and P.W. Zandstra, Growth factors, matrices, and forces 
combine and control stem cells. Science, 2009. 324(5935): p. 1673-7. 
 
[60] Higuchi, A., et al., Physical cues of cell culture materials lead the direction of differentiation 
lineages of pluripotent stem cells. Journal of Materials Chemistry B, 2015. 3(41): p. 
8032-8058. 
 
[61] Lee, B.H., B. Li, and S.A. Guelcher, Gel microstructure regulates proliferation and 
differentiation of MC3T3-E1 cells encapsulated in alginate beads. Acta biomaterialia, 
2012. 8(5): p. 1693-702. 
 
[62] Banerjee, A., et al., The influence of hydrogel modulus on the proliferation and 
differentiation of encapsulated neural stem cells. Biomaterials, 2009. 30(27): p. 4695-
4699. 
 
[63] Strand, B.L., A.E. Coron, and G. Skjak-Braek, Current and Future Perspectives on Alginate 
Encapsulated Pancreatic Islet. Stem cells translational medicine, 2017. 6(4): p. 1053-
1058. 
 
[64] Robinton, D.A. and G.Q. Daley, The promise of induced pluripotent stem cells in research 
and therapy. Nature, 2012. 481(7381): p. 295-305. 
 169 
 
[65] Kriks, S., et al., Dopamine neurons derived from human ES cells efficiently engraft in 
animal models of Parkinson's disease. Nature, 2011. 480(7378): p. 547-51. 
 
[66] Chong, J.J., et al., Human embryonic-stem-cell-derived cardiomyocytes regenerate non-
human primate hearts. Nature, 2014. 510(7504): p. 273-7. 
 
[67] Maruotti, J., et al., Small-molecule-directed, efficient generation of retinal pigment 
epithelium from human pluripotent stem cells. Proceedings of the National Academy of 
Sciences of the United States of America, 2015. 112(35): p. 10950-5. 
 
[68] Rodin, S., et al., Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin 
matrix in defined and xeno-free environment. Nature communications, 2014. 5: p. 3195. 
 
[69] Braam, S.R., et al., Recombinant vitronectin is a functionally defined substrate that supports 
human embryonic stem cell self-renewal via alpha V beta 5 integrin. Stem Cells, 2008. 
26(9): p. 2257-2265. 
 
[70] Jenkins, M.J. and S.S. Farid, Human pluripotent stem cell-derived products: advances 
towards robust, scalable and cost-effective manufacturing strategies. Biotechnology 
journal, 2015. 10(1): p. 83-95. 
 
[71] Simaria, A.S., et al., Allogeneic cell therapy bioprocess economics and optimization: single-
use cell expansion technologies. Biotechnology and bioengineering, 2014. 111(1): p. 69-
83. 
 
[72] Want, A.J., et al., Large-scale expansion and exploitation of pluripotent stem cells for 
regenerative medicine purposes: beyond the T flask. Regenerative medicine, 2012. 7(1): 
p. 71-84. 
 
[73] Oh, S.K.W., et al., Long-term microcarrier suspension cultures of human embryonic stem 
cells. Stem cell research, 2009. 2(3): p. 219-230. 
 
[74] Gerecht-Nir, S., S. Cohen, and J. Itskovitz-Eldor, Bioreactor cultivation enhances the 
efficiency of human embryoid body (hEB) formation and differentiation. Biotechnology 
and bioengineering, 2004. 86(5): p. 493-502. 
 
 170 
[75] Abbasalizadeh, S. and H. Baharvand, Technological progress and challenges towards cGMP 
manufacturing of human pluripotent stem cells based therapeutic products for allogeneic 
and autologous cell therapies. Biotechnology Advances, 2013. 31(8): p. 1600-1623. 
 
[76] Lock, L.T. and E.S. Tzanakakis, Expansion and Differentiation of Human Embryonic Stem 
Cells to Endoderm Progeny in a Microcarrier Stirred-Suspension Culture. Tissue 
Engineering Part A, 2009. 15(8): p. 2051-2063. 
 
[77] Fridley, K.M., M.A. Kinney, and T.C. McDevitt, Hydrodynamic modulation of pluripotent 
stem cells. Stem Cell Research & Therapy, 2012. 3. 
 
[78] Watanabe, K., et al., A ROCK inhibitor permits survival of dissociated human embryonic 
stem cells. Nat Biotechnol, 2007. 25(6): p. 681-6. 
 
[79] Li, L., S.A. Bennett, and L. Wang, Role of E-cadherin and other cell adhesion molecules in 
survival and differentiation of human pluripotent stem cells. Cell Adh Migr, 2012. 6(1): 
p. 59-70. 
 
[80] Lanza, R.P., et al., Transplantation of encapsulated canine islets into spontaneously diabetic 
BB/Wor rats without immunosuppression. Endocrinology, 1992. 131(2): p. 637-42. 
 
[81] O'Shea, G.M., M.F.A. Goosen, and A.M. Sun, Prolonged survival of transplanted islets of 
Langerhans encapsulated in a biocompatible membrane. Biochimica et Biophysica Acta 
(BBA) - Molecular Cell Research, 1984. 804(1): p. 133-136. 
 
[82] Maki, T., et al., Treatment of Diabetes by Xenogeneic Islets Without Immunosuppression: 
Use of a Vascularized Bioartificial Pancreas. Diabetes, 1996. 45(3): p. 342-347. 
 
[83] Iwata, H., et al., Evaluation of Microencapsulated Islets in Agarose-Gel as Bioartificial 
Pancreas by Studies of Hormone-Secretion in Culture and by Xenotransplantation. 
Diabetes, 1989. 38: p. 224-225. 
 
[84] Leung, A., et al., Tissue transplantation by stealth—Coherent alginate microcapsules for 
immunoisolation. Biochemical Engineering Journal, 2010. 48(3): p. 337-347. 
 
[85] Shen, F., et al., Mechanically enhanced microcapsules for cellular gene therapy. Journal of 
biomedical materials research. Part B, Applied biomaterials, 2009. 90(1): p. 350-61. 
 171 
 
[86] Hillberg, A.L., et al., Improving alginate-poly-L-ornithine-alginate capsule biocompatibility 
through genipin crosslinking. Journal of biomedical materials research. Part B, Applied 
biomaterials, 2013. 101(2): p. 258-68. 
 
[87] Jaramillo, M. and I. Banerjee, Endothelial cell co-culture mediates maturation of human 
embryonic stem cell to pancreatic insulin producing cells in a directed differentiation 
approach. Journal of visualized experiments : JoVE, 2012(61). 
 
[88] Watanabe, K., et al., A ROCK inhibitor permits survival of dissociated human embryonic 
stem cells. Nat Biotech, 2007. 25(6): p. 681-686. 
 
[89] Heiligenstein, S., et al., In vitro and in vivo characterization of nonbiomedical- and 
biomedical-grade alginates for articular chondrocyte transplantation. Tissue engineering. 
Part C, Methods, 2011. 17(8): p. 829-42. 
 
[90] Thomas, F.T., et al., Anoikis, extracellular matrix, and apoptosis factors in isolated cell 
transplantation. Surgery, 1999. 126(2): p. 299-304. 
 
[91] Rezania, A., et al., Maturation of human embryonic stem cell-derived pancreatic progenitors 
into functional islets capable of treating pre-existing diabetes in mice. Diabetes, 2012. 
61(8): p. 2016-29. 
 
[92] Bruin, J.E., et al., Maturation and function of human embryonic stem cell-derived pancreatic 
progenitors in macroencapsulation devices following transplant into mice. Diabetologia, 
2013. 56(9): p. 1987-98. 
 
[93] Cozar-Castellano, I., et al., Molecular Control of Cell Cycle Progression in the Pancreatic β-
Cell. Endocrine Reviews, 2006. 27(4): p. 356-370. 
 
[94] Tuch, B.E., T.C. Hughes, and M.D. Evans, Encapsulated pancreatic progenitors derived 
from human embryonic stem cells as a therapy for insulin-dependent diabetes. 
Diabetes/metabolism research and reviews, 2011. 27(8): p. 928-32. 
 
[95] Martín, F., et al., Mechanisms of glucose hypersensitivity in beta-cells from 
normoglycemic, partially pancreatectomized mice. Diabetes, 1999. 48(10): p. 1954-1961. 
 
 172 
[96] Ungrin, M.D., et al., Reproducible, ultra high-throughput formation of multicellular 
organization from single cell suspension-derived human embryonic stem cell aggregates. 
Plos One, 2008. 3(2): p. e1565. 
 
[97] Nair, R., et al., Gene Expression Signatures of Extracellular Matrix and Growth Factors 
during Embryonic Stem Cell Differentiation. PLoS ONE, 2012. 7(10): p. e42580. 
 
[98] Brafman, D.A., et al., Regulation of endodermal differentiation of human embryonic stem 
cells through integrin-ECM interactions. Cell death and differentiation, 2013. 20(3): p. 
369-81. 
 
[99] Jones, L.E., et al., Comprehensive analysis of matrix metalloproteinase and tissue inhibitor 
expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 
predicts poor survival. Clinical cancer research : an official journal of the American 
Association for Cancer Research, 2004. 10(8): p. 2832-45. 
 
[100] Singh, A.M., et al., Signaling Network Crosstalk in Human Pluripotent Cells: A Smad2/3-
Regulated Switch that Controls the Balance between Self-Renewal and Differentiation. 
Cell Stem Cell, 2012. 10(3): p. 312-326. 
 
[101] Conery, A.R., et al., Akt interacts directly with Smad3 to regulate the sensitivity to TGF-
beta-induced apoptosis. Nature Cell Biology, 2004. 6(4): p. 366-372. 
 
[102] Remy, I., A. Montmarquette, and S.W. Michnick, PKB/Akt modulates TGF-beta signalling 
through a direct interaction with Smad3. Nature Cell Biology, 2004. 6(4): p. 358-365. 
 
[103] Richardson, T., P.N. Kumta, and I. Banerjee, Alginate Encapsulation of Human Embryonic 
Stem Cells to Enhance Directed Differentiation to Pancreatic Islet-Like Cells. Tissue 
engineering. Part A, 2014. 
 
[104] Darrabie, M.D., W.F. Kendall, and E.C. Opara, Effect of alginate composition and gelling 
cation on microbead swelling. Journal of microencapsulation, 2006. 23(6): p. 613-21. 
 
[105] Wang, X.W. and H.G. Spencer, Calcium alginate gels: Formation and stability in the 
presence of an inert electrolyte. Polymer, 1998. 39(13): p. 2759-2764. 
 
[106] Schneider, S., et al., Intraportal transplantation of allogenic pancreatic islets encapsulated 
in barium alginate beads in diabetic rats. Artificial organs, 2003. 27(11): p. 1053-6. 
 173 
 
[107] Safley, S.A., et al., Biocompatibility and immune acceptance of adult porcine islets 
transplanted intraperitoneally in diabetic NOD mice in calcium alginate poly-L-lysine 
microcapsules versus barium alginate microcapsules without poly-L-lysine. Journal of 
diabetes science and technology, 2008. 2(5): p. 760-7. 
 
[108] Veiseh, O., et al., Size- and shape-dependent foreign body immune response to materials 
implanted in rodents and non-human primates. Nature materials, 2015. 14(6): p. 643-51. 
 
[109] Herrero, E.P., E.M. Del Valle, and M.A. Galan, Immobilization of mesenchymal stem cells 
and monocytes in biocompatible microcapsules to cell therapy. Biotechnology progress, 
2007. 23(4): p. 940-5. 
 
[110] Penolazzi, L., et al., Encapsulation of mesenchymal stem cells from Wharton's jelly in 
alginate microbeads. Tissue engineering. Part C, Methods, 2010. 16(1): p. 141-55. 
 
[111] Gaetani, P., et al., Adipose-derived stem cell therapy for intervertebral disc regeneration: 
an in vitro reconstructed tissue in alginate capsules. Tissue engineering. Part A, 2008. 
14(8): p. 1415-23. 
 
[112] Estes, B.T., et al., Isolation of adipose-derived stem cells and their induction to a 
chondrogenic phenotype. Nature Protocols, 2010. 5(7): p. 1294-1311. 
 
[113] Dean, S.K., et al., Differentiation of encapsulated embryonic stem cells after 
transplantation. Transplantation, 2006. 82(9): p. 1175-84. 
 
[114] Keung, A.J., et al., Soft microenvironments promote the early neurogenic differentiation 
but not self-renewal of human pluripotent stem cells. Integrative biology : quantitative 
biosciences from nano to macro, 2012. 4(9): p. 1049-58. 
 
[115] Eroshenko, N., et al., Effect of substrate stiffness on early human embryonic stem cell 
differentiation. Journal of biological engineering, 2013. 7(1): p. 7. 
 
[116] Hazeltine, L.B., et al., Temporal impact of substrate mechanics on differentiation of human 
embryonic stem cells to cardiomyocytes. Acta Biomaterialia, 2014. 10(2): p. 604-12. 
 
 174 
[117] Candiello, J., et al., Early differentiation patterning of mouse embryonic stem cells in 
response to variations in alginate substrate stiffness. Journal of biological engineering, 
2013. 7(1): p. 9. 
 
[118] Jaramillo, M., et al., Inducing endoderm differentiation by modulating mechanical 
properties of soft substrates. Journal of tissue engineering and regenerative medicine, 
2015. 9(1): p. 1-12. 
 
[119] Task, K., et al., Systems level approach reveals the correlation of endoderm differentiation 
of mouse embryonic stem cells with specific microstructural cues of fibrin gels. Journal 
of the Royal Society, Interface / the Royal Society, 2014. 11(95): p. 20140009. 
 
[120] Zhang, X.N., et al., Analysis of Regulatory Network Involved in Mechanical Induction of 
Embryonic Stem Cell Differentiation. PloS one, 2012. 7(4). 
 
[121] Musah, S., et al., Glycosaminoglycan-binding hydrogels enable mechanical control of 
human pluripotent stem cell self-renewal. ACS nano, 2012. 6(11): p. 10168-77. 
 
[122] Candiello, J., et al., Biomechanical properties of native basement membranes. The FEBS 
journal, 2007. 274(11): p. 2897-908. 
 
[123] Otonkoski, T., et al., Unique basement membrane structure of human pancreatic islets: 
implications for beta-cell growth and differentiation. Diabetes, obesity & metabolism, 
2008. 10 Suppl 4: p. 119-27. 
 
[124] Riopel, M. and R. Wang, Collagen matrix support of pancreatic islet survival and function. 
Frontiers in bioscience, 2014. 19: p. 77-90. 
 
[125] Goh, S.K., et al., Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic 
tissue and whole organ engineering. Biomaterials, 2013. 34(28): p. 6760-6772. 
 
[126] Singh, A.M., et al., Signaling network crosstalk in human pluripotent cells: a Smad2/3-
regulated switch that controls the balance between self-renewal and differentiation. Cell 
stem cell, 2012. 10(3): p. 312-26. 
 
[127] Cho, C.H.H., et al., Inhibition of activin/nodal signalling is necessary for pancreatic 




[128] Afrikanova, I., et al., Inhibitors of Src and Focal Adhesion Kinase Promote Endocrine 
Specification IMPACT ON THE DERIVATION OF beta-CELLS FROM HUMAN 
PLURIPOTENT STEM CELLS. Journal of Biological Chemistry, 2011. 286(41): p. 
36042-36052. 
 
[129] Dennler, S., et al., Induction of sonic hedgehog mediators by transforming growth factor-
beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. 
Cancer research, 2007. 67(14): p. 6981-6. 
 
[130] Sugimoto, M., et al., What is the nature of pancreatic consistency? Assessment of the 
elastic modulus of the pancreas and comparison with tactile sensation, histology, and 
occurrence of postoperative pancreatic fistula after pancreaticoduodenectomy. Surgery, 
2014. 156(5): p. 1204-1211. 
 
[131] EPA, Toxicological Review of Barium and Compounds. Cincinnati, OH: Unitied States 
Environmental Protection Agency, 2005: p. 1-57. 
 
[132] Qi, M., et al., Survival of human islets in microbeads containing high guluronic acid 
alginate crosslinked with Ca2+ and Ba2+. Xenotransplantation, 2012. 19(6): p. 355-64. 
 
[133] Kelly, O.G., et al., Cell-surface markers for the isolation of pancreatic cell types derived 
from human embryonic stem cells. Nature Biotechnology, 2011. 29(8): p. 750-U114. 
 
[134] Kroon, E., et al., Pancreatic endoderm derived from human embryonic stem cells generates 
glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology, 2008. 26(4): p. 
443-52. 
 
[135] Sui, L., et al., Transplantation of Human Embryonic Stem Cell-Derived Pancreatic 
Endoderm Reveals a Site-Specific Survival, Growth, and Differentiation. Cell 
Transplantation, 2013. 22(5): p. 821-830. 
 
[136] Tuch, B.E., T.C. Hughes, and M.D.M. Evans, Encapsulated pancreatic progenitors derived 
from human embryonic stem cells as a therapy for insulin-dependent diabetes. Diabetes-
Metabolism Research and Reviews, 2011. 27(8): p. 928-932. 
 
[137] Narayanan, K., et al., Extracellular matrix-mediated differentiation of human embryonic 
stem cells: differentiation to insulin-secreting beta cells. Tissue engineering. Part A, 
2014. 20(1-2): p. 424-33. 
 176 
 
[138] Saha, S., et al., TGFbeta/Activin/Nodal pathway in inhibition of human embryonic stem 
cell differentiation by mechanical strain. Biophysical journal, 2008. 94(10): p. 4123-33. 
 
[139] Saha, S., et al., Inhibition of human embryonic stem cell differentiation by mechanical 
strain. Journal of cellular physiology, 2006. 206(1): p. 126-37. 
 
[140] Allen, J.L., M.E. Cooke, and T. Alliston, ECM stiffness primes the TGFbeta pathway to 
promote chondrocyte differentiation. Molecular biology of the cell, 2012. 23(18): p. 
3731-42. 
 
[141] Song, K., et al., Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated 
Smad3 activation. The EMBO journal, 2006. 25(1): p. 58-69. 
 
[142] Remy, I., A. Montmarquette, and S.W. Michnick, PKB/Akt modulates TGF-beta signalling 
through a direct interaction with Smad3. Nature cell biology, 2004. 6(4): p. 358-65. 
 
[143] Nostro, M.C., et al., Stage-specific signaling through TGF beta family members and WNT 
regulates patterning and pancreatic specification of human pluripotent stem cells (vol 
138, pg 861, 2011). Development, 2011. 138(7): p. 1445-1445. 
 
[144] Guo, T.X., et al., Factors Expressed by Murine Embryonic Pancreatic Mesenchyme 
Enhance Generation of Insulin-Producing Cells From hESCs. Diabetes, 2013. 62(5): p. 
1581-1592. 
 
[145] Lopez-Carballo, G., et al., Activation of the phosphatidylinositol 3-kinase/Akt signaling 
pathway by retinoic acid is required for neural differentiation of SH-SY5Y human 
neuroblastoma cells. The Journal of biological chemistry, 2002. 277(28): p. 25297-304. 
 
[146] Gittes, G.K., Developmental biology of the pancreas: a comprehensive review. 
Developmental biology, 2009. 326(1): p. 4-35. 
 
[147] Shevde, L.A. and R.S. Samant, Nonclassical hedgehog-GLI signaling and its clinical 
implications. International journal of cancer. Journal international du cancer, 2014. 
135(1): p. 1-6. 
 
[148] Mih, J.D., et al., A Multiwell Platform for Studying Stiffness-Dependent Cell Biology. 
Plos One, 2011. 6(5). 
 177 
 
[149] Ankam, S., et al., Substrate topography and size determine the fate of human embryonic 
stem cells to neuronal or glial lineage. Acta biomaterialia, 2013. 9(1): p. 4535-45. 
 
[150] Pan, F., et al., Topographic effect on human induced pluripotent stem cells differentiation 
towards neuronal lineage. Biomaterials, 2013. 34(33): p. 8131-9. 
 
[151] Flaim, C.J., S. Chien, and S.N. Bhatia, An extracellular matrix microarray for probing 
cellular differentiation. Nature methods, 2005. 2(2): p. 119-25. 
 
[152] Derda, R., et al., High-Throughput Discovery of Synthetic Surfaces That Support 
Proliferation of Pluripotent Cells. Journal of the American Chemical Society, 2010. 
132(4): p. 1289-1295. 
 
[153] Zhang, D. and K.A. Kilian, Peptide microarrays for the discovery of bioactive surfaces that 
guide cellular processes: a single step azide-alkyne "click" chemistry approach. Journal 
of Materials Chemistry B, 2014. 2(27): p. 4280-4288. 
 
[154] Gobaa, S., et al., Artificial niche microarrays for probing single stem cell fate in high 
throughput. Nature methods, 2011. 8(11): p. 949-55. 
 
[155] Ranga, A., et al., 3D niche microarrays for systems-level analyses of cell fate. Nature 
communications, 2014. 5: p. 4324. 
 
[156] Yang, F., et al., Combinatorial extracellular matrices for human embryonic stem cell 
differentiation in 3D. Biomacromolecules, 2010. 11(8): p. 1909-14. 
 
[157] Lee, M.Y., et al., Three-dimensional cellular microarray for high-throughput toxicology 
assays. Proceedings of the National Academy of Sciences of the United States of 
America, 2008. 105(1): p. 59-63. 
 
[158] Fernandes, T.G., et al., Three-dimensional cell culture microarray for high-throughput 
studies of stem cell fate. Biotechnology and bioengineering, 2010. 106(1): p. 106-18. 
 
[159] Richardson, T., et al., Capsule stiffness regulates the efficiency of pancreatic 
differentiation of human embryonic stem cells. Acta biomaterialia, 2016. 
 
 178 
[160] Lee, L.H., et al., Micropatterning of human embryonic stem cells dissects the mesoderm 
and endoderm lineages. Stem cell research, 2009. 2(2): p. 155-62. 
 
[161] Toyoda, T., et al., Cell aggregation optimizes the differentiation of human ESCs and iPSCs 
into pancreatic bud-like progenitor cells. Stem cell research, 2015. 14(2): p. 185-197. 
 
[162] Lei, Y. and D.V. Schaffer, A fully defined and scalable 3D culture system for human 
pluripotent stem cell expansion and differentiation. Proceedings of the National Academy 
of Sciences of the United States of America, 2013. 110(52): p. E5039-48. 
 
[163] Chen, V.C., et al., Scalable GMP compliant suspension culture system for human ES cells. 
Stem cell research, 2012. 8(3): p. 388-402. 
 
[164] Richardson, T., P.N. Kumta, and I. Banerjee, Alginate encapsulation of human embryonic 
stem cells to enhance directed differentiation to pancreatic islet-like cells. Tissue 
engineering. Part A, 2014. 20(23-24): p. 3198-211. 
 
[165] Kutner, M.H., Applied linear statistical models. 5th ed. The McGraw-Hill/Irwin series 
operations and decision sciences2005, Boston: McGraw-Hill Irwin. xxviii, 1396 p. 
 
[166] Efron, B. and R. Tibshirani, An introduction to the bootstrap. Monographs on statistics and 
applied probability1993, New York: Chapman & Hall. xvi, 436 p. 
 
[167] Mathew, S., et al., Analysis of alternative signaling pathways of endoderm induction of 
human embryonic stem cells identifies context specific differences. Bmc Systems 
Biology, 2012. 6: p. 154. 
 
[168] Gong, H.B., et al., In Vivo Imaging of Xenograft Tumors Using an Epidermal Growth 
Factor Receptor-Specific Affibody Molecule Labeled with a Near-infrared Fluorophore. 
Neoplasia, 2010. 12(2): p. 139-U59. 
 
[169] Tong, R., et al., Polylactide Nanoparticles Containing Stably Incorporated Cyanine Dyes 
for In Vitro and In Vivo Imaging Applications. Microscopy Research and Technique, 
2010. 73(9): p. 901-909. 
 
[170] Tichauer, K.M., et al., In Vivo Quantification of Tumor Receptor Binding Potential with 




[171] Task, K., et al., Systems level approach reveals the correlation of endoderm differentiation 
of mouse embryonic stem cells with specific microstructural cues of fibrin gels. Journal 
of the Royal Society Interface, 2014. 11(95). 
 
[172] Mathew, S., et al., Analysis of alternative signaling pathways of endoderm induction of 
human embryonic stem cells identifies context specific differences. Bmc Systems 
Biology, 2012. 6. 
 
[173] Stock, P.G. and M.S. German, A Path to Insulin Independence: "The End of the 
Beginning''. Cell stem cell, 2016. 18(4): p. 431-433. 
 
[174] Califano, J.P. and C.A. Reinhart-King, Substrate Stiffness and Cell Area Predict Cellular 
Traction Stresses in Single Cells and Cells in Contact. Cellular and molecular 
bioengineering, 2010. 3(1): p. 68-75. 
 
[175] Chowdhury, F., et al., Soft substrates promote homogeneous self-renewal of embryonic 
stem cells via downregulating cell-matrix tractions. Plos One, 2010. 5(12): p. e15655. 
 
[176] Fu, J., et al., Mechanical regulation of cell function with geometrically modulated 
elastomeric substrates. Nature methods, 2010. 7(9): p. 733-6. 
 
[177] Ghosh, K., et al., Cell adaptation to a physiologically relevant ECM mimic with different 
viscoelastic properties. Biomaterials, 2007. 28(4): p. 671-9. 
 
[178] Cavo, M., et al., Microenvironment complexity and matrix stiffness regulate breast cancer 
cell activity in a 3D in vitro model. Scientific reports, 2016. 6: p. 35367. 
 
[179] Banerjee, A., et al., The influence of hydrogel modulus on the proliferation and 
differentiation of encapsulated neural stem cells. Biomaterials, 2009. 30(27): p. 4695-9. 
 
[180] Schaffer, A.E., et al., Nkx6 Transcription Factors and Ptf1a Function as Antagonistic 
Lineage Determinants in Multipotent Pancreatic Progenitors. Developmental Cell, 2010. 
18(6): p. 1022-1029. 
 
[181] Wu, J., Y. Fan, and E.S. Tzanakakis, Increased Culture Density Is Linked to Decelerated 
Proliferation, Prolonged G1 Phase, and Enhanced Propensity for Differentiation of Self-
 180 
Renewing Human Pluripotent Stem Cells. Stem Cells and Development, 2014. 24(7): p. 
892-903. 
 
[182] Stephan, S., W.E. Johnson, and S. Roberts, The influence of nutrient supply and cell 
density on the growth and survival of intervertebral disc cells in 3D culture. European 
cells & materials, 2011. 22: p. 97-108. 
 
[183] Nelson, C.M. and C.S. Chen, Cell-cell signaling by direct contact increases cell 
proliferation via a PI3K-dependent signal. FEBS letters, 2002. 514(2-3): p. 238-42. 
 
[184] Gray, D.S., et al., Engineering amount of cell-cell contact demonstrates biphasic 
proliferative regulation through RhoA and the actin cytoskeleton. Experimental Cell 
Research, 2008. 314(15): p. 2846-2854. 
 
[185] Tang, J., R. Peng, and J. Ding, The regulation of stem cell differentiation by cell-cell 
contact on micropatterned material surfaces. Biomaterials, 2010. 31(9): p. 2470-6. 
 
[186] Ludwig, T.E., et al., Feeder-independent culture of human embryonic stem cells. Nature 
methods, 2006. 3(8): p. 637-646. 
 
[187] Serra, M., et al., Improving expansion of pluripotent human embryonic stem cells in 
perfused bioreactors through oxygen control. Journal of Biotechnology, 2010. 148(4): p. 
208-215. 
 
[188] Chen, A.K.L., et al., Critical microcarrier properties affecting the expansion of 
undifferentiated human embryonic stem cells. Stem Cell Research, 2011. 7(2): p. 97-111. 
 
[189] Kehoe, D.E., et al., Scalable stirred-suspension bioreactor culture of human pluripotent 
stem cells. Tissue engineering. Part A, 2010. 16(2): p. 405-21. 
 
[190] Schulz, T.C., et al., A scalable system for production of functional pancreatic progenitors 
from human embryonic stem cells. Plos One, 2012. 7(5): p. e37004. 
 
[191] Abbasalizadeh, S., et al., Bioprocess development for mass production of size-controlled 
human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part 
C Methods, 2012. 18(11): p. 831-51. 
 
 181 
[192] Amit, M., et al., Dynamic suspension culture for scalable expansion of undifferentiated 
human pluripotent stem cells. Nat Protoc, 2011. 6(5): p. 572-9. 
 
[193] Chen, V.C., et al., Scalable GMP compliant suspension culture system for human ES cells. 
Stem Cell Res, 2012. 8(3): p. 388-402. 
 
[194] Krawetz, R., et al., Large-scale expansion of pluripotent human embryonic stem cells in 
stirred-suspension bioreactors. Tissue Eng Part C Methods, 2010. 16(4): p. 573-82. 
 
[195] Olmer, R., et al., Long term expansion of undifferentiated human iPS and ES cells in 
suspension culture using a defined medium. Stem Cell Res, 2010. 5(1): p. 51-64. 
 
[196] Olmer, R., et al., Suspension culture of human pluripotent stem cells in controlled, stirred 
bioreactors. Tissue Eng Part C Methods, 2012. 18(10): p. 772-84. 
 
[197] Singh, H., et al., Up-scaling single cell-inoculated suspension culture of human embryonic 
stem cells. Stem Cell Res, 2010. 4(3): p. 165-79. 
 
[198] Zweigerdt, R., et al., Scalable expansion of human pluripotent stem cells in suspension 
culture. Nat Protoc, 2011. 6(5): p. 689-700. 
 
[199] Wang, Y., L. Cheng, and S. Gerecht, Efficient and scalable expansion of human 
pluripotent stem cells under clinically compliant settings: a view in 2013. Ann Biomed 
Eng, 2014. 42(7): p. 1357-72. 
 
[200] Kurosawa, H., Application of Rho-associated protein kinase (ROCK) inhibitor to human 
pluripotent stem cells. J Biosci Bioeng, 2012. 114(6): p. 577-81. 
 
[201] Rodin, S., et al., Clonal culturing of human embryonic stem cells on laminin-521/E-
cadherin matrix in defined and xeno-free environment. Nat Commun, 2014. 5: p. 3195. 
 
[202] Nagaoka, M., et al., Culture of human pluripotent stem cells using completely defined 
conditions on a recombinant E-cadherin substratum. BMC Dev Biol, 2010. 10: p. 60. 
 
[203] Melkoumian, Z., et al., Synthetic peptide-acrylate surfaces for long-term self-renewal and 
cardiomyocyte differentiation of human embryonic stem cells. Nature Biotechnology, 
2010. 28(6): p. 606-U95. 
 182 
 
[204] Deng, Y., et al., Long-term self-renewal of human pluripotent stem cells on peptide-
decorated poly(OEGMA-co-HEMA) brushes under fully defined conditions. Acta 
biomaterialia, 2013. 9(11): p. 8840-50. 
 
[205] Higuchi, A., et al., Long-term xeno-free culture of human pluripotent stem cells on 
hydrogels with optimal elasticity. Scientific reports, 2015. 5: p. 18136. 
 
[206] Rowley, J.A., G. Madlambayan, and D.J. Mooney, Alginate hydrogels as synthetic 
extracellular matrix materials. Biomaterials, 1999. 20(1): p. 45-53. 
 
[207] Sinaga, E., et al., Increasing paracellular porosity by E-cadherin peptides: discovery of 
bulge and groove regions in the EC1-domain of E-cadherin. Pharm Res, 2002. 19(8): p. 
1170-9. 
 
[208] Chappuis-Flament, S., Multiple cadherin extracellular repeats mediate homophilic binding 
and adhesion. The Journal of Cell Biology, 2001. 154(1): p. 231-243. 
 
[209] Renaud-Young, M. and W.J. Gallin, In the first extracellular domain of E-cadherin, 
heterophilic interactions, but not the conserved His-Ala-Val motif, are required for 
adhesion. J Biol Chem, 2002. 277(42): p. 39609-16. 
 
[210] Kobayashi, N., et al., Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 
cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion. J 
Pharmacol Exp Ther, 2006. 317(1): p. 309-16. 
 
[211] Chen, T., et al., E-cadherin-mediated cell-cell contact is critical for induced pluripotent 
stem cell generation. Stem Cells, 2010. 28(8): p. 1315-25. 
 
[212] Boggon, T.J., et al., C-cadherin ectodomain structure and implications for cell adhesion 
mechanisms. Science, 2002. 296(5571): p. 1308-13. 
 
[213] Parisini, E., et al., The crystal structure of human E-cadherin domains 1 and 2, and 
comparison with other cadherins in the context of adhesion mechanism. Journal of 
molecular biology, 2007. 373(2): p. 401-11. 
 
 183 
[214] Kiptoo, P., et al., Enhancement of drug absorption through the blood-brain barrier and 
inhibition of intercellular tight junction resealing by E-cadherin peptides. Mol Pharm, 
2011. 8(1): p. 239-49. 
 
[215] Makagiansar, I.T., et al., Improving the selectivity of HAV-peptides in modulating E-
cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers. 
Pharm Res, 2001. 18(4): p. 446-53. 
 
[216] Noe, V., et al., Inhibition of adhesion and induction of epithelial cell invasion by HAV-
containing E-cadherin-specific peptides. J Cell Sci, 1999. 112 ( Pt 1): p. 127-35. 
 
[217] Bian, L.M., et al., Hydrogels that mimic developmentally relevant matrix and N-cadherin 
interactions enhance MSC chondrogenesis. Proceedings of the National Academy of 
Sciences of the United States of America, 2013. 110(25): p. 10117-10122. 
 
[218] Zhu, M.L., et al., Hydrogels functionalized with N-cadherin mimetic peptide enhance 
osteogenesis of hMSCs by emulating the osteogenic niche. Biomaterials, 2016. 77: p. 44-
52. 
 
[219] Melkoumian, Z., et al., Synthetic peptide-acrylate surfaces for long-term self-renewal and 
cardiomyocyte differentiation of human embryonic stem cells. Nature Biotechnology, 
2010. 28(6): p. 606-10. 
 
[220] Nagaoka, M., et al., Culture of human pluripotent stem cells using completely defined 
conditions on a recombinant E-cadherin substratum. Bmc Developmental Biology, 2010. 
10. 
 
[221] Rodin, S., et al., Clonal culturing of human embryonic stem cells on laminin-521/E-
cadherin matrix in defined and xeno-free environment. Nature communications, 2014. 5. 
 
[222] Sinaga, E., et al., Increasing paracellular porosity by E-cadherin peptides: discovery of 
bulge and groove regions in the EC1-domain of E-cadherin. Pharmaceutical research, 
2002. 19(8): p. 1170-9. 
 
[223] Kiptoo, P., et al., Enhancement of Drug Absorption through the Blood-Brain Barrier and 
Inhibition of Intercellular Tight Junction Resealing by E-Cadherin Peptides. Molecular 
Pharmaceutics, 2011. 8(1): p. 239-249. 
 
 184 
[224] Bardy, J., et al., Microcarrier suspension cultures for high-density expansion and 
differentiation of human pluripotent stem cells to neural progenitor cells. Tissue 
engineering. Part C, Methods, 2013. 19(2): p. 166-80. 
 
[225] Ting, S., et al., An intermittent rocking platform for integrated expansion and 
differentiation of human pluripotent stem cells to cardiomyocytes in suspended 
microcarrier cultures. Stem cell research, 2014. 13(2): p. 202-213. 
 
[226] Haque, A., et al., The effect of recombinant E-cadherin substratum on the differentiation of 
endoderm-derived hepatocyte-like cells from embryonic stem cells. Biomaterials, 2011. 
32(8): p. 2032-42. 
 
[227] D'Amour, K.A., et al., Production of pancreatic hormone-expressing endocrine cells from 
human embryonic stem cells. Nature Biotechnology, 2006. 24(11): p. 1392-401. 
 
[228] Lim, J.J., et al., Three-Step Method for Proliferation and Differentiation of Human 
Embryonic Stem Cell (hESC)-Derived Male Germ Cells. Plos One, 2014. 9(4). 
 
[229] Higuchi, A., et al., Physical Cues of Biomaterials Guide Stem Cell Differentiation Fate. 
Chemical Reviews, 2013. 113(5): p. 3297-3328. 
 
[230] Vegas, A.J., et al., Long-term glycemic control using polymer-encapsulated human stem 
cell-derived beta cells in immune-competent mice. Nature Medicine, 2016. 22(3): p. 306-
311. 
 
[231] Tannenbaum, S.E., et al., Derivation of xeno-free and GMP-grade human embryonic stem 
cells--platforms for future clinical applications. Plos One, 2012. 7(6): p. e35325. 
 
 
 
 
 
